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Constipation is one of the most common complications after a stroke. There 
are limited studies on constipation complicating stroke and limited evidence-




The overall aim of the study was to develop a feasible evidence-based bowel 
management programme to manage constipation in hospitalised patients with 
stroke. Phase 1 study identified the incidence and predictors of constipation. A 
bowel management programme was developed based on its findings. Phase 2 
study assessed the feasibility of the new bowel management programme. 
 
Methods 
Phase 1 was a prospective matched cohort study comparing stroke patients 
(n=55) with orthopaedic patients (n=55) admitted to a large tertiary hospital. 
Both cohorts were matched by age and gender. Incidence of new-onset 
constipation and predictors of constipation were determined during patients’ 
hospitalisation or within the first four weeks, whichever was earlier. Phase 2 
was a single quasi-experimental post-test study evaluating feasibility of the 
new bowel management programme in patients admitted for acute stroke 
(n=30). The bowel management programme consisted of an education 
protocol and three clinical practice protocols.  
xiii 
Results 
In Phase 1 study, the incidence of new-onset constipation was similarly high 
for both stroke (33%) and orthopaedic patients (27%; p=0.66). Seven stroke 
patients (39%) and four orthopaedic patients (27%) developed their first onset 
of constipation on Day 2 of admission. Mobility gains (RR 0.741, p<0.001) 
and the use of prophylactic laxatives (RR 0.331, p<0.01) were protective 
against constipation. Bedpan use (RR 2.058, p<0.05) and longer length of stay 
(RR 1.032, p<0.05) increased the risk of developing new-onset constipation.  
 
In Phase 2 study, the screening, recruitment and retention rates were 100%, 
66.7% and 100% respectively. All patients successfully received education on 
preventive measures of constipation on Day 1 of their admission. The 
adherence rates to the clinical protocols ranged from 70% to 100%. No 
patients experienced adverse effects from prophylactic laxatives. Five patients 
(16.7%) developed new-onset of constipation during the study.  
 
Conclusion 
New-onset constipation is a common complication of stroke and orthopaedic 
conditions during acute hospitalisation. Healthcare providers should actively 
assess, prevent and manage constipation in this group of hospitalised patients. 
The early occurrence of constipation calls for prompt preventive intervention 
which should be initiated as early as Day 1 of admission. The bowel 
management programme is feasible and safe. It has the potential to be further 
tested for effectiveness in a larger population of patients with acute stroke, 
utilising a randomised controlled study design. 
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Glossary of Terms 
 




The number of newly diagnosed cases of a disease or 
condition (Department of Health, 1999). 
Prevalence 
 
The number of existing cases of a disease or condition at a 
given point in time, expressed as a proportion of the 
population at risk (Portney & Watkins, 2009). 
Risk factor 
 
A risk factor is any attribute, characteristic or exposure of 
an individual that increases the likelihood of developing a 
disease or injury (WHO, 2014). 
Predictor 
 
A variable that is used to try to predict values of another 
variable known as an outcome variable (Field, 2013). 
Defecation A reflex act involving colon, rectum, anal sphincters and 
many striated muscles (diaphragm, abdominal and pelvic 
muscles) which produces a temporal release of anal 




Difficulty in swallowing. It can be further classified 
according to anatomical localisation of the dysphagia: 
Oropharyngeal dysphagia, esophageal dysphagia, 




Abnormality in speech, in particular language such as 
spontaneous speech, comprehension, repetition, naming 
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T5L2 Thoracic vertebra number 5, Lumber vertebra number 2 
S2-4 Sacral vertebra number 2 to 4 
p  The attained level of significance  
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r  Coefficient of determination (Correlation Coefficient’s) 
T  t-statistic (for Student’s/Welch’s t-test)  
χ2  Chi Squared, used in Bartlett’s Test of Sphericity  
n  Sample size  
M  Mean  
SD  Sample Standard Deviation  
CI Confidence Interval 
α Cronbach’s alpha 
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ICC Intraclass Correlation Coefficient  
% Percent 
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1.1 Thesis Statement 
Constipation is one of the most common medical complications for patients 
with acute stroke. There are limited evidence-based guidelines to guide 
clinical management. This thesis was based on a comprehensive study on the 
incidence, predictors and management of constipation in hospitalised patients 
with stroke. Several phases of study were undertaken.  
 
Firstly, a two-part literature review was conducted. Part 1 covered an 
overview of stroke and the physiology of colon and defecation in stroke. 
Studies on prevalence of constipation in the stroke population and its 
associated risk factors were further reviewed. Treatment strategies for 
constipation were discussed. Part 2 focused on a systematic review which 
critically appraises existing bowel management strategies for managing 
constipation in patients with stroke. With limited evidence, the systematic 
review suggests that structured bowel programmes and nurse-led interventions 
in bowel care have a significant effect in improving bowel evacuations.  
 
Secondly, a two-phase study was initiated. Phase 1 study investigated the 
incidence and predictors of constipation. Based on the findings of Phase 1 
study, another phase of study was dedicated to the development of a new 
bowel management programme framework. Phase 2 study evaluated the 
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feasibility of the new bowel management programme in patients admitted for 
acute stroke.  
 
1.2 Stroke and Its Impact on Health  
Stroke is a major health problem globally. Worldwide, there are 15 million 
people suffering from stroke each year (World Health Organisation [WHO], 
2011). In USA, the prevalence of stroke is seven million (Roger et al., 2011) 
and in Europe, the incidence varies from 101.1 to 239.3 per 100,000 men and 
63.0 to 158.7 per 100,000 women (The European Registers of Stroke, 2009). 
The incidence of stroke in Singapore is 1.8/1000 person years with a 
prevalence of 4.03% in residents above the age of 50 (Venketasubramanian & 
Chen, 2008). It is the fourth leading cause of death, accounting for 9% of all 
principal causes of death and one of the top ten conditions of hospitalisation 
(Ministry of Health [MOH], 2011). Stroke is a devastating disease as its 
impact often causes long term disability. After a stroke, almost one-third of the 
patients die and another one-third is left permanently disabled (WHO, 2011). 
Studies on outcomes post stroke found that many of the stroke patients are still 
dependent or with high mortality rate at six months after their stroke onset 
(Kelly-Hayes et al., 2003; Lee et al., 2009; Rundek & Sacco, 2004). Stroke is 
a multi-factorial disease with strong association of environmental factors, 
nutrition, alcohol, tobacco, education, lifestyle and behaviour (Galimanis, 
Mono, Arnold, Nedeltchev, & Mattle, 2009). With the high prevalence of risk 
factors such as hypertension, diabetes, hyperlipidemia, obesity and smoking, it 
is expected that the number of disabled stroke survivors will continue to rise 
over the years. The World Health Organisation (WHO) predicts that the 
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disability-adjusted life years lost to stroke will rise from 38 million in 1990 to 
51 million in 2020 (WHO, 2011). This places a huge economic burden on 
society and patients’ families. 
  
1.3 Complications of Stroke 
During the acute and rehabilitative phase of stroke management, there are 
numerous medical and rehabilitative issues that must be addressed to 
maximise patients’ functional recovery. Medical complications can often 
occur and limit a patient's functional recovery. After a stroke, patients are 
susceptible to many complications as they commonly have pre-existing co-
morbidities such as hypertension, diabetes, heart disease that increase their 
risk of medical complications. Medical complications can arise as a result of 
the stroke itself or due to ensure disabilities or immobility. If the 
complications are not recognised and addressed early, it can be of significant 
detriment, affecting patients’ length of stay (Saxena, Ng, Yong, Fong, & 
Gerald, 2006; Tan, Chong, Chua, Heng, & Chan, 2010), which significantly 
correlates with the cost of the hospital stay (Saxena, et al., 2006).  
 
1.4 Constipation in Stroke 
Constipation is one of the most common medical complications of acute 
stroke. The prevalence of constipation is 55% at acute stage within one month 
after first stroke in patients admitted to the Department of Neurology and 
Stroke Centre in a University Hospital (Su et al., 2009) and 30% after a period 
of median 36 weeks after stroke onset in patients undergoing motor 
rehabilitation in a Rehabilitation Center (Bracci et al., 2007).  Despite this 
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high prevalence, constipation is often a neglected subject of study as it is often 
viewed as a non-life threatening condition as compared to other complications 
such as pneumonia, deep vein thrombosis or urinary tract infections. There are 
many studies on complications after stroke but these studies often investigate a 
set of predefined medical complications which did not include constipation 
(Indredavik, Rohweder, Naalsund, & Lydersen, 2008; Kumar, Selim, & 
Caplan, 2010; Langhorne et al., 2000). 
 
1.4.1 Definition of Constipation 
There are various definitions of constipation. Some define it based on 
symptoms and others define constipation based on the interval between 
defecations or both. Some examples include ‘a motion every four days or less’ 
(Herz et al., 1996) and ‘fewer than three bowel movements a week or has 
bowel movements with stools that are hard, dry, and small, making them 
painful or difficult to pass’ (National Digestive Diseases Information 
Clearinghouse [NDDIC], 2013). Clinically, the diagnosis of constipation is 
commonly based on the basis of symptoms although there have been several 
other remarkable developments in the diagnosis testing of constipation e.g. 
using 1) radiographic studies: plain abdominal radiograph, barium enema, 
defecography, magnetic resonance imaging, endoscopy (flexible 
sigmoidoscopy or colonoscopy); 2) tests for colonic function: colonic transit 
study, wireless motility capsule, colonic manometry; 3) tests for anorectal 
function: high resolution manometry, anorectal manometry; balloon expulsion 
test, rectal barostat test (S. S. C. Rao & Meduri, 2011). Other than different 
definitions of constipation among researchers and clinicians, there is also 
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different perception on symptoms to be regarded as constipation between 
physicians and patients. Constipation is defined as defecation every 2 days or 
less and as hard stool alone by patients whereas doctors defined constipation 
as defecation every three or four days or less, sometimes in combination with 
hard stool (Herz, et al., 1996). In the clinical evaluation of constipation, a 
detailed medical, surgical, dietary and drug history are essential to facilitate 
diagnosis and treatment. Components of history that are useful in the 
evaluation of patient with constipation include description of premorbid bowel 
habits, onset of symptoms, duration of symptom, severity of symptoms, 
history of precipitating events, laxative use (type, number and frequency), 
dietary history (fiber and fluid intake) and family history of bowel function (S. 
S. C. Rao & Meduri, 2011). In recent years, consensus criteria such as the 
Rome criteria have been proposed by experts and widely recognised and used 
in research studies and clinically to improve the diagnosis for constipation.  
The Rome criteria is a system developed by Rome Foundation, an organisation 
of international effort, to classify functional gastrointestinal disorders and 
disorders of the digestive system in which symptoms cannot be explained by 
the presence of structural or tissue abnormality based on clinical symptoms. 
For the purpose of this study, constipation was defined based on symptoms 
adapted from Rome III criteria as: (1) having two or more of the following 
symptoms: straining, lumpy or hard stools, sensation of incomplete evacuation, 
sensation of anorectal obstruction/blockage, less than three defecations per 
week and requires manual maneuvers to facilitate defecations; (2) Loose stools 
were rarely present without the use of laxatives and (3) Insufficient criteria for 
irritable bowel syndrome (Rome Foundation. 2010).  
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1.4.2 Constipation and Its Impact on Quality of Life 
Constipation not only causes discomfort, it is also associated with significant 
morbidities such as acute confusion, nausea and vomiting, abdominal pain and 
subacute intestinal obstruction. These effects not only affect a person’s 
physical well-being but also psychological well being. This consequence has a 
great impact on a person’s quality of life and constitutes a poorer outcome 
(Camara-Lemarroy, Ibarra-Yruegas & Gongora-Rivera, 2014; Dennison et al., 
2005; Eoff, 2008; Norton, 2006). 
 
1.5 Management of Constipation 
Management of constipation in patients with stroke is often based on clinical 
experience and anecdotal evidence. Currently there are limited evidence-based 
guidelines to guide clinical management of constipation in the stroke 
population. Although there are various suggested conservative bowel 
management strategies for managing constipation in other populations such as 
older adults and at chronic stage of constipation, these strategies are used to 
manage existing bowel symptoms rather than prevent the development of new-
onset constipation. Conservative bowel management strategies are classified 
into non-pharmacology and pharmacology treatments. Non-pharmacological 
treatments include the use of diet modification, fluid intake, bowel training, 
abdominal massage and increased mobility (Ernst, 1999; Frizelle & Barclay, 
2007; Hsieh, 2005). The clinical efficacy of these treatments on stroke patients 
has yet to be demonstrated. The effect of pharmacological treatments such as 
fibre supplements and laxatives (bulk forming, stool softeners, stool lubricants, 
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stimulants and hyperosmotics) on constipation remained unclear (Coggrave, 
Norton & Cody, 2014; Johanson, 2007; Ramkumar & Rao, 2005).  
 
1.6 Problem Statement  
Although constipation is one of the most common complications for patients 
who have experienced stroke, studies of constipation are limited both for 
constipation complicating stroke as well as studies comparing stroke with 
other medical conditions. Several studies on post-stroke complications also did 
not include constipation as a medical complication (Davenport, Dennis, 
Wellwood, & Warlow, 1996; Langhorne et al., 2000) and studies that are 
available were conducted either retrospectively, using cross-sectional design 
or in chronic stroke patients (Bracci et al., 2007; Doshi, Say, Young, & 
Doraisamy, 2003; Otegbayo et al., 2006). There are also limited studies that 
investigate the incidence of early onset constipation, hence there is uncertainty 
regarding the predictors of new-onset constipation during acute hospitalisation, 
and management options for constipation in acute stroke patients are 
somewhat limited due to this lack of knowledge.  
 
1.7 Research Aims 
The overall aim of this study was to develop a feasible evidence-based bowel 
management programme to manage constipation in patients with stroke. 
Firstly, this study investigated and compared incidence of constipation in 
hospitalised patients with stroke with a non-stroke group (orthopaedic 
patients). Secondly, this study identified predictors of new-onset constipation 
in both groups. The predictors of interest included demographic data (age, 
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gender, ethnicity), medical conditions (stroke, orthopaedic), co-morbidities 
(diabetes, heart disease, previous stroke), clinical factors [Mini Mental State 
Examination (MMSE), length of hospital stay (LOS), use of prophylactic 
laxatives, dysphagia, dysphasia, mobility gains, oral fluid intake, bedpan use], 
laboratory parameters [white blood cell (WBC) count, potassium] and 
medications [antithrombotics, opioids, nonsteroidal anti-inflammatory drugs 
(NSAIDs), antacids]. A bowel management programme was developed based 
on the identified modifiable predictors. Lastly, the feasibility of the new bowel 
management programme was tested on patients admitted for acute stroke. 
 
Specifically, this study involved two phases which aimed to investigate 
constipation with a focus on the following: 
 
Phase 1: The incidence of new-onset constipation in stroke versus non-stroke 
and predictors of constipation during acute hospitalisation. The research 
questions were: 
 1. What is the incidence of new-onset constipation in patients 
with stroke compared to orthopaedic conditions during acute 
hospitalisation? 
 2. What are the predictors of new-onset constipation in patients 
with stroke and orthopaedic conditions during acute 
hospitalisation? 
 
Phase 2: The feasibility of a new bowel management programme. The 
research questions were: 
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Primary Outcomes 
1. What are the screening, recruitment and retention rates 
of the feasibility study? 
2. What are the adherence rates of the education and 
clinical protocols of the Bowel Management 
programme? 
3. What are the rates of patients developing adverse effects 
to the prophylactic laxatives? 
 
Secondary Outcome 
1. What is the incidence of constipation in hospitalised 
patients with stroke after the implementation of the new 
bowel management programme? 
 
1.8 Significance of the Study 
In a challenging and changing healthcare landscape and growing burden of 
chronic diseases, it is essential that patients continue to gain access to quality 
healthcare. This study addressed an important yet often neglected fundamental 
aspects of basic care. Currently, there are limited studies on constipation as a 
complication post-stroke. In addition, there is a lack of evidence-based 
practice guidelines to guide clinicians in the clinical management of 
constipation in stroke.  As such, it is critical that predictors of constipation are 
identified and evidence-based preventive strategies are implemented to reduce 
the incidence of constipation. Such evidence-based strategies in bowel care 
management could serve as a useful guide to clinicians and further enhance  
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the quality of care for patients with stroke, optimising stroke rehabilitation 
outcomes. 
 
1.9 Organisation of the Thesis 
This thesis is organised into seven chapters.  
 
Chapter 1 introduces stroke as a major health disease and burden of care. It 
identifies constipation as one of the most common medical complications after 
a stroke. This chapter further defines constipation, highlights the physical and 
psychological effect of constipation and outlines the research aims and 
significance of the study.  
 
Chapter 2 presents the literature review on stroke and its acute and 
rehabilitative management.  It discusses the physiology of colon and 
defecation, classification of constipation and the changes in mechanism of 
colonic motility and defecation after stroke. This chapter also presents the 
literature review on prevalence and risk factors associated with constipation in 
stroke. A detailed description of available studies and its methodological 
quality are discussed. The last section focuses on treatment strategies of 
constipation. 
 
Chapter 3 presents a systematic review on management strategies of 
constipation in stroke. It discusses the literature gap, findings and proposes 
recommendations for practice and future research. 
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Chapter 4 presents Phase 1 of the research study. A matched cohort study was 
undertaken to investigate the incidence of constipation in stroke versus non-
stroke (orthopaedic patients) and its predictors during acute hospitalisation. 
The findings of this Phase 1 study were used to develop a new bowel 
management programme.  
 
Chapter 5 outlines the process of developing the new bowel management 
programme framework. The bowel management framework encompasses 
several preventive strategies in reducing the incidence of constipation in 
patients with stroke. This chapter details the integration of the framework into 
practice using the Roger’s Diffusion of Innovation Theory. 
 
Chapter 6 presents Phase 2 of the research study. A feasibility study on bowel 
management programme was implemented and the process, implementation 
and safety outcomes of patients admitted with acute stroke were assessed.  
 
Chapter 7 concludes and summarises the significant research findings. It also 







Literature Review (Part 1) 
Stroke and Constipation 
 
2.1 Introduction 
This chapter provides a comprehensive overview of stroke, focusing on the 
types of stroke and its management in acute and rehabilitative phases. An 
overview of the physiology of colon and defecation and classification of 
constipation are included.  This chapter also highlights the changes in the 
mechanism of colonic motility and defecation after stroke and further presents 
a literature review, describing and evaluating existing studies on prevalence of 
constipation in the stroke population and its associated risk factors. Lastly, a 
range of treatment strategies for managing constipation are discussed. These 
strategies were further tested in the Phase 2 feasibility study. 
 
2.2 Acute Stroke  
Stroke or cerebrovascular accident (CVA) is a condition of rapid loss of brain 
function due to interrupted blood supply to the brain. It can be classified into 
ischemic or haemorrhagic stroke. Ischemic stroke results when blood flow to 
the brain is disrupted due to occlusion of the cerebral vessels e.g. thrombosis, 
arterial embolism or cessation of cerebral blood flow (Tang, Zheng, Yenari, & 
Li, 2006). A normal cerebral blood flow is approximately 50ml/100g brain 
tissue/min and cerebral dysfunction occurs when cerebral blood flow reduces 
to 16 to 20ml/100g/min, followed by cell death when the cerebral blood flow 
is less than 10ml/100g/min (Zheng, Lee, & Yenari, 2003). Haemorrhagic 
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stroke occurs when a weakened blood vessel e.g. aneurysms or arteriovenous 
malformations ruptures (American Heart Association, 2013). This causes 
blood to accumulate and compress the surrounding brain tissue. There are two 
types of haemorrhagic strokes: intracerebral (within the brain) haemorrhage 
and subarachnoid (surface of the brain) haemorrhage. Brain injury occurs as a 
result of the initial mass effect (haematoma and oedema) and effect of the 
mediators’ (blood, plasma products etc) responses causing secondary brain 
injury (Gustavo, Jawad, Mustapha, & Adnan, 2006). 
 
2.3  Types of Stroke 
In the acute phase, the general clinical presentation of patients with stroke 
includes sudden onset or a step-wise progression over hours or even days of 
weakness, urinary incontinence, paralysis, dysarthria, aphasia, confusion, 
swallowing problems and coma (Di Carlo et al., 2003). Depending on the 
focal lesion of the affected artery and collateral supplies, stroke presentations 
may be more specific (Longmore M, 2004).  
 
2.3.1 Cerebral Hemisphere Infarct 
Patients with cerebral hemisphere infarct usually present with contralateral 
hemiplegia (which is initially flaccid then becomes spastic), contralateral 






2.3.2 Brainstem Infarct 
Patients with brainstem infarct may present with quadriplegia, disturbances of 
gaze and vision and locked-in syndrome (aware but unable to respond) 
(Longmore M, 2004).  
 
2.3.3 Lacunar Infarct 
Lacunar infarcts which are small infarcts around basal ganglia, internal 
capsule, thalamus and pons may cause pure motor, pure sensory, mixed motor 
and sensory signs, or ataxia with intact cognition and consciousness. There are 
five classic lacunar syndromes established in the 1960s and 1970s: pure motor 
hemiparesis, pure sensory stroke, sensorimotor stroke, ataxic hemiparesis and 
clumsy-hand dysarthria ("Lacunar Stroke," 2013; Papamitsakis, 2013). 
 
2.3.3.1 Pure Motor Hemiparesis 
Pure motor hemiparesis is the most common of the lacunar syndromes. The 
location of infarct involves the corona radiata, internal capsule (especially the 
genu and posterior limb), pons or medullary pyramid. Patients present with 
hemiparesis or hemiplegia that typically affects the face, arm, or leg on one 
side without sensory signs, visual field defect, dysphasia or apractagnosia. 
Dysarthria, dysphagia and transient sensory symptoms may also present 
("Lacunar Stroke," 2013; Papamitsakis, 2013). 
 
2.3.3.2 Pure Sensory Stroke 
Pure sensory stroke is less common than pure motor hemiparesis. The location 
of infarct involves the contralateral thalamus, corona radiata, posterior limb of 
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internal capsule and midbrain. Patients experience symptoms which are 
limited to persistent or transient numbness, tingling, pain, burning, or another 
unpleasant sensation on one side of the body ("Lacunar Stroke," 2013; 
Papamitsakis, 2013) 
 
2.3.3.3 Sensorimotor Stroke 
This syndrome includes both sensory and motor deficits – hemiparesis with 
ipsilateral sensory impairment. The locations of infarct are in the thalamus and 
adjacent posterior internal capsule and lateral pons ("Lacunar Stroke," 2013; 
Papamitsakis, 2013). 
 
2.3.3.4 Ataxic Hemiparesis 
This syndrome is the second most frequent syndrome after pure motor 
hemiparesis. Areas involved are the posterior limb of the internal capsule, 
basis pontis and corona radiata, red nucleus, lentiform nucleus, Superior 
Cerebral Artery (SCA) infarcts and Anterior Cerebral Artery (ACA) infarcts. 
Patients experience a combination of cerebellar and motor symptoms, 
including weakness and clumsiness on the contralateral side of the body. It 
usually affects the leg more than the arms ("Lacunar Stroke," 2013; 
Papamitsakis, 2013). 
 
2.3.3.5 Clumsy-Hand Dysarthria 
This syndrome has been described as a variant of ataxic hemiparesis. It is 
characterised by the combination of facial weakness, severe dysarthria, with 
mild hand weakness and clumsiness, which often are more prominent when 
 16 
patient is writing. Mild weakness of the arm or leg may present. Areas of 
infarcts include basis pontis, anterior limb or genu of internal capsule, corona 
radiata, basal ganglia, thalamus and cerebral peduncle ("Lacunar Stroke," 
2013; Papamitsakis, 2013). 
 
2.4  Stroke Management 
The acute management of stroke includes the essential components of 
neurological diagnosis, intervention (medical or surgical) and general medical 
care which is best provided in a dedicated stroke unit. Organised stroke unit 
care is a form of care provided in hospital by healthcare professionals such as 
nurses, doctors and therapists who specialise in looking after patients with 
stroke. They work as a coordinated team. Patients who received inpatient care 
in an organised stroke unit, where care is provided by the multidisciplinary 
team that exclusively manages patients with stroke, were more likely to be 
alive, independent and living at home one year after their stroke as compared 
with alternative services ("Organised inpatient (stroke unit) care for stroke," 
2013). After an acute stroke event, a full medical assessment should be 
undertaken and multidisciplinary assessment considered for all patients in 
order to define the nature of the stroke event, the need for investigations, 
further management and rehabilitation (MOH, 2009). Neuroimaging plays an 
important role in the diagnosis and subsequent management of patients with 
stroke as the success and safety of pharmacologic and mechanical 
interventions depends on the precise diagnosis and exclusion of other 
pathologies (José & Steven, 2006). Patients with an acute stroke syndrome 
should have a computed tomography (CT) or magnetic resonance imaging 
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(MRI) brain scan as soon as possible, preferably within 24 hours. A 
swallowing assessment should also be undertaken as part of the clinical 
assessment (MOH, 2009). Potential stroke participants for the two study 
phases were recruited from a stroke unit in a tertiary hospital with their stroke 
diagnoses confirmed by a neurologist and CT scan / MRI. Swallowing 
assessment was conducted upon participants’ admission to the stroke unit as 
dysphagia is identified as one of the possible predictors of constipation. 
 
2.4.1 Management of Ischemic Stroke  
There are three main components in the medical treatment of patients with 
ischemic stroke (Uchino, 2011) :  
• Acute therapy and optimisation of neurological status 
This includes use of intravenous recombinant tissue plasminogen 
activator (TPA) if patient meets the criteria for treatment, support 
blood pressure, maintain euvolaemia, use of antiplatelet therapy, and 
control hyperthermia and hypervolaemia. 
• Etiological work-up for secondary prevention 
This includes finding of etiology (cardioembolic source, arterial 
stenosis) through further screening e.g brain imaging, vascular 
evaluation, cardiac evaluation, risk factor screening. 
• Prevention of neurological deterioration or medical complications such 





2.4.2 Management of Haemorrhagic stroke 
2.4.2.1 Intracranial Haemorrhage 
The medical management of patients with intracerebral haemorrhage involves 
the broad categories of emergent management (airway, breathing, circulation), 
prevention of haematoma growth (blood pressure management, correction of 
coagulopathies, haemostasis manipulation), treatment of secondary 
complications (increased intracranial pressure, herniation syndromes, cerebral 
oedema, seizures) and treatment of precipitating causes (aneurysms, 
arteriovenous malformations, hypertension) (Neeraj & Carhuapoma, 2006).  
 
2.4.2.2 Subarachnoid Haemorrhage  
The early critical care of patients with subarachnoid haemorrhage includes 1) 
routine care and monitoring (serial neurologic examinations and continuous 
cardiac, blood pressure, electrolytes, body weight, fluid balance and blood 
flow velocity monitoring); 2) use of anticonvulsants if appropriate; 3) use of 
steroids to reduce meningeal irritation and intra and postoperative oedema; 4) 
rebleeding and hydrocephalus monitoring and 5) prevention of late 
complications (venous thromboembolism, hyperglycaemia, fever, vasospasm 
etc) (Yekaterina & Michael, 2006). 
 
2.5 Stroke Rehabilitation  
After the acute stage, optimal outcome requires a more comprehensive and 
interdisciplinary approach, which includes rehabilitation management 
(Brandstater & Shutter, 2002). The aim of rehabilitation is to maximise 
function and minimise activity limitation and participation restriction resulting 
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from an underlying impairment such as stroke. Early and intensive 
rehabilitation predicts good functional outcomes. Increased rehabilitation 
intensity potentially benefits patients especially those with severe and 
moderate stroke (Hu, Hsu, Yip, Jeng, & Wang, 2010). Findings from a 7-site 
large study, Post-Stroke Rehabilitation Outcomes Project (PSROP), further 
confirms that starting therapy earlier is better than later and moving patients 
on to higher order and more difficult activities more quickly produces better 
patient outcomes (DeJong, Horn, Conroy, Nichols, & Healton, 2005). Early 
rehabilitation refers to the timing from stroke onset and/or timing from acute 
care to rehabilitation. Fewer days between onset of stroke symptoms and 
admission to inpatient rehabilitation is associated with better functional 
outcomes at discharge for patients with moderate and severe stroke. Also, 
fewer days between onset of stroke symptoms and admission to inpatient 
rehabilitation is associated with shorter rehabilitation length of stay for 
patients with moderately impaired stroke (Maulden, Gassaway, Horn, Smout, 
& DeJong, 2005). 
 
A successful rehabilitation programme requires not only patient’s active 
participation but also interdisciplinary effort and collaboration between health 
professionals. A rehabilitation team commonly includes physiatrists, nurses, 
physical therapists, occupational therapists, speech therapists, medical social 
workers, psychologists and music therapists. In this interdisciplinary model, 
each health professional evaluates the patient separately and discusses the 
findings with all members of the team. The team meets regularly in structured 
team meetings to discuss the patient’s progress, treatment goals and discharge 
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plans. The focus of rehabilitation is on functioning and reintegration into 
community rather than treatment of disease. The component of conventional 
structured inpatient rehabilitation consists of active physical, occupational and 
speech therapies. Physical modalities may be used in conjunction with the 
active therapies. Rehabilitative functional progress is often not an equal, 
steady or orderly progression. It is unique to each patient’s situation and 
condition (Kaplan, 2002). Progress can be irregular and varies among 
individuals and at various stages of an individual’s timeline. It is often slow at 
the beginning and slows again (plateau) towards the end of the rehabilitation 
stay (Kaplan, 2002). Functional progress during the rehabilitation period is 
often monitored by functional outcome scales. There are various functional 
outcome scales in use. Some scales are used across various conditions and 
some are specific to certain diseases or disorders. These scales are used as a 
tool to measure patients’ progress and rehabilitation outcomes in clinical 
settings as well as research studies. The most commonly used scale to measure 
functional outcomes in rehabilitation setting is the Functional Independence 
Measure (FIM). This scale is mentioned in detail in the methodology section 
of Phase 1 study.  
 
2.6 Physiology of Colon and Defecation  
The physiology of colon is complex and modulated through several separate 
systems such as neural, endocrine, and luminal factors (Winge, Rasmussen, & 
Werdelin, 2003). Generally, the neural system links the brain and spinal cord 
to the colonic mucosa and pelvic floor (Figure 2.1).  Any lesion affecting the 
brain or spinal cord can lead to bowel dysfunction.  
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Figure 2.1.  Neural System and Colon. 
Note. From http://rjh.goingeast.ca/wp-content/SCI4/NeurogenicBowel.html 
 
The neural control of the colon is separated into the intrinsic colonic nervous 
system and extrinsic colonic nervous system. The extrinsic colonic nervous 
system innervates the gut and acts as a modulator of visceral activity through 
sympathetic and parasympathetic functions (Winge, et al., 2003). The medial 
prefrontal area and anterior cingulate gyrus are the two high function areas in 
the central nervous system that regulate voluntary bowel function involving 
the timing and initiation of defecation. The sympathetic innervations from the 
thoracolumber outflow of T5L2 control the contraction of the internal anal 
sphincter which maintained bowel continence. The parasympathetic 
innervations from the vagus nerves in cranial division and pelvic nerves S2-4 
from sacral division are involved in innervating the gut and rectal wall. The 
striated muscles of the external anal sphincter which controls voluntary 
defecation is innervated by the branches of the pudendal nerves (from pelvic 
 22 
nerves) (Brading & Ramalingam, 2006). Table 2.1 summarises the function of 
the extrinsic colonic nervous system and central nervous system in the 
physiology of colon (Winge, et al., 2003). 
 
Table 2.1  
 
Summary of Neural Control in Physiology of Colon and Defecation 
Neural System Functions 
Central nervous system (CNS): 
• Medial prefrontal area 
• Anterior cingulate gyrus 
Regulate bowel function; involved in timing 
and initiation of defecation (effects over 
voluntary control being mediated through 
spinal pathways). 
Extrinsic colonic nervous system: 




- Inhibit effect of noradrenaline on 
enteric nerves 
- Contraction of the internal anal 
sphincter (resting anal pressure). 
• Cranial Division 
(Vagus nerves) 
Parasympathetic innervations: 
- Increases overall activity of the 
gastrointestinal tract (e.g increases 
peristalsis, local blood flow and 
intestinal secretion) 
- Innervates foregut and midgut 
(vagus nerves) 
- Innervates hindgut (descending, 
sigmoid & anorectum) (pelvic 
nerves) 
- Innervates tension and stretch in 
rectal wall and proximal part of anal 
canal (pelvic nerves). 
• Sacral Division 
(Pelvic nerves S2-4) 
Pudendal nerves (S2-4) - Innervates external 
anal sphincter, perianal area and perineum 
sensation. 
Note: Adapted from “Constipation in neurological diseases” by Winge et al., 2003, 
Journal of Neurology, Neurosurgery and Psychiatry, 74(1), p13. 
 
A successful bowel movement process involves the mechanisms of colonic 
motility and defecation. It requires the integration of smooth muscle activity 
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which is autonomically innervated, with skeletal muscle activity involving 
segmental nerves, complicated reflex patterns and suprasegmental control 
(Almy, 1954; Tortora & Derrickson, 2013). 
 
2.6.1 Mechanism of Colonic Motility 
Most phasic activity in the colon is non-propulsive. Colonic motility involves 
the propulsion of faeces from the right colon to the rectum by brief peristaltic 
rushes which occur infrequently at several times per day, usually 
stimulated .by the ingestion of food or fluids. This pathway is known as the 
“gastrocolic reflex” (Almy, 1954; Sembulingam & Sembulingam, 2007). 
Peristaltic rushes often start in the transverse colon as a tight ring, continuing 
as a long contraction wave ("Gastrointestinal function and disorders," 2004). 
Constipation develops when the gastrocolic reflex, with resulting mass 
peristalsis, is impaired. This can be due to either a diminished gastric motility 
or a marked reduction in the bulk of fluid, food or its residue, causing 
diminished vigour of peristalsis rushes in the lower bowel (Almy, 1954; Patton 
& Thibodeau, 2013). 
 
2.6.2 Mechanism of Defecation 
The emptying of the rectum or defecation is a complex act involving both 
voluntary and reflex mechanisms in colon, rectum, anal sphincters and many 
striated muscles (diaphragm, abdominal and pelvic muscles). The primary 
defecation reflex, as in a newborn child, is organised at the segmental level by 
a centre in sacral cord (Almy, 1954; Michael, 2011). This mechanism is 
simplified in Figure 2.2.  
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Distention of rectum by a stool
Relaxation of anal sphincter
and pelvic floor muscle
Drawing up of thighs
Contraction of muscles of the lower back, 
anterior abdominal wall and diaphragm
Forcible expiration with glottis closed
Defecation
 
Figure 2.2.  Primary Defecation Reflex. 
Note: Illustration adapted from “Physiological and psychological factors in the 
production of constipation” by Almy, 1954, Annals of the New York Academy of 
Sciences, 58, p398 & Fundamentals of Medical Physiology, p447, by Michael, 2011, 
New York: Thieme. 
 
 
As a person grows older, this reflex is influenced by more complex 
conditionings such as toilet training and social pressures which allow 
suppression of defecation according to various situations or places. The 
suppression of defecation involves the tightening of the anal sphincter 
followed by holding body in an erect position. Breathing becomes shallower 
with high diaphragm and rectum is conditioned to accommodate itself to the 
distended force. The urge to defecate is subsequently suppressed (Almy, 1954; 
Michael, 2011).          
                              
In a normal person at rest, continence is maintained by normal rectal sensation 
(empty rectum) and tonic contraction of the smooth internal anal sphincter 
muscle (due to its sympathetic fibres from the lumbar medulla through 
hypogastric nerves and the inferior mesenteric ganglion) (Figure 2.3). 
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Figure 2.3.  Defecation Reflex. 
Note: From "Gastrointestinal function and disorders," 2004, p7. 
 
 When stools fill the rectum, the recto-sigmoid region distends and releases 
awareness of the urge to defecate, an intrinsic defecation reflex and a strong 
spinal reflex. The strong spinal reflex relaxes the smooth muscles of the 
internal anal sphincter (due to its parasympathetic, cholinergic fibres in the 
pelvic splanchnic nerves [S2-S4]) and contraction of the striated muscles of the 
external anal sphincter (innervated by somatic fibres in the pudental nerve). 
This inhibits the reflex and cause receptive relaxation, which is the last 






At rest, the puborectalis muscle which wraps around the anorectum remains 
contracted, and the anorectal angle is maintained at between 80 and 110 
degrees (Figure 2.4 – Panel A).  
 
 
Figure 2.4. Sagittal View of the Anorectum at Rest (Panel A) and during 
Straining to Defecate (Panel B). 




During defecation, the pelvic floor muscles (including the puborectalis) relax, 
allowing the anorectal angle to straighten and increase by at least 15 degrees 
and the perineum descends by 1.0 to 3.5 cm (Figure 2.4 Panel B). The external 
anal sphincter also relaxes and reduces pressure on the anal canal (Lembo & 
Camilleri, 2003).  
 
2.7 Classification of Constipation 
Generally, constipation can be classified into three types: normal transit, 




2.7.1 Normal Transit (Functional) Constipation 
Normal transit constipation is the most common type of constipation. Most 
patients present with normal stool frequency. They often report symptoms of 
perceived difficulty in defecation or presence of hard stool. Patients usually 
respond well to therapy with dietary fiber alone or with the addition of an 
osmotic laxative (Lembo & Camilleri, 2003).  
 
2.7.2 Defecating Disorder 
 The three main causes of defecating disorder are  
1. Dysfunction at pelvic floor or sphincter 
2. Prolonged avoidance of pain associated with passage of large hard 
stool or anal fissure or haemorrhoids 
3. Dyssynergia of abdominal, rectoanal and pelvic floor muscles during 
defecation (Lembo & Camilleri, 2003).  
 
2.7.3 Slow Transit Constipation 
Slow transit constipation occurs most commonly in young women with 
infrequent bowel movements. It is mainly attributed to dietary and cultural 
factors, causing mildly delayed colon transit. Treatment with high fiber diet 
may help (Lembo & Camilleri, 2003).  
 
2.8  Mechanism of Colonic Motility and Defecation After Stroke 
Constipation in a person with a neurological disease is mainly attributable to 
an inability to relax the pelvic floor and inability to reduce the anorectal angle 
(Winge, et al., 2003). Specifically, a suggested cause of constipation in 
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patients with stroke has been the disruption of neural control of 
gastrointestinal (GI) motility due to interruption or alterations of information 
flow between the cortex and the GI system. This causes prolonged colonic 
transit time. Weakness of the abdominal and pelvic muscles may also occur 
depending on the location of the lesion (Duraski, Denby, & Clemens, 2009).  
 
Dehydration is also common after a stroke as a result of dysphagia (Crary, 
2013; Gordon, Hewer, & Wade, 1987). In patients with dysphagia, their 
colonic motility can be easily affected as lack of fluid intake and insufficient 
intake of diet and/or dietary fibre cause impairment of the gastrocolic reflexes. 
In patients with lesions affecting the pontine defecatory centre, there is a 
disruption of the sequencing of sympathetic and parasympathetic components 
of defecation (Ullman & Reding, 1996) which may cause disruption and 
impairment of coordination of the peristaltic wave, relaxation of the pelvic 
floor and external anal sphincter. These effects affect the mechanism of 
colonic motility and process of defecation which can lead to bowel 
dysfunctions such as constipation. 
 
In addition to the affected changes in the mechanism of colonic motility and 
defecation after a stroke, there are several other factors that could place 
patients at further risk of constipation. A literature review was conducted to 





2.9 Prevalence and Associated Risk Factors of Constipation in Stroke   
2.9.1 Aim and Methods 
This review aimed to explore the prevalence and risk factors associated with 
constipation in stroke.  
 
2.9.2 Description of Studies 
The search undertaken included studies published from January 1990 up to 
March 2011 across ten electronic databases revealed that there were few 
studies which investigated constipation as a complication post-stroke. Many 
studies focusing on medical complications did not include constipation as a 
complication. There were only four studies identified that included 
constipation as one of the main complications studied in post-stroke (Table 
2.2).  Three of these studies further explored the relationship of constipation 
with the site of neurological lesion, physical immobilisation, pharmacotherapy 




Table 2.2  
Description of Studies Included in the Literature Review 
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In a retrospective review of 140 stroke patients transferred to an inpatient 
rehabilitation setting in Singapore, constipation (complicating 22.9% of 
strokes) was found to be the most common symptom among other symptoms 
such as acute retention of urine (20.9%), urinary tract infections (14.3%), 
depression (9.3%) and limb pain (8.6%) (Doshi et al,  2003). 
 
In two other cross-sectional studies comparing stroke patients with non-stroke 
patients, constipation was also identified as the most dominant gastrointestinal 
(GI) symptom. In the first cross-sectional study, Otegbayo et al (2006) 
compared stroke patients (n=54) with volunteers and inpatients with non-
neurological / non-GI disorders (n=46) admitted over an 18-month period in a 
medical ward in Nigeria. The most dominant GI symptom was constipation 
(25.9%), followed by masticatory difficulty (20.4%). The second cross- 
sectional study by Bracci et al (2007) studied 90 hemiplegic and 81 
orthopaedic patients following stroke / orthopaedic injuries after a period of 
physical immobilisation of at least three months in a rehabilitation centre, Italy. 
Constipation was found to be significantly and independently associated with 
hemiplegic with an increased risk of straining at stool (OR: 4.33), reduced call 
to evacuate (OR: 4.13), sensation of incomplete evacuation (OR: 3.69) and use 
of laxatives (OR: 3.75). A fourth study, which was a prospective cohort study 
by Su et al (2010), studied 154 patients admitted with their first stroke at the 
Department of Neurology and Stroke Centre in China. They reported a 
cumulative incidence of new-onset constipation of 55.2% at 4 weeks post-
stroke.   
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Overall, there was no significant difference in the gastrointestinal symptom in 
either gender  (Bracci et al., 2007; Otegbayo et al., 2006; Su et al., 2009),  site 
(Bracci et al., 2007; Otegbayo et al., 2006) or type of stroke (Otegbayo et al., 
2006; Su et al., 2009), except that constipation and incomplete evacuation 
were more common in ischemic stroke (Otegbayo et al., 2006).  A positive 
association was also found between constipation and physical dependence, use 
of bedpan for defecation (Su et al., 2009) and use of nitrates and 
antithrombotics (Bracci et al., 2007). In addition, patients with constipation at 
four weeks and presenting with moderate stroke severity (NIHSS 4 to 11) at 
baseline had poorer outcomes at 12 weeks (Su et al., 2009). 
 
2.9.3 Methodological Quality of Studies & Discussion 
There was a wide variation in the prevalence studies due to differences in 
study designs, patient cohort & selection, definition of constipation, length of 
inpatient stay and duration of follow-up. The retrospective study by Doshi et 
al (2003) had great limitations as their data were dependent on accurate 
documentation. One of the cross-sectional studies (Bracci et al., 2007) 
interviewed subjects ≥ 3 months post-stroke thus giving rise to high 
possibilities of recall bias. Two studies (Otegbayo et al., 2006; Su et al., 2009) 
were conducted in an acute setting rather than in rehabilitation setting 
therefore the data may not be a true reflection of constipation rate post-stroke 
due to short period of follow-up. All studies did not use a standardised 
definition of constipation and one relied on patients’ self-definition. The 
definitions included Rome II criteria (Bracci et al., 2007; Su et al., 2009), 
bowels not open ≥  2 days and/or using suppositories or enema, on regular oral 
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laxatives (Doshi et al., 2003) and patients’ self report (Otegbayo et al., 2006).  
In addition, two of the studies (Doshi et al., 2003; Otegbayo et al., 2006) did 
not exclude patients with pre-existing constipation.  
 
2.9.4 Limitations of the Review 
Studies in this review are limited and have small sample sizes so 
generalisability has to be interpreted with caution. The restriction of these 
reviews to English language may have resulted in language bias with 
potentially relevant studies published in other languages being missed.  
 
2.9.5 Conclusion of the Review 
Constipation remains as one of the most common complications post-stroke. 
Despite its high prevalence, studies on constipation as a post-stroke 
complication remain limited. There were no associations between constipation 
and gender of patients, site or types of stroke. Constipation was associated 
with physical dependence and use of bedpan for defecation. Future studies 
should adopt a more robust study design, recruiting a larger sample size, 
utilising a standardised definition of constipation and investigating 
constipation at acute and post-acute stages of stroke. 
 
2.10 Overview of Bowel Management Strategies 
There is a range of treatment strategies for managing constipation and 
conservative bowel management remains as the most common and preferred 
first-line preventive options. These measures can be classified into non-
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pharmacological and pharmacological treatments, and was further tested in the 
Phase 2 feasibility study. 
 
2.10.1 Non-Pharmacological Measures  
2.10.1.1 Oral Fluids 
Fluids are an important physiological requirement to sustain life in humans. 
Lack of fluid intake is associated with many medical complications, including 
and of particular relevance to this study, constipation. Fluid requirements may 
vary from person to person. It also depends on a variety of factors. A normal 
healthy adult is usually encouraged to consume about 1.5 to 2L of fluids per 
day. During an acute illness, more or less fluids may be required. Oral fluid 
intake is prompted by sense of thirst, which is a natural survival mechanism in 
humans. If a person’s sense of thirst is attenuated as in the case of an elderly 
person, the risk of inadequate oral fluid is high (Kenney & Chiu, 2001). Thirst 
results from a complex interaction of drinking behaviour (non-homeostatic 
control) and dehydration (homeostatic control) (Figure 2.5) (Kenney & Chiu, 
2001). In non-homeostatic controls, psychological and environmental factors 
such as drinking in association with meals, availability of the beverage and 
preferences of beverage influence the stimulation of thirsts. In homeostatic 
control, physiological thirst results from dehydration and is stimulated by the 
mechanisms of cellular dehydration (increases in cellular tonicity) and 





Figure 2.5.  Homeostatic Versus Non-Homeostatic Control of Thirst in Humans. 
Note: From “Influence of age on thirst and fluid intake” by Kenney & Chiu, 2001, 
Medicine and Science in Sports and Exercise, 33(9), Figure 1, p1525. 
 
Cellullar dehydration, which is an important thirst stimulus in humans, is 
sensed by osmoreceptors in the central nervous system. In cellular dehydration, 
there is an increase in the effective osmotic pressure of the plasma which 
stimulates drinking. Central osmoreceptors sense the level of dehydration and 
feedback to the hypothalamus to maintain homeostasis (left portion of Figure 
2.6). It is a single feedback loop with correction proceeding until the 




Figure 2.6.  Simplified Model for Homeostatic Control of Thirst. 
Note: From “Influence of age on thirst and fluid intake” by Kenney & Chiu, 2001, 
Medicine and Science in Sports and Exercise, 33(9), Figure 2, p1525. 
 
Extracellular dehydration is monitored by baroreceptors in the vascular 
compartment and is a more complex process (right portion of Figure 2.6). The 
process involves both baroreceptors in large vessels (activated with decrease 
in blood volume) and renal mechanisms (renin-angiotensin-aldosterone system 
elicited in decreased renal perfusion and other stimuli). Hypovolaemic thirst is 
a double-loop negative feedback system in which water alone cannot correct 
the plasma volume deficit. As such, water intake is not maintained despite the 
presence of a hypovolaemic stimulus. Plasma volume is expanded with 
sodium intake to avoid excess osmotic dilution. 
 
Other than the elderly group, stroke patients are another high risk group with 
inadequate fluid intake. In a study of oral fluid intake patterns of over a period 
of three hospitalisation days, stroke patients were noticed to be drinking less 
than the minimum standard of 1500 ml per day regardless of whether they 
were receiving thin fluids (range of 158 to 637 ml below standard) or 
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thickened fluids (range of 317 to 806 ml below standard) (McGrail & 
Kelchner, 2012). This lack of fluid intake can be attributed to various factors: 
dysphagia, dissatisfaction with thickened liquids in dysphagic patients, limited 
access to fluids in patients with impaired upper limb function and the 
psychological fear of the need to go to the toilet in mobility impaired patients. 
Maintaining good hydration is one of the immediate recommended 
management measures following acute stroke (MOH, 2009). However, no 
amount of required fluids is specified. There are recommended strategies to 
promote oral fluid intake and these strategies were incorporated into the Phase 
2 feasibility study. These included encouraging patients to consume oral fluids, 
reminding them to ingest fluid during and between each meal, and providing 
them easy access to fluids. Patients were further encouraged to consume oral 
fluids during the day and limit to small amounts in the evening as a measure to 




Bedpan is a device used as an alternative bathroom solution for defecation. It 
was first patented in 1877 in USA ("Improvement in bed-pans," 1877) and 
since then bedpans have been widely used in hospitals and residential homes. 
It is regularly used in inpatient units where patients are confined to bed due to 
impaired mobility or acute illness. Patients with stroke often present with 
symptoms of upper or/and lower limb weakness. These symptoms limit their 
mobility status and leads to high tendency of them to use a bedpan for both 
urination (females) and/or defecation (both sexes). It may also be a preferred 
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choice of the nursing staff as it is more convenient than bringing patients to 
the toilet. Other alternatives to using bedpans for patients with limited 
mobility include bedside commode or transferring patients to the bathroom 
using commode. Transferring patients from bed to commode requires some 
assessment of task, patient load, environment and staff’s personal capability. 
The transfer may or may not require the aid of mechanical or non-mechanical 
aids. During transfers, there may be an element of injury risk to staff and 
patients. Various programmes on safe patient handling are being developed 
and tested. Most demonstrated good safety outcomes in staff and patients 
(Letourneau, 2013). One of the more established programmes is the Veterans 
Health Administration Patient Safety Centre project ‘Safe Patient Handling 
and Movement (Nelson et al., 2003). The programme has six elements: 
ergonomic assessment protocols, patient handling assessment criteria and 
decision algorithms, peer leader role, patient handling and moving equipment, 
after action reviews and a no manual lift policy.  
 
Two of the six elements involved patient assessments:  
1) Patient Assessment Criteria guide staff in evaluating patient characteristics 
that affect decisions about equipment and techniques for safe handling and 
moving patients. It involves assessing patients’ characteristics such as their 
ability to provide assistance with weight-bearing capability and upper body 
strength, ability to comprehend instructions and cooperate with the staff and 




2) Algorithms for Patient Handling and Movement to standardise processes. 
This guides the decision on type of equipment to use and number of staff 
necessary to perform the transfer activity safely.  
 
The avoidance of bedpan strategy in Phase 2 feasibility study will implement 
the alternatives of using bedside commode or transferring patients to the 
bathroom using commode. A simple patient assessment checklist was 
developed to guide the staff’s decision making which included assessing 
patients’ medical stability and fitness to be moved out of bed, and patients’ 
ability to transfer safely with or without assistance (Appendix 12). 
 
2.10.2 Pharmacological Treatments 
There are several options to categorise laxatives. It can be classified according 
to chemical class (sugars and sugar alcohols, non-absorbable polysaccharides, 
bile acids, hydroxylated fatty acids, inorganic salts, molecules with anthranoid 
structure, derivatives of diphenylmethane), site of action (small intestine, large 
intestine, whole intestinal tract), mode of action (bulk forming agents, 
lubricants, osmotics, stimulants / irritants), intensity of effect (laxative, 
cathartic, purgative), site of action (small intestine, large intestine, whole 
intestinal tract), or origin (natural, synthetic) (Capasso & Gaginella, 1997). 
The most common way to categorise laxatives is using the mode of action 
although most laxatives work by multiple modes of action. For the purpose of 





2.10.2.1 Bulk-Forming Agents  
Bulk-forming laxatives can be both natural and semisynthetic polysaccharides 
and celluloses derived from grains, seed husks or kelp, psyllium, 
methylcellulose and carboxymethylcellulose and synthetic resin polycarbophil. 
These laxatives are not absorbed systematically. The intestinal bacterial flora 
converts the polysaccharides in these drugs to osmotically active metabolites, 
which then draw water into the intestine (Alvan et al., 2008). The increased 
stool mass and water content promotes peristalsis and bowel movement. 
Psyllium or Ispaghula husk is a commonly used bulk-forming laxative. It 
comes in powder form. Possible adverse effects include abdominal gas, 
fullness, intestinal obstruction and faecal impaction (with concurrent 
inadequate fluid intake), oesophageal obstruction and severe diarrhoea (Berry 
et al., 2009). 
 
2.10.2.2. Osmotic Laxatives 
Osmotic laxatives can derived from carbohydrates (glycerin, lactulose) or 
saline compounds (magnesium salts, sodium biphosphate, sodium phosphate, 
polyethylene glycol [PEG], and electrolytes) (Alvan et al., 2008; Berry et al., 
2009). Osmotic laxatives act by drawing water into the intestine. The fluid 
accumulates and distends the bowel which promotes peristalsis and 
subsequent bowel movement. Most osmotic laxatives are formulated for oral 
use except glycerine and sodium phosphate which are formulated as 
suppository and enema for rectal use. The most commonly used osmotic 
laxatives in local settings include lactulose, sodium phosphate and PEG. 
Adverse effects of most osmotic laxatives include fluid and electrolyte 
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imbalances (Berry et al., 2009). The range of osmotic laxatives is discussed 
specifically in the following: 
 
Glycerin 
Glycerin is administered as a suppository directly into the colon. It is not 




Lactulose is taken orally in liquid form. It is minimally absorbed in the GI 
tract and distributed only in the intestine where it is metabolised by bacteria 
and excreted in stool. Possible adverse effects include abdominal distension, 
gas, cramps, nausea, vomiting, diarrhoea, hypokalaemia, hypovolaemia and 
increased blood glucose level. 
 
Saline Compounds 
Saline compounds are administered orally or as an enema. It is indicated when 
prompt and complete bowel evacuations is needed. The presence of anions and 
cations in these compounds act by retaining water in order to maintain an 
osmotic equilibrium, thus indirectly stimulate peristalsis. Some of the ions are 
absorbed and excreted in urine. The unabsorbed ions are excreted in stool. The 
osmotic effect exerted by the salts determines the laxative action.  Some salt 
combinations produce greater laxative effect compared to others (Table 2.3) 
(Capasso & Gaginella, 1997). The most commonly used saline compound 
laxative in local settings is sodium phosphate. It is used as an enema for quick 
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relief of bowels. When compared with other laxatives it is least used on 
elderly persons as they are not able to retain the liquid form for considerable 
time for it to take effect. Possible adverse effects include hypernatremia, 
hypermagnesia, hyperphosphatemia, hypocalcaemia, cardiac arrhythmias and 
shock.  
 
Table 2.3  
 
Relative Effectiveness of Inorganic Salts as Osmotic Laxatives 
 
Note: From Laxatives, Figure 9, p43, by Capasso & Gaginella, 1997, Milan: Springer. 
 
Polyethylene glycol (PEG) 
PEG is non-absorbable and as such, it does not alter electrolyte balance. It 
comes in powder form for oral use. Some adverse effects include nausea, 
explosive diarrhoea and bloating. 
 
2.10.2.3 Stimulant Laxatives 
Stimulant laxatives consist of diphenylmethanes derivatives (bisacodyl) and 
anthraquinones (senna) (Alvan et al., 2008). Bisacodyl can be administered via 
oral or rectal route. Senna is administered orally. Stimulant laxatives promote 
peristalsis by irritating the intestinal mucosa or stimulating nerve endings of 
the intestinal smooth muscle. Possible adverse effects include weakness, 
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nausea, abdominal cramps, mild inflammation of the rectum and anus and 
urine discoloration (senna) (Berry et al., 2009). 
 
2.10.2.4 Stool Softeners 
Stool softeners come in preparation of calcium, potassium and sodium salts of 
docusate (Alvan et al., 2008). These laxatives are administered orally and are 
absorbed and excreted through bile in stool. Stool softeners emulsify the fat 
and water components of stool in small and large intestines making it softer 
and easier to eliminate. Stool softeners also stimulate electrolyte and fluid 
secretion from intestinal mucosal cells. Adverse effects although rare, may 
include bitter taste, diarrhoea, throat irritation and mild, transient abdominal 
cramping (Berry et al., 2009).  
 
2.10.3 Conclusion 
In clinical settings, there is a lack of evidence-based guidelines in managing 
constipation in patients with stroke. The clinical efficacy of the suggested 
range of pharmacological and non-pharmacological treatment modalities on 
stroke patients presented in this chapter remains unclear. As such, there is a 
need to conduct a systematic review to identify effective evidence-based 
management strategies to manage constipation in patients with stroke. This 








Literature Review (Part 2) 
A Systematic Review on Management Strategies of Constipation in Stroke 
 
3.1 Introduction 
This chapter focuses on a systematic review which was conducted to identify 
effective strategies in the management of constipation in stroke. This 
systematic review provides a summary of medical literature that uses explicit 
methods to perform a comprehensive literature search, followed by a critical 
appraisal of individual studies. Literature gaps and recommendations for 
practice and future research are discussed in this chapter. 
 
3.2 Rationale for Conducting the Review  
There is no systematic review on management of constipation in the stroke 
population to guide clinical practice. The constipation management strategies 
in clinical settings are typically based on experience and anecdotal evidence. 
The available systematic reviews were either focused on chronic constipation 
in older adults (Joanna Briggs Institute [JBI], 2008b) or on adults with central 
neurological diseases (Coggrave, Wiesel, & Norton, 2006). A Best Practice 
Information Sheet (BPIS) on managing constipation was developed based on a 
systematic review and best practice guideline to provide an evidence-based 
information sheet for health professionals (JBI, 2008a; JBI, 2008b). This BPIS 
addressed traditional therapies for managing chronic constipation in older 
adults and major types of intervention which include: osmotic laxatives, 
bulking agents, wetting agents, stimulant laxatives and others. As there was 
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limited research evidence available, a summary of treatment options on 
different expert opinion was suggested. The other review by Coggrave et al 
(2006) was based on randomised or quasi-randomised trials evaluating 
conservative or surgical measures and specific therapies for treatment of 
constipation in neurological diseases that indirectly affect bowel dysfunction. 
The review was not able to provide any recommendations specifically for 
stroke patients due to the different interventions.  
 
3.3 Review Aim 
To identify the effectiveness of bowel management strategies for managing 
constipation in adults with stroke.  
 
3.4 Review Question 
What is the effectiveness of contemporary bowel management strategies for 
constipation in stroke patients for promoting bowel evacuation? 
 
3.5 Criteria for Considering Studies for this Review 
3.5.1 Types of Participants 
This review included studies of people of 18 years of age or more with a 
clinical diagnosis of stroke. 
 
3.5.2 Types of Interventions 
This review included studies that evaluated any types of bowel management 
strategies. Strategies included, but was not limited to, dietary and fluid 
manipulation, oral and rectal medications (bulking agent, osmotic laxatives, 
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stool softeners, stimulant laxatives), bowel management programmes and 
assistive techniques (digital stimulation, manual evacuation and abdominal 
massage). 
 
3.5.3 Type of Comparisons 
In comparing management strategies, the following comparisons were made 
where possible: 
• A particular treatment versus placebo 
• A particular treatment versus usual care  
• A combination of treatments versus a particular treatment. 
 
3.5.4 Types of Outcomes 
This review considered studies that included bowel evacuation as the outcome 
measure. 
 
3.5.5 Types of Studies 
This review considered any Randomised Controlled Trials (RCTs); in the 
absence of RCTs, other research designs such as non-RCTs, before and after 
studies, cohort, case control and observational studies were considered for 
inclusion to enable the identification of current best evidence regarding the 
effect of management strategies for constipation in adults with stroke. 
 
3.6 Search Strategy 
This review included studies published and unpublished in English, conducted 
from January 1990 up to March 2011. The search was dated back to Year 
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1990 as the initial search of studies from Year 2000 to 2011 yielded limited 
results.   A three-step search strategy was utilised. An initial limited search of 
MEDLINE and CINAHL was undertaken, followed by analysis of the text 
words contained in the title and abstract, and of the index terms used to 
describe the article. A second search using all identified keywords and index 
terms was undertaken across all included electronic databases.  Databases 
searched were CINAHL, Medline, SCOPUS, ScienceDirect, Web of Science, 
Mosby's Nursing Consult, Expanded Academic ASAP, Dissertation Abstracts 
International and Mednar. Thirdly, the reference lists of all identified reports 
and articles were searched for additional studies. Initial keywords used were: 
stroke, cerebrovascular accident, CVA, constipation, fec* impaction, bowel 
management, bowel care, bowel training and bowel program*. An initial 
review involved screening the titles and abstracts of studies identified from the 
literature search. Subsequently, reviewers examined full-text articles to 
determine eligibility and methodological quality. 
 
3.7 Methods of the Review 
3.7.1 Screening 
All studies derived from the electronic search strategy were screened by the 
PhD candidate and hand searched by titles and abstracts. Reports of potentially 







3.7.2 Assessment of Methodological Quality 
The eligibility and methodological quality of the full text articles were 
assessed by two reviewers (PhD candidate and A/Prof Charmaine Childs) 
independently prior to inclusion in the review using standardised critical 
appraisal instruments from the Joanna Briggs Institute-Meta Analysis of 
Statistics Assessment and Review Instrument (JBI-MAStARI) (Appendix 1). 
Any disagreements that arose between the reviewers were resolved through 
discussion. 
 
3.7.3 Data Extraction 
Data was extracted from included studies using a standardised data extraction 
tool from JBI-MAStARI (Appendix 2). The data extracted included specific 
details about the interventions, populations, study methods and outcomes of 
significance to the review question and specific objectives. 
 
3.7.4 Data Synthesis 
There was heterogeneity in the types of intervention and outcome measures 
where statistical pooling of the findings was not appropriate. Hence, the 
studies were grouped according to types of intervention where possible and 
the findings were presented in narrative form. 
 
3.8 Level of Evidence 
Studies included in this review were assigned a level of evidence according to 





3.9.1 Description of Studies 
Two thousand five hundred and thirty-three articles were identified and 
reviewed according to the preset inclusion and exclusion criteria. Two 
thousand five hundred and twenty-five articles were deemed not relevant at 
this screening stage based on the title and abstract. Five articles were in 
languages other than English: Chinese (Huang & Li, 2002; Wang, Wang, 
Kong, Wang, & Cui, 2008), Korean (Jeon & Jung, 2005; Lee & Shon, 2006) 
and Japanese (Ikari et al., 1993) (Appendix 4). Three studies met the eligibility 
criteria and full-text articles were retrieved and assessed for methodological 















Figure 3.1. Summary of Literature Search. 
Articles excluded 
5 
- Not in English 
Studies meeting eligibility 
criteria and assessed for 
methodological quality 
3 
References located following 
searches 
2533 Excluded after review of abstract 
and title 
2525 
- Not for stroke patients  
- Not on constipation 
- Not an intervention study Articles assessed in detail 
against eligibility criteria 
8 




1 Non-RCT  
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The eligibility and methodological quality of the full text articles were 
assessed by two reviewers (PhD candidate and A/Prof Charmaine Childs) 
before inclusion in the review. Any disagreements arising between the 
reviewers were resolved through discussion. As there were differences in the 
types of intervention and outcome measures, statistical pooling of the findings 
was not appropriate. The findings were therefore presented in narrative form. 
Due to the small number of studies, all three studies were included in this 
review (Table 3.1) and assigned a level of evidence according to JBI Level of 




Table 3.1  
 
Description of Studies Included in the Systematic Review 
Authors & 
Year 
Study Design & 
Setting 









































Group 1 - morning bowel training and 
mandatory suppository. 
 
Group 2 - morning bowel training and 
optional suppository. 
 
Group 3 - evening bowel training and 
mandatory suppository. 
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however, patients in 
the control group 
who achieved 
regularity took less 
time to do it.  
Patients with right-
side hemiplegia 
(t=2.21, p<0.05) and 
less mobility (r=0.31) 
required more time to 
establish their bowel 
regularity. 
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73 stroke patients 
received intervention 
consisted of 
- a single (once only) 
assessment 
by a nurse  
- provision of booklet 
and 
- diagnostic summary 
and treatment 
recommendations sent 
to patient’s GP, and 
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Percentage of bowel 
movements (BMs) 
per week graded as 
"normal" by patients 
in a prospective one 
week stool diary was 
significantly higher 
in intervention versus 
control group at 6 
months (72% versus 
55%; p=0.027), as 
was mean number of 
BMs per week.  
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3.9.2 Clinical and Geographical Settings 
The three studies included in the review were conducted in London (Harari, 
Norton, Lockwood, & Swift, 2004) and Midwestern United States 
(Munchiando & Kendall, 1993; Venn, Taft, Carpentier, & Applebaugh, 1992). 
Two studies were carried out in a single centre [rehabilitation unit in either a 
general hospital (Munchiando & Kendall, 1993) or a community hospital 
(Venn et al., 1992)] and one was carried out in multi-centres [three 
rehabilitation units and local communities (Harari et al., 2004)]. 
 
3.9.3 Published Year 
The studies were published  in 1992 (Venn et al., 1992), 1993 (Munchiando & 
Kendall, 1993) and 2004 (Harari et al., 2004). 
 
3.9.4 Study Design 
Two of the studies were RCTs (Harari et al., 2004; Venn et al., 1992) and one 
was a non-randomised trial (Munchiando & Kendall, 1993). 
 
3.9.5 Sample Sizes 
Sample sizes ranged from 48 (Munchiando & Kendall, 1993),  58 (Venn et al., 
1992) and 146 participants (Harari et al., 2004).  
 
3.9.6 Types of Participants 
All participants had a diagnosis of stroke. Their mean age ranged from 69.5 
years (Munchiando & Kendall, 1993) to 72 years (Harari et al., 2004; Venn et 
al., 1992). Two studies recruited patients who were admitted with newly-
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diagnosed stroke (Munchiando & Kendall, 1993; Venn et al., 1992) and one 
study recruited patients with stroke onset beyond one month and within four 
years (Harari et al., 2004) (mean time of 21 to 25 months post-stroke). One 
study included subjects of white and black African-Caribbean population and 
with additional inclusion criteria of defined bowel dysfunction (Harari et al., 
2004). The two other studies did not provide any description of their subjects’ 
race and without the inclusion criteria of defined bowel dysfunction 
(Munchiando & Kendall, 1993; Venn et al., 1992). 
 
3.9.7 Types of Interventions 
One of the three studies compared a nurse-led intervention with routine care 
(Harari et al., 2004). The intervention consisted of a one-off assessment 
(history and rectal examination) by a nurse followed by targeted patient/carer 
education with booklet.  The booklet contained generic education with 
instructions on regular toilet habits, pelvic floor and sphincter-strengthening 
exercises, suppository insertion, and laxative and loperamide dose titration. 
The diagnostic summary and treatment recommendations according to a pre-
established protocol were further sent to patient’s general practitioner, and 
ward physician if patient is in hospital. Two of the studies compared a bowel 
programme versus another bowel programme. The first study compared an 
existing bowel programme that incorporated either every other day use of 
digital stimulation as part of the bowel care or daily digital stimulation. The 
existing bowel programme required both groups of patients to be placed on the 
toilet or commode the same time each day. Interventions progressed from 
digital stimulation, insertion of suppository followed by fleet enema and 
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finally use of soapsuds enema (Munchiando & Kendall, 1993). The other 
study compared four bowel programmes based on the timing of bowel care 
and suppository use: 1) morning bowel training, mandatory suppository; 2) 
morning bowel training, optional suppository if the patient had a bowel 
movement within the previous four hours; 3) evening bowel training, 
mandatory suppository; 4) evening bowel training, optional suppository if the 
patient had a bowel movement within the previous four hours (Venn et al., 
1992). 
 
3.9.8 Outcome Measures 
The outcomes measured were: 1) self-reported number of bowel movements 
per week,  percentage of bowel movements graded as normal, quality of life 
measures, and treatment and resource use (Harari et al., 2004); 2) number of 
patients who established a bowel programme (e.g., spontaneous bowel 
movement or a bowel movement following digital stimulation occurred within 
a series of four consecutive successful timed defecations) and mean number of 
days in which patients established a bowel programme (Munchiando & 
Kendall, 1993);  and 3) efficiency rating determined by number of days 
needed to achieve effectiveness (e.g., five consecutive daily bowel movements 
was given an efficiency rating of 16.  Rating dropped by one point for each 
additional two days required to establish effectiveness) (Venn et al., 1992). 
 
3.9.9 Timing of Measurement 
Two of the studies measured responses immediately following the 
interventions (Munchiando & Kendall, 1993; Venn et al., 1992). One study 
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measured outcomes at one, three, six and twelve months following 
intervention (Harari et al., 2004). 
 
3.9.10 Effectiveness of Interventions 
Nurse-Led Intervention Versus Routine Care 
Harari et al. (2004) compared the outcomes of a nurse-led intervention versus 
routine care in a group of 146 stroke patients presenting with bowel 
dysfunction. The intervention consisted of a one-time assessment (history and 
rectal examination) undertaken by a nurse followed by targeted patient and 
carer education with provision of a booklet.  A diagnostic summary using an 
established protocol was sent to the patient’s general practitioner or ward 
physician if the patient was in hospital. The percentage of bowel movements 
(BMs) per week, graded as "normal" by patients, in a prospective one-week 
stool diary was significantly higher in the nurse-led intervention group versus 
the routine care group at one month (75% versus 55%; p=0.03) and six months 
(72% versus 55%; p=0.027), as was mean number of BMs per week (at one 
month: 5.5 versus 4.1; p=0.01; at six months: 5.2 versus 3.6; p=0.005).   
 
Daily Digital Stimulation Versus Every Other Day 
Munchiando and Kendall (1993) compared the effectiveness of daily versus 
alternate day bowel care with digital stimulation to establish a regulated bowel 
evacuation for a group of 48 stroke patients. The bowel programmes required 
both groups of patients to be placed on the toilet or commode at the same time 
each day. Interventions progressed from digital stimulation, insertion of 
suppository followed by fleet enema and finally use of a soapsuds enema, if 
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necessary, in addition to the standard care of diet modification (prune juice) 
and medications (fibre supplements, pericolace and senokot). Patients assigned 
to receive daily digital stimulation achieved higher rates of bowel regularity (a 
series of four consecutive timed defecations, whether spontaneous or assisted, 
that occur at least every other day) than patients who received alternate day 
digital stimulation (96% versus 69.6%; x2=6.02 p<0.05); however, patients in 
the alternate day group who achieved bowel regularity took less time to do it 
as compared to the patients in the daily group (7.7 days versus 13 days). 
Patients with right-side hemiplegia (t=2.21, p<0.05) and less mobility (r=0.31, 
p<0.05) required more time to establish their bowel regularity. 
 
Morning Versus Evening Schedule of Bowel Evacuation 
Venn et al. (1992) compared four bowel programmes based on the timing of 
bowel evacuations and suppository use: 1) morning bowel training with a 
mandatory suppository; 2) morning bowel training with an optional 
suppository if the patient had a bowel movement within the previous four 
hours; 3) evening bowel training with a mandatory suppository; 4) evening 
bowel training with an optional suppository if the patient had a bowel 
movement within the previous four hours. The outcome measure was an 
efficiency rating determined by number of days needed to achieve bowel 
training effectiveness (e.g., five consecutive daily bowel movements was 
given an efficiency rating of 16.  Rating dropped by one point for each 
additional two days). 80% of the stroke patients (n=39) achieved effective 
bowel training within one month. Patients assigned to morning bowel schedule 
were more efficient than those assigned to evening schedule (13.3 versus 7.37; 
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p≤ 0.01). No differences were found between mandatory or optional 
suppository uses. Efficiency was highest for those assigned to a bowel training 
group whose time coincided with their previous bowel pattern and lowest for 
those assigned to a group whose time conflicted with their previous bowel 
pattern (p≤0.01).  
 
3.10 Methodological Quality of Included Studies 
Although the three studies met the inclusion criteria, only one published study 
by Harari et al. (2004) met the criteria of a high quality paper. The remaining 
studies failed to report baseline characteristics of the subjects, inclusion 
criteria, interventions used and also used unvalidated methods to measure 
outcomes (Munchiando & Kendall, 1993; Venn et al., 1992). Table 3.2 


























Table 3.2  
 
Methodological Quality of Included Studies 
Authors & Year Criteria 












Blinding of participants to 
treatment allocation 
No No No 
Allocation concealment No No Yes 
Outcomes of people who 
withdrew described and included 
in analysis 
No No Yes 
Blinding of outcome assessors to 
treatment allocation 
No No No 
Groups comparable at entry No No Yes 
Groups treated identically other 
than for the named interventions 
Yes Yes Yes 
Outcomes measured the same 
way for all groups 
Yes Yes Yes 
Outcomes measured in a reliable 
way 
No No Yes 
Appropriate statistical analysis 
used 
Yes Yes Yes 
 
The study by Harari et al. (2004) has good methodological qualities of 
randomisation (computer generated numbers), allocation concealment (closed 
envelopes) and intention to treat analysis. In addition, power analysis was used 
to calculate the sample size in the study. Baseline comparison between groups 
was clearly presented. The study described clearly the inclusion criteria of a 
defined term of constipation. Risk of bias in this study included the following: 
1) the treatment recommendations were based on an unvalidated protocol and 
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the targeted education programme was not fully described; 2) the patients’ 
adherence to treatment recommendations was not assessed; therefore, it was 
difficult to determine that the positive effects were due to the treatment 
recommendations; 3) the outcome measure of using a grading system of bowel 
movement rated as normal by the patients was not described; and 4) the nurse-
led intervention had a multicomponent intervention whereby it was difficult to 
define which single action had most effect on the positive outcomes.  
 
The digital stimulation study by Munchiando and Kendall (1993) has several 
biases. Firstly, loss of patients was acknowledged as one of the study’s 
limitations but the drop-out rates were not reported. Although there was some 
baseline comparison between the groups which found no statistical 
significance, there was no description of the study patients’ race and stroke 
characteristics or severity. There was no description of the statistical analysis 
method used. Another variable which could have influenced study outcomes 
was the patients’ pre-existing bowel dysfunction, which was not determined 
prior to the interventions. Lastly, the criteria of the established bowel 
programme were devised by the researchers and not validated, thus making the 
results difficult to be interpreted. 
 
The risk of bias in the RCT of comparing four bowel programmes by Venn et 
al. (1992) included firstly, the non-description of its randomisation process. 
The study also did not indicate details of the patients’ characteristics (gender, 
onset and severity of stroke, concomitant treatments, etc.) and did not report 
baseline comparison of the study groups to determine if the effect difference 
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was truly due to the intervention alone. The study outcomes were recorded 
based on several staff members’ clinical observations which could affect the 
reliability of the measurements. The efficiency rating used to assess the 
patients’ bowel function was devised by the researchers and not validated. 
Lastly, there was no description of the numbers and types of suppository used 
by the mandatory suppository group and whether the groups assigned to the 
optional suppository received any suppositories. 
 
3.11 Discussion 
The objective of this systematic review was to assess the effectiveness of 
bowel management strategies for constipation in adults with stroke. The 
number of studies meeting the inclusion criteria for this review was small, and 
the studies varied in their inclusion criteria, types of intervention used and 
outcome measures. Despite the high prevalence of constipation in the stroke 
population, there is still a lack of high quality studies. There are various 
challenges in the research of constipation. Firstly, there is a lack of interest by 
clinical researchers as constipation is often viewed as a non-life threatening 
condition. Many studies focusing on medical complications do not include 
constipation as a complication. Although bowel care is the fundamental area 
of patient care, constipation is still a neglected study subject. Secondly, there 
is a lack of a consensus definition of constipation. There are various 
definitions of constipation. Most are based on reported symptoms. In this 
review, only one study (Harari et al., 2004) defined bowel dysfunction based 
on Rome III diagnostic criteria for functional constipation (Rome Foundation, 
2010). The remaining two studies used other criteria to define bowel 
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dysfunction. As a result, it was difficult to compare and interpret the 
effectiveness of the interventions used. Importantly, there were differences in 
the prevalence of constipation in various studies. For example, Bracci et al. 
(2007) reported a high prevalence of 30% but included only small number of 
patients (n=90), and the outcomes were measured at different time points (e.g. 
at median 36 weeks after stroke onset). In a slightly larger population of 154 
patients who were assessed one month after stroke onset, the prevalence was 
55% (Su et al., 2009).  However, in a larger cohort of patients (11,757) with 
stroke, only seven percent had constipation (Ingeman, Andersen, Hundborg, 
Svendsen, & Johnsen, 2011b). The articles included in the review were 
primarily of small populations: 48 (Munchiando and Kendall, 1993), 58 (Venn 
et al., 1992) and 146 (Harari et al., 2004). These differences highlight that the 
prevalence is unclear and raises the question of whether the difference, in 
constipation prevalence are related to the size of the study group, the inclusion 
criteria, variations in definition of constipation and also in which phase of 
health care and time point the patients were included and assessed. It will be 
of interest to study the prevalence of constipation among larger numbers of 
stroke patients in an epidemiological group with a ‘first-ever’ stroke because 
that would give a clear indication of the percentage of people having problems 
with constipation after stroke. 
 
In recent years, we have seen an emerging trend of nurses advancing their 
clinical role to address the growing burden of caring for patients with multiple 
chronic diseases. These nurses are taking the lead in managing patients in 
collaboration with medical physicians. They are able to assess (perform 
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history taking and physical examinations), diagnose and treat common 
ailments. Studies have shown that patients under these nurse-led care 
initiatives have improved health outcomes in various settings: nursing home, 
hospital and community care (Blozik et al., 2010; Mac Lellan, 2004; Sindhu, 
Pholpet, & Puttapitukpol, 2010). The nurse-led intervention by Harari et al 
(2004), which is the only high quality study in this review, has further 
highlighted that active involvement of nurses in the management and 
prevention of health conditions such as constipation merits further 
investigation with respect to patient assessment, planning and implementing 
structured bowel management interventions and individualised education 
programmes.  
 
One of the studies advocated the use of daily bowel care with digital 
stimulation to achieve higher rates of bowel regularity (Munchiando and 
Kendall, 1993). Although there have been major advances and rigorous effort 
in the scientific field of acute stroke management, research in the field of 
managing stroke complications such as bowel dysfunction is comparably slow.  
Digital stimulation has been commonly utilised to facilitate defecation in 
patients with spinal cord injury (Faaborg, Christensen, Finnerup, Laurberg, & 
Krogh, 2008; Haas, Geng, Evers, & Knecht, 2005; Valles et al., 2007), and has 
remained essentially unchanged in the past decades. Digital stimulation could 
evoke an anorectal colonic reflex resulting in enhanced contractions of the 
descending colon and rectum (Korsten et al., 2007). The effect of digital 
stimulation should be further evaluated with considerations in a subset of 
stroke population who do not respond to other interventions as the stroke 
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patients in the study by Munchiando and Kendall (1993) were already on an 
every other day digital stimulation programme at baseline in addition to the 
standard care of diet modification and medications. In recent reviews there 
have been some new promising ideas of using assistive devices such as 
irrigation techniques and electrical stimulation to manage neurogenic bowel 
management in patients with spinal cord injury (Krassioukov, Eng, Claxton, 
Sakakibara, & Shum, 2010), a condition which similarly affects the central 
nervous system and the pathway of reflexes involved in the defecation process 
(gastro colic and spinal reflex). These new techniques could be further 
evaluated in this subset of the stroke population.  
 
Management of constipation should also focus on factors that could influence 
normal bowel functioning other than the latest innovations alone. The findings 
of association between right hemiplegic (possibly expressive dysphasia) and 
reduced mobility with prolonged time required for bowel regularity by 
Munchiando and Kendall (1993), suggests that mobility and speech 
impairment may be an important risk factor of constipation. Constipation is 
often associated with prolonged bed rest and immobility in the elderly (Hsieh, 
2005). Failure to respond to defecation urges can also lead to suppression of 
rectal sensation and subsequently, faecal retention and constipation (Talley et 
al., 1996). Future studies should therefore evaluate the influence of impaired 
physical mobility and communication deficits in establishing bowel regularity. 
The timing of defecation also affects normal bowel functioning. Regular 
timing influences reflex activity which promotes normal defecation. People 
with regular bowel patterns have been shown to empty their bowel at 
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approximately the same time every day (Heaton, Wood, Cripps, & Philipp, 
1994). This supports Venn et al.’s (1992) study whereby bowel efficiency was 
highest when patients were assigned to a bowel training group that coincide 
with their previous bowel habits. The importance of assessing previous bowel 
habits in detail as part of the history taking and incorporating it into patient 
management plan should therefore be emphasised. This again, explores the 
essential role that nurses can play and have a dramatic impact on patient care.  
 
Colonic activity has been found to be greatest at waking and after breakfast 
(Heaton et al., 1994; S. S. C. Rao, Sadeghi, Beaty, Kavlock, & Ackerson, 
2001) and the most common time for call to defecation are immediately on 
rising or after breakfast (Heaton et al., 1994). Therefore, the optimal time for 
attempting defecation should be in the morning and after breakfast for those 
whose previous bowel habits are in the morning, as indicated by the outcome 
of Venn et al.’s (1992) study. The findings of mandatory or optional use of 
suppositories which had no significant differences in achieving bowel 
efficiency is difficult to interpret as the types and numbers of suppositories 
used for both groups of patients were not reported. Nevertheless, the use of 
pharmacological agents as part of the treatment in bowel management 
programmes should be further explored in terms of necessity, types and 






3.12 Recommendations for Practice 
The following recommendations are provided based on the JBI Level of 
Evidence for Effectiveness: 
 
1. Time-scheduled bowel evacuation which followed premorbid bowel habits 




- Premorbid bowel habits should be assessed in detail as part of the 
history taking during admission. 
- Bowel evacuation to be scheduled according to premorbid bowel 
habits. 
- Optimal time for bowel evacuation is in the morning, after breakfast 
for those whose premorbid bowel habits are in the morning. 
 
2. Daily bowel care with digital stimulation achieved higher regularity of 
bowel evacuation compared to every other day (Munchiando & Kendall, 
1993) (Level of Evidence 2). 
 
Recommendations 
Daily digital stimulation could be considered as part of a bowel care 
programme for selected groups of patients who do not respond to standard 
measures of diet modifications and medication. 
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3. A one-off structured nurse assessment and intervention effectively 




Bowel management programmes should incorporate a nursing component 
where comprehensive and individualised care plans are implemented 
 
3.13 Limitations of the Reviews 
All three studies in this review have small sample sizes where generalisation 
has to be taken with caution. The restriction of this review to English language 
might have resulted in language bias with potentially relevant studies 
published in other languages being missed. This review did not include 
unpublished abstracts from relevant Gastroenterology or Geriatric conferences. 
Low level methodological quality studies were included due to limited number 
of studies available and utilised a narrative approach to provide a broad 
overview of the subject, hence the conclusions drawn are no conclusive.  In 
addition, the latest management strategies study identified was published in 
2004, highlighting a lack of primary research on this subject.  
 
3.14 Conclusion 
Studies on bowel management strategies for constipation in adults with stroke 
are limited. The available evidence suggests that structured bowel programmes 
and nurse-led interventions in bowel care have a significant effect in 
improving bowel evacuations, which merits further evaluation. Moving 
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forward, large randomised controlled studies are needed to explore all aspects 
of care that could improve bowel dysfunction which include pharmacological 
and non-pharmacological interventions. The development of future studies 
should adopt an agreed definition of bowel dysfunction and validated 
intervention protocols and education programmes. The outcome measures 
should include measures of social factors such as quality of life and 
caregivers’ burden of care to add further value to established bowel 
programmes.  
 
Two manuscripts were published based on this systematic review (Lim & 
Childs, 2011, 2013) (Appendix 17).  
 
As the evidence on constipation management strategies are limited and the 
available evidence of treatment modalities supporting their use in stroke 
remains unclear, it is important that predictors of constipation are identified 
and preventive strategies are developed. As such, a two-phase study was 
conducted to address the research and practice gaps and is presented in the 










Phase 1 Study 
Incidence and Predictors of Constipation in Patients with Stroke during 
Hospitalisation 
 
4.1 Introduction  
The available evidence from the systematic review presented in Chapter 3 
suggests that structured bowel programmes and nurse-led interventions in 
bowel care are promising, which merits further evaluation. However, before 
developing a programme, there needs to be an investigation of the incidence of 
constipation and the predictors of constipation in the local context. This 
chapter presents Phase 1 of this study using a matched cohort to compare 
stroke with non-stroke (orthopaedic) patients. The findings of this Phase 1 
study will inform the development of a bowel management programme 
framework which will be evaluated for its feasibility in the Phase 2 of this 
thesis. The STROBE statement checklist for cohort study is incorporated into 
the presentation of this study. STROBE is an international collaborative 
initiative by epidemiologists, methodologists, statisticians, researchers and 
journal editors in the field of conducting and disseminating observational 
studies. The aim of STROBE initiative is to strengthen the reporting of 
observational studies in epidemiology (“STROBE statement,” 2014). There is 
a total of six sections with twenty-two recommendation items in the STROBE 





The aims of this study were to investigate the incidence of new-onset 
constipation in patients with stroke versus orthopaedic conditions and the 
predictors of constipation for both populations during acute hospitalisation.  
 
4.3 Research Questions 
1. What is the incidence of new-onset constipation in patients with stroke 
compared to orthopaedic conditions during acute hospitalisation? 
2. What are the predictors of new-onset constipation in patients with stroke 
and orthopaedic conditions during acute hospitalisation? 
 
4.4 Methodology 
4.4.1 Study Design  
A prospective matched cohort study was conducted comparing stroke and non-
stroke patients. The conventional epidemiological design for matched case-
control study is retrospective. Retrospective study design is used when an 
incidence of a disease or study subject is low and an extremely large 
prospective study will be needed to collect an adequate number of cases (Van 
Belle, Fisher, Heagerty, & Lumley, 2004). However, there are disadvantages 
or risks of bias in a retrospective study. As such, it is often viewed as inferior 
to a prospective study. In this study, a prospective matched cohort study 
design was used instead. This prospective design could reduce the 
methodological limitations of recall or information bias, difficulty in 
validating information, incomplete control of extraneous variables, difficulty 
in selecting appropriate comparison group and inability to determine incidence 
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rates. The common standard index of risk calculated from case-control studies 
is the odds ratio (OR). However, as this is a prospective cohort study, the 
incidence rate of constipation and relative risk (RR) of predictors will be 
presented. The possible predictors of constipation included demographics (age, 
gender, ethnicity), conditions (stroke, orthopaedic), co-morbidities (diabetes, 
heart disease, previous stroke), clinical factors (MMSE, length of hospital stay, 
use of prophylactic laxatives, dysphagia, dysphasia, mobility gains, oral fluid 
intake, use of bedpan), laboratory parameters (WBC count, potassium) and 
medications (antithrombotics, opioids, NSAIDs, antacids).  
 
4.4.2 Study Settings 
This study was conducted at a 1,600-bedded large tertiary hospital in 
Singapore. This site was selected to ensure that the study would have access to 
a large pool of potential study participants. The hospital caters to over 1 
million patients per year and accounts for about a quarter of the total acute 
hospital beds in the public sector and about one-fifth of acute beds nationwide. 
The stroke group was recruited from the Stroke Unit dedicated for patients 
admitted with acute stroke. There were a total of 1,203 inpatient discharges for 
stroke in 2012 (Singapore General Hospital, 2013b). Matched study is feasible 
when there is a large pool of controls. The non-stroke group (orthopaedic) was 
recruited from the Orthopaedic Unit which is the oldest and most established 
Orthopaedic Department in Singapore with a large pool of patients (a total of 
7,272 inpatient discharges in 2012) (Singapore General Hospital, 2013a). 
Matched cases and controls were recruited for a period of four months. They 
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were followed-up during the period of their hospitalisation or within the first 
four weeks, whichever was earlier. 
 
4.4.3 Study Participants 
4.4.3.1 Selection of Cases 
The strategy for matched study is to start with the ‘cases’. The inclusion and 
exclusion criteria have to be clearly defined before selecting the cases. In this 
study, the stroke group was identified as ‘cases’ (stroke) and were selected 
when the patients were newly-admitted to the Stroke Unit of the large tertiary 
hospital.  
 
Inclusion Criteria (stroke group) 
The new-onset stroke must be diagnosed by the primary neurologist 
and further confirmed by CT scan or MRI. Patients must be aged 21 
years old or older, communicable and recruited within 48 hours of their 
admission. 
 
Exclusion Criteria (stroke group) 
Excluded from the study were patients with pre-existing 
gastrointestinal dysfunctions including constipation, faecal 
incontinence, pathological diseases or cancer of the colon or rectum. 
 
4.4.3.2 Selection of Controls 
The next stage is to find appropriate controls for the cases. This is one of the 
most challenging aspects of a matched study. In a matched study, the 
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distribution of exposure should be the same among cases and controls and they 
should stem from the same source population (Van Belle et al., 2004). The 
controls may also be selected from an at-risk population, with potential to 
develop the outcome. Overall, the controls should be identical to the cases in 
all relevant aspects except possibly for the risk factors. In this study, patients 
from the Orthopaedic Unit were selected as controls as this group have similar 
mobility issues and do not have the acute neurological deficits that could 
potentially cause constipation.  
 
Inclusion Criteria (orthopaedic group) 
The matched controls were recruited within a window period of five 
days to eliminate any practice changes that may occur within the two 
groups as a function of time. All included patients were ≥ 21 years old, 
communicable and recruited within 48 hours of their admission. 
 
Exclusion Criteria (orthopaedic group) 
Excluded from the study were patients with pre-existing 
gastrointestinal dysfunctions including constipation, faecal 
incontinence, pathological diseases or cancer of the colon or rectum. 
 
4.4.3.3 Matching of Cases and Controls 
Matching method is used to ensure comparability between cases and controls 
thus reducing variability and thereby adjusting for potential confounders to 
increase the precision of the comparison. Matching allows the following: 1) 
eliminating influence of measurable confounders such as age and gender; 2) 
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eliminating influence of confounders that are difficult to measure; 3) easy 
selection of controls for convenience sampling; 4) improving study efficiency 
due to smaller sample size (Van Belle et al., 2004). However, matching can 
also be time-consuming and requires matched analysis. In most cases, one 
control is identified for each case. In this study, consecutively screened 
patients in the Stroke Unit were matched with controls by age and gender from 
an Orthopaedic Unit. Both groups were matched one to one and followed-up 
throughout the period of hospitalisation or during the first four weeks, 
whichever was earlier.  
 
4.4.4 Study Procedure 
4.4.4.1 Stroke Group 
The list of potential participants was obtained from the Stroke Unit Admission 
List in the Electronic Medical Record (EMR) system. All patients admitted to 
the Stroke Unit presenting with acute stroke symptoms were screened 
consecutively for eligibility using a Patient Eligibility Check form (Appendix 
6). The form consists of all the pre-determined inclusion and exclusion criteria 
for the study.  After determining their eligibility, a detailed explanation of the 
study was given to participants or their legal representatives. Informed consent 
was obtained from participants or their legal representatives using the Patient 
Information Sheet and Informed Consent Form (Appendix 7). Participants’ 
baseline assessments were conducted immediately and they were followed-up 
daily till the day of their discharge or until Week 4, whichever was earlier. 
Figure 4.1 details the flow of the study procedure. 
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4.4.4.2 Orthopaedic Group 
The list of potential participants was obtained from the Orthopaedic Unit 
Admission List in the EMR system. All patients admitted to the Orthopaedic 
Unit were screened consecutively for matching by age (up to 6 years older or 
younger) and gender with the stroke group, and eligibility using the Patient 
Eligibility Check form (Appendix 6).  The interval from recruitment of cases 
to controls was 5 days. Case matching within this time phase was possible as 
there was a large pool of controls. Subsequent procedure was similar to the 
stroke group as detailed in Figure 4.1. 
 
Obtain the list of potential participants from the Stroke Unit admission list in the 
Electronic Medical System
Screen potential participants for eligibility based on the inclusion and exclusion criteria 
using the Eligibility Check Form 
Approach eligible potential participants or their legal representatives and provide verbal explanation 
regarding the study as indicated in the Participant Information Sheet and 
Informed Consent Form 
Hand the Participant Information Sheet and Informed Consent Form to potential participants or their 
legal representative and obtain informed consent if they agree to participate in the study
Enter participants’ particulars in the study entry register
Assess participants and collect data on Day 1 
Assess participants and collect data daily till the day of participants’ discharge or at Week 4, whichever 
was earlier. 
 
Figure 4.1.  Phase 1 Flowchart of Study Procedure. 
 
4.4.5 Outcome Measures and Instruments 
4.4.5.1 Incidence of Constipation 
The diagnostic criterion of constipation was based on the symptoms adapted 
from Rome III criteria (Rome Foundation, 2010). Constipation was diagnosed 
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as: (1) having two or more of the following symptoms: straining, lumpy or 
hard stools, sensation of incomplete evacuation, sensation of anorectal 
obstruction/blockage, less than three defecations per week and requires 
manual maneuvers to facilitate defecations; (2) Loose stools were rarely 
present without the use of laxatives and (3) Insufficient criteria for irritable 
bowel syndrome.  
Data Sources / Measurement: Daily records of patients’ symptoms 
were collected by the PhD candidate using a standardised criteria form 
(Appendix 8) during the period of patients’ hospitalisation or the first 
four weeks, whichever was earlier. The criteria form consists of five 
categories. The first category identifies the symptoms of constipation 
which are presence or absence of defecation (criteria of < three 
defecations per week), straining, lumpy or hard stools, sensation of 
incomplete evacuations, sensation of anorectal obstructions / blockage, 
requires manual maneuvers to evacuate. The second category identifies 
any presence of loose stools and any use of laxatives. This is to address 
the second criteria for constipation which is ‘loose stools were rarely 
present without the use of laxatives’. The third category identifies 
symptoms of irritable bowel syndrome which can present as pain or 
discomfort during defecation. This is to address the third criteria for 
constipation which is to exclude irritable bowel syndrome. The fourth 
category identifies the defecation devices used at each defecation 
episode and any associated difficulties when using the devices. The 
last category identifies any self-treatment to facilitate defecation. This 
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is to identify any confounding factors that might affect the constipation 
outcome. 
 
4.4.5.2 Variables Measured as Possible Predictors of Constipation 
Structured questionnaires were administered and assessments were conducted 
in the same manner for the stroke group and controls upon recruitment. 
 
Demographics  
Information about demographic factors (age, gender, ethnicity, marital status) 
and social status (educational level) were obtained through an interview 
process using a structured questionnaire. Co-morbidities (diabetes, heart 
disease, previous stroke) were recorded from patients’ electronic medical 
record. All interviews were conducted by the PhD candidate.  
Instrument: The structured questionnaire consists of two sections. 
Section one consists of questions pertaining to baseline characteristics 
such as ‘time from stroke onset’, diagnosis, demographics of age, 
gender, marital status, ethnicity, language spoken, educational level, 
medical history, social history (smoking, drinking alcohol, exercises), 
self-reported treatments for defecation, fluid intake, bowel history and 
current medication. Section two is to record initial and subsequent 
assessment data such as National Institutes of Health Stroke Scale 
(NIHSS) scores, Glasgow coma scale (GCS) scores, WBC count and 
Potassium, MMSE scores, dysphasia and dysphagia status, Functional 
Independence Measure (FIM) mobility scores and fluid intake. 
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Stroke Severity (stroke group only) 
Stroke severity was assessed for the stroke group using the National Institutes 
of Health Stroke Scale (NIHSS) (Brott et at., 1989).  
Instrument: The NIHSS is a well validated and reliable assessment tool 
used to objectively quantify the neurological impairment caused by 
stroke. The scale scores had been validated against patients' infarction 
size measured by CT scan and to patients' clinical outcome at three 
months (scale-lesion size r=0.68, scale-outcome r=0.79) (Brott et al., 
1989). NIHSS also showed a reliability of Cronbach’s alpha, α=0.6310 
and with 14 out of the 15 items displayed good inter-rater agreement 
(kappa coefficient, κ>0.8; p<0.001) among staff nurses from the same 
Stroke Unit at the tertiary hospital (Tan & Chang, 2003). The NIHSS is 
composed of 15 items measuring level of consciousness (level of 
consciousness [LOC], LOC questions, LOC commands), best gaze, 
visual field, facial palsy, motor arm, motor leg, limb ataxia, sensory, 
best language, dysarthria and neglect. Each item scores a specific 
ability between a 0 and 4. A score of 0 indicates normal function in 
that specific ability, while a higher score is indicative of some level of 
impairment. The minimum total score is 0 and the maximum possible 
score is 42. The total scores of 1 to 4 indicate minor stroke severity, 5 
to 15 score indicate moderate stroke severity, 16 to 20 score indicate 
moderate to severe stroke and 21 to 42 score indicate severe stroke. 
This scale was administered on admission by the admitting nurse. All 
nurses in the Stroke Unit were trained and assessed to be competent in 
using the NIHSS.  
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Cognitive Status 
Cognitive status was assessed using the local version of mini mental state 
examination (MMSE) (Folstein, Folstein, & McHugh, 1975) by the PhD 
candidate.  
Instrument: The MMSE is a 30-point questionnaire test which 
measures cognitive functioning on domains that include memory, 
attention, language, praxis, visuospatial ability and orientation. The 
summed scores of MMSE ranged from a score of 0 to a maximum 
score of 30, with higher scores denoting better cognitive functioning. A 
score of greater than or equal to 25 indicates a normal cognition, 19 to 
24 point indicates mild cognitive impairment, 10 to 18 point indicates 
moderate cognitive impairment and a score of below or equal to 9 
indicates severe cognitive impairment. The local MMSE version 
contained the English, Chinese and Malay versions (Appendix 9). The 
Chinese version was validated in Shanghai (Katzman et al., 1988; 
Zhang et al., 2005) and Singapore (Feng, Chong, Lim, & Ng, 2012; T.-
P. Ng, Niti, Chiam, & Kua, 2007; Sahadevan, Lim, Tan, & Chan, 
2000). The Malay version was developed by forward and back 
translation from English and validated in a local study which 
discriminated well between elderly with and without dementia (T.-P. 
Ng et al., 2007).  
 
A summary of the modifications in the Chinese and Malay version are 
as follows (Feng et al., 2012; T.-P. Ng et al., 2007): 
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• The question (Q5) on seasons was replaced with the question 
“Without looking at your watch, what time is it?” (Reason: there 
are no seasons in Singapore) 
• The question (Q8) on city/town was replaced with the question 
“What area are we in?” (Reason: Singapore is a city country) 
• The question (Q10) on state/province was replaced with the 
question “Which part of Singapore is this place (North, South, East, 
West or Central)?” (Reason: Singapore is a city country) 
• For immediate recall (Q11–Q13) and delayed recall (Q19–Q21), 
“ball, flag, tree” were used in the English version, and “柠檬，锁
匙，气球” (lemon, key, balloon) were used in the Chinese version 
(in local Chinese language, ball, flag and tree are single-syllable 
words)  
• For sentence repetition (Q24), “no ifs, ands or buts” in the English 
version was used, “四十四只石狮子” (forty-four stone lions) was 
used in the Chinese version and “marah, merah, murah” (“angry, 
red, cheap”) was used in the Malay version (Reason:  direct 
translation of the original English sentence is meaningless). 
 
Dysphagic and Dysphasic Status  
The initial dysphagia and dysphasia screenings were conducted by the 
PhD candidate based on an established ST screening criterion. Positive 
results if any, were further confirmed with the speech therapists’ 
reports. The results were coded as present or absent. 
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Admission Mobility Score and Mobility Gain Score 
Mobility scores were assessed on admission and at endpoint of study by the 
PhD candidate using the locomotion score in the Functional Independence 
Measure (FIM) instrument (The Uniform Data System for Medical 
Rehabilitation [UDSMR], 1987). 
Instrument: The FIM instrument is the gold standard for measuring 
function of patients in rehabilitation settings. It has a well-established 
reliability with Intraclass Correlation Coefficient (ICC) ranging from 
0.83 to 0.99 (Hamilton, Laughlin, Fiedler, & Granger, 1994; 
Ottenbacher, Hsu, Granger, & Fiedler, 1996) and validity which 
adequately discriminates capabilities of rehabilitation patients (Dodds, 
Martin, Stolov, & Deyo, 1993). FIM can be administered quickly and 
uniformly to patients with stroke (Kidd et al., 1995).  It measures the 
level of a patient’s disability and indicates how much assistance is 
required for the person. The locomotion score is graded on a 7-point 
ordinal scale which indicates the burden of care and distance walked, 
ranging from 1 (complete dependence) to 7 (independence). A score of 
7 indicates complete independence and ability to walk a distance of at 
least 50 meters, a score of 6 indicates status of modified independence 
and ability to walk a distance of at least 50 meters, a score of 5 
indicates that supervision is needed and ability to walk at least 50 
meters or ability to walk at least 15 meters independently with or 
without devices, a score of 4 indicates that minimal contact assistance 
is needed to walk a minimum of 50 meters, a score of 3 indicates that 
moderate assistance is needed to walk a minimum of 15 meters, a score 
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of 2 indicates that maximal assistance is needed to walk a minimum of 
15 meters and a score of 1 indicates that total assistance is needed to 
walk a minimum of 15 meters. The mobility gain scores were obtained 
by subtracting the locomotion score at endpoint of study from the 
admission score. The FIM mobility gain score was chosen as the 
variable for predictor of constipation instead of number of physical 
therapy (PT) sessions or FIM admission mobility score as the measure 
of mobility gain score is more meaningful since it takes into account 
each patient’s own baseline mobility.  
 
Laboratory Parameters  
WBC count and potassium measures were collected within the first week of 
patients’ admission and were recorded from patients’ electronic medical 
records. 
 
Physical Therapy  
The number of PT sessions were monitored and recorded from patients’ 
progress notes throughout the study period. 
 
Oral Fluids 
Oral fluid intake was measured using a standard system in millilitres (ml). 
Each patient was given a standard cup and chart by their bedside to self-
document their fluid intake. For patients who were not able to self-document, 
their caregivers (family and/or nurses) documented the chart. 
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Use of Medications 
Medications which may affect gastrointestinal functions such as 
antithrombotics, antacids, opioids and NSAIDs were recorded throughout the 
study period. 
 
Use of Defecating Devices 
Use of defecating devices such as diapers, bedpan, bedside commode or toilet 
at each defecation was recorded throughout the study period. 
 
4.4.6 Rigor of Study 
A local version of MMSE was used to ensure validity and reliability in the 
cognitive assessment for our local population with permission sought from the 
author (T.-P. Ng et al. (2007). Other measuring instruments such as NIHSS 
and FIM were reliable and well validated. The assessments and study data 
were collected by one investigator (PhD candidate) to ensure reliability of the 
study results. Patients were recruited within 48 hours of their admission and 
asked to record their own fluid intake. They were each given a standardised 
cup to self-record their fluid intake in millilitres. Patients’ self-recorded fluid 
intake was matched against the recorded intake in the electronic medical 
record to ensure accuracy. Any discrepancies were clarified with patients. The 
same standardised cups were provided to patients who were dependent on 
caregivers for their fluid intake. Case matching was possible in this study as 
there was a large pool of orthopaedic patients as controls. The controls were 
recruited within five days of the stroke cases’ admissions. Cases and controls 
that were matched more than five days were excluded from the study. This 
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was to address any practice changes that could occur as a function of time. 
Stroke patients with their stroke diagnosis unconfirmed by either CT scan or 
MRI were excluded from the study. All potential patients were screened for 
history of any pre-existing bowel dysfunctions for the past three months prior 
to this hospitalisation. This was to ensure that the constipation outcome, if any, 
was a new-onset after a stroke or after an orthopaedic condition. 
 
4.4.7 Sample Size Calculation 
The sample size calculation was based on an estimate of proportions from a 
prevalence study. The study compared 90 consecutive hemiplegic patients 
with 81 consecutive orthopaedic patients after a period of physical 
immobilisation for at least three months. The stroke group with constipation 
was at 30% and the non-stroke (orthopaedic) group with constipation was 8% 
(Bracci et al., 2007). To achieve 80% power and a two-sided type I error of 
5%, 100 patients with 50 patients per group were needed. Further assuming a 
20% drop out rate, this study aimed to recruit 120 patients with 60 per group.  
 
4.4.8 Statistical Analysis  
Descriptive statistics for quantitative variables were presented as mean±sd, 
median, range and n (%) for categorical variables. The quantitative variables 
included age, cognitive status (MMSE), admission mobility and mobility gain 
scores, WBC count, potassium and oral fluids. Categorical variables were 
gender, ethnicity, marital status, educational level, co-morbidity, incidence of 
constipation, dysphagia, dysphasia, medications and bedpan use. Paired-
Samples T Test was used to compare the quantitative variables between the 
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two cohorts if normality assumption was satisfied, otherwise the Wilcoxon 
Signed Rank test was used. McNemar Test was performed for categorical 
variables when comparing between the stroke and orthopaedic groups. The 
association between PT sessions and mobility gains was examined using the 
Spearman Rank Correlation Coefficient. Univariate and multivariate 
conditional logistic regression analysis were performed to determine the 
association between constipation and possible predictors. In the multivariate 
analysis, all clinical variables such as age, gender, ethnicity, conditions, co-
morbidity, length of hospital stay, MMSE, mobility gains, oral fluid intake, 
dysphagia, dysphasia, use of bedpan, laboratory parameters, use of 
prophylactic laxatives, antithrombotics, opioids, NSAIDs and antacids were 
included to account for different patient profiles of both groups. This model is 
more conservative compared to the usual statistical modelling of including 
only univariate significant variables. There was no missing data. Since it was a 
prospective study, relative risk (RR) with 95% CI was presented. Data was 
analysed using Statistical Package for the Social Sciences (SPSS) Version 
18.0. Statistical significance was set as p<0.05. 
 
4.5 Ethical Considerations  
This study was approved by the SingHealth Centralised Institutional Review 
Board and funded by the Ministry of Health Nursing Research Committee. 
The aims and study procedures were explained to all potential participants and 
they were given opportunities to ask question. They were also informed that 
their participation in this study was entirely voluntary and they were free to 
withdraw their consent and discontinue their participation at any time without 
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prejudice to them or effect on their medical care. Written consent was 
obtained for all participants or their representatives after they expressed 
willingness to participate. A copy of the information sheet and consent form 
was given to them along with the contact details of Principal Investigator and 
SingHealth Centralised Institutional Review Board. 
 
4.6 Confidentiality of Study and Medical Records 
Participants were informed that the information collected for this study would 
be kept confidential. Study participants' records, to the extent of the applicable 
laws and regulations, would not be made publicly available. Only the study 
investigators had access to the confidential information being collected. 
However, the Regulatory Agencies, Institution Review Board and Ministry of 
Health would be granted direct access to the original medical records if they 
need to check study procedures and data, without making any of the 
participant’s information public. All research data was stored in a hard disk 
which was kept locked at the main office of the Principal Investigator. Study 
participants’ confidentiality was protected through coding of research data and 
the links between subjects’ identifiers and the codes were stored separately 
from the research data. In the event of any publication arising from this study, 
the participant’s identity would remain confidential. 
 
4.7 Potential Risks, Discomforts or Inconveniences of Study 
This study did not involve any risks or discomfort. It might cause 
inconvenience to some subjects as the initial baseline assessments and 
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subsequent follow-up sessions required some of the subjects’ time. This 
information was provided and explained to the study participants.  
 
4.8 Potential Benefits of Study 
Participants were informed that there was no assurance that they would benefit 
from this study. However, their participation would contribute to the medical 
knowledge about constipation after a stroke and contribute to the development 
of a bowel management programme.  
 
4.9 Results 
A total of 102 patients from the stroke group and 72 patients from the control 
group were screened for eligibility. In the stroke group, a total of 42 patients 
were excluded from the study. Fourteen patients had pre-existing bowel 
dysfunctions, two patients were unable to communicate, ten patients declined 
to participate, seven patients were critically ill, three patients were clinically 
diagnosed as having a stroke but their diagnoses were not confirmed by 
radiological findings and six patients were unable to find a match in the 
control group within five days. Twelve patients in the orthopaedic group were 
excluded from the study. Three of them have pre-existing bowel dysfunctions, 
three patients declined to participate and six patients were matched more than 
5 days from the stroke group’s recruitment day. One hundred and twenty 
patients (60 per group) met the inclusion criteria and were recruited in the 
study. During the study period, five matched cases were excluded from the 
analysis due to death (one from the stroke group), critical illness (two from the 
stroke group; one from the control group) and new-onset of stroke (one from 
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the orthopaedic group). At the end of the study, a total of 110 patients (55 per 














Assessed for eligibility (n=102)
Excluded (n=42)
- Not meeting inclusion criteria (n=16)
- Declined to participate (n=10)
- Too ill to participate (n=7)
- Clinical stroke (n=3)
- Long match (n=6)
Assessed for eligibility (n=72)
Excluded (n=12)
- Not meeting inclusion criteria (n=3)
- Declined to participate (n=3)
- Long match (n=6)
Orthopaedic GroupStroke Group
 
Figure 4.2.  Phase 1 Flowchart of Recruitment Process. 
 
4.9.1 Demographics and Baseline Characteristics 
Table 4.1 shows the baseline comparisons between the stroke group and 
controls.  
 
Age of Participants 
The participants’ age for both groups was similar as they were matched by age. 




Gender of Participants 
Sixty-six (60%) participants were male. There was equal number of males and 
females among the stroke and orthopaedic group since both groups were 
matched by gender. 
 
Ethnicity of Participants 
Chinese formed the largest ethnicity group with 87 participants (78% stroke 
group vs 80% orthopaedic group). Twelve participants were Malay (11% for 
both groups) followed by nine Indians (11% stroke group vs 5% orthopaedic 
group) and two Eurasians (4% orthopaedic group). There was no statistical 
significance between both groups. 
 
Marital Status of Participants 
There were four categories of marital status: single, married, divorced or 
widowed. The majority of participants were married (76% stroke group vs 
89% orthopaedic group), followed by single (11% stroke group vs 4% 
orthopaedic group), widowed (9% stroke group vs 6% orthopaedic group) and 
divorced (4% stroke group vs 2% orthopaedic group). There was no statistical 
significance between both groups. 
 
Educational Level 
Among the five categories of educational level, the majority of patients 
completed secondary school (46.3% stroke group vs 36.4% orthopaedic group), 
followed by primary school (29.1% for both groups) and no formal education 




The stroke group had lower MMSE scores as compared to the orthopaedic 
group (24 ± 5.1 vs 27±3.1; p<0.001).  
 
Co-morbidity 
There were patients with previous stroke (p<0.05) in the stroke group. Other 
co-morbidities were not statistically significant.  
 
Admission Mobility Scores 
The mean mobility score for the stroke group was 2 (maximum dependence) 
and the mean mobility score for the control group was 1 (complete 
dependence). Although significantly different, clinically, patients who scored 
as 1-‘total dependent’ and 2-‘maximum dependent’ were similarly immobile. 
This is because the FIM instrument measures functional disability which 
directly correlates with burden of care. In a hospital setting, regardless of 
whether a patient is scored 1 or 2, the same burden of care is required for the 
patient - i.e. requires maximal assistance to help the patient with daily 
ambulatory tasks such as the need for a wheelchair to transport the patients. 
 
Diagnosis of Participants 
Forty-five patients (81.8%) from the orthopaedic group underwent surgery: 
thirty patients (66.7%) had knee surgeries, three patients (6.7%) had knee 
arthroplasties, two patients (4.4%) had hip surgeries and ten patients (22.2%) 
had other miscellaneous surgeries. Most of the patients underwent surgery 
within two days of their admission. All patients from the stroke group except 
one had ischemic stroke.  
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NIHSS Scores 
The median NIHSS score for the stroke group was 5.0 (0-17) which indicates 
moderate stroke severity. 
 








Stroke  group 





Age (mean± SD) 61.2 ± 9.7 61.7± 9.6 







Ethnicity    
Chinese 43 (78) 44 (80) 
Malay 6 (11) 6 (11) 
Indian 6 (11) 3 (5) 
Others 0 2 (4) 
Marital Status    
Single 6 (11) 2 (4) 
Married 42 (76) 49 (89) 
Divorced 2 (4) 1 (2) 
Widowed 5 (9) 3 (6) 
Educational Level     
Degree 2 (3.6) 2 (3.6) 
Diploma 3 (5.5) 7 (12.7) 
Secondary 24 (43.6) 20 (36.4) 
Primary 16 (29.1) 16 (29.1) 
None 10 (18.2) 10 (18.2) 
MMSE (mean± SD) 24 ± 5.1** 27±3.1** 
FIM Admission Mobility score 
(mean± SD) 2 ± 2.1* 1± 0* 
Co-morbidities    
Previous stroke 10 (18.2)* 0* 
Diabetes 20 (36.4) 16 (29.1) 
Heart Disease 8 (14.5) 8 (14.5) 




4.9.2 Incidence of New-Onset Constipation 
The median length of stay for the stroke group was eight days (range 2-70) 
and four days (range 2-15) for the controls (p=0.001). During hospitalisation, 
18 (33%) patients from the stroke group and 15 (27%) controls developed 
new-onset constipation (p=0.66).  Seven patients (39%) from the stroke group 
and four (27%) controls developed the first onset of constipation on Day 2 of 
their admissions. Constipation developed in both groups between Day 2 and 
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Figure 4.3. Day of New-Onset Constipation in Patients with Stroke and 
Orthopaedic Conditions during Acute Hospitalisation. The development of new-
onset constipation is from the 2nd to 14th day of admission. 
 
4.9.3 Predictors of New-Onset Constipation 
Table 4.2 shows the association between new-onset constipation and possible 
predictors. For both groups, the risk of developing new-onset constipation was 
significantly higher in the Indian ethnic group as compared with the Chinese 
ethnic group. Patients, who were dysphagic, stayed in the hospital longer, used 
bedpan for defecation or used antacids had a higher risk of developing 
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constipation whereas patients who used prophylactic laxatives, gained higher 

































Table 4.2  
 
Univariate Analysis on the Association between New-Onset Constipation and Demographics, Co-














no (%) / 
mean±SD / 
median 





0.598 0.992 0.964 1.021 
Gender Male 20 (30) 46 (70) . 1.000 . . 
  
Female 13 (30) 31 (70) 0.934 0.975 0.533 1.783 
Conditions Orthopaedic 15 (27) 40 (73) . 1.000    
  
Stroke 18 (33) 37 (67) 0.513 1.200 0.695 2.073 
Ethnicity Chinese 24 (27) 63 (72) . 1.000 . . 
  
Malay 3 (25) 9 (75) 0.875 0.927 0.361 2.377 
  
Indian 5 (56) 4 (44) 0.016 2.150 1.154 4.006 
  
Others 1 (50) 1 (50) 0.587 1.677 0.259 10.855 
Co-
morbidity 




0.300 0.664 0.306 1.441 
  
Heart Disease 6 (38) 10 (62) 0.300 1.362 0.760 2.441 
  




 (12-30)  
27  
(9-30)  
0.145 0.959 0.906 1.015 















0.026 0.452 0.224 0.911 
  Dysphagia 13 (46) 15 (54) 0.015 1.881 1.129 3.132 
  Dysphasia 1 (33) 2 (67) 0.893 1.103 0.262 4.650 
  
Mobility Gains 0 (0-5) 4 (0-6) <0.001 0.722 0.620 0.839 
  
Fluid Intake 530 (348) 663 (262) 0.044 0.999 0.998 1.000 
  
Use of Bedpan 9 (75) 3 (25) <0.001 3.125 2.061 4.739 
Lab 
Parameters 




0.377 1.038 0.956 1.127 
  




0.475 1.158 0.775 1.730 
Medications Antithrombotics 19 (26) 54 (74) 0.209 0.701 0.403 1.220 
  
Opioids 10 (23) 34 (77) 0.150 0.637 0.344 1.177 
  
NSAIDs 10 (22) 35 (78) 0.160 0.630 0.331 1.201 
  






Twelve patients (10.9%) used bedpan for a certain time and eight out of the 
twelve patients (66.7%) verbalised difficulty in defecating when using the 
bedpan. Four patients used diapers and eighty-one patients were assisted to the 
toilet. No patients used bedside commode for defecation during the study 
period. Stroke, MMSE, dysphasic, use of antithrombotics, opioids and 
NSAIDs, were not associated with the risk of constipation. 
 
In the multivariate analysis, the following variables were included in the 
model: age, gender, ethnicity, conditions, co-morbidity, length of hospital stay, 
MMSE, mobility gains, oral fluid intake, dysphagia, dysphasia, use of bedpan, 
laboratory parameters, use of prophylactic laxatives, antithrombotics, opioids, 
NSAIDs and antacids.  Length of stay, prophylactic laxatives, mobility gains 
and use of bedpan remained as significant predictors. For every one day 
increase in hospital stay, the risk of new-onset constipation would increase by 
3.2% (95% CI: 0.6 % to 6.0 %). Patients who took prophylactic laxatives had 
their risk decreased by more than half (67%) compared to those without 
prophylaxis (95% CI: 15.5 % to 70.3 %). For every one point of mobility 
gained in FIM score, the risk also decreased by 25.9% (95% CI: 12.7 % to 
47.0%). Patients who used bedpan for defecation were twice more likely to 
develop constipation compared with those who did not use bedpan (95% CI: 








Multivariate Analysis on the Association between New-Onset Constipation and 
Demographics, Co-morbidity, Clinical Factors, Laboratory Parameters and 
Medications 
Variables p value RR 95% CI 
Age   0.602 0.989 0.949 1.031 
Gender Male . 1.000 . . 
  
Female 0.728 1.108 0.621 1.977 
Conditions Orthopaedic . 1.000 . . 
  
Stroke 0.270 0.417 0.088 1.971 
Ethnicity Chinese . 1.000 . . 
  
Malay 0.399 0.576 0.160 2.074 
  
Indian 0.077 2.272 0.914 5.645 
  
Others 0.194 4.482 0.466 43.063 
Co-morbidity No Diabetes . 1.000 . . 
  
Diabetes 0.139 0.537 0.236 1.224 
  
No Heart Disease . 1.000 . . 
  
Heart Disease 0.159 0.586 0.278 1.233 
  
No Previous Stroke . 1.000 . . 
  
Stroke 0.954 0.973 0.389 2.433 
Clinical Factors MMSE 0.592 0.978 0.900 1.062 
  





 1.000   
  
Use of Prophylactic 
laxatives  
0.004 0.331 0.155 0.703 
  
No Dysphagia  1.000   
 
Dysphagia 0.220 1.827 0.697 4.789 
  
No Dysphasia . 1.000 . . 
  
Dysphasia 0.087 0.039 0.001 1.603 
  
Mobility Gains <0.001 0.741 0.630 0.873 
  
Fluid Intake 0.746 1.000 0.999 1.002 
  
Did Not Use 
Bedpan  1.000   
  
Use Bedpan 0.012 2.058 1.172 3.614 
Laboratory 
Parameters 
WBC Count 0.627 1.027 0.923 1.141 
  







Antithrombotics 0.088 0.528 0.254 1.099 
  
No Opioids  1.000   
  
Opioids 0.823 1.141 0.359 3.624 
  
No NSAIDs  1.000   
  
NSAIDs 0.428 0.669 0.247 1.808 
  
No Antacids  1.000   
  




4.9.4 Number of Physiotherapy Sessions 
Ninety patients (81.8%) attended at least one PT session during the study 





4.9.5 Use of Prophylactic Laxatives 
Forty-one patients (37.3%) were prescribed one or more prophylactic laxatives 
during their hospitalisation. The most frequently prescribed laxatives were 
lactulose (n=39) and sennosides (n=27) (Figure 4.4). Eleven patients were 
prescribed one laxative, twenty-four patients were prescribed two laxatives 

































Figure 4.4. Types of Prophylactic Laxatives Used during Acute Hospitalisation. 
 
4.10 Discussion and Recommendations 
4.10.1 Incidence of New-Onset Constipation 
The incidence of new-onset constipation during hospitalisation is considerably 
high for both groups, but lower compared with previous studies of 55% 
(inpatients with first stroke at the Department of Neurology and Stroke Centre 
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in a University Hospital) (Su, et al., 2009) to 60% (inpatients of a stroke 
rehabilitation centre) (Robain, Chennevelle, Petit, & Piera, 2002). These 
differences could be due to the variation in definitions and study periods. In 
clinical practice, healthcare practitioners often define constipation as bowel 
frequency less than three per week (Bracci et al., 2007; Robain et al., 2002) or 
absence of bowel movements for two or more consecutive days (Doshi et al., 
2003). However, symptoms such as straining and hard stools were strongly 
associated with self-reported constipation (Harari, Gurwitz, Avorn, Bohn, & 
Minaker, 1997), highlighting that stool frequency should not be the only 
criteria used to define constipation. Su et al. (2009) defined constipation 
according to Rome II criteria, recruited only patients with first stroke and 
measured outcomes at four weeks. We defined constipation based on the 
symptoms adapted from Rome III criteria, recruited patients with acute stroke 
without pre-existing bowel dysfunctions and measured outcomes during 
patients’ hospitalisation or within the first four weeks, whichever was earlier. 
As such, we were unable to adopt the duration criteria of Rome III where 
symptoms have to be present for the last three months with onset of at least six 
months prior to diagnosis. It is also challenging to manage patients with new-
onset constipation clinically if treatment initiation is based on fulfilling the 
percentage criteria of Rome III e.g. straining during at least 25% of 
defecations etc. Treatments are often sought by patients and initiated by 
physicians at first few instances of reported symptoms, and physicians do not 
wait till patients fulfil the percentage criteria. These suggest that Rome III 
criteria may have its limits for interventional use on patients presenting with 
acute symptoms of constipation and with short hospital stay. Perhaps some 
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modifications may need to be considered before it is feasibly used to manage 
patients in acute clinical settings.  
 
4.10.2 Stroke and New-Onset Constipation 
Stroke, per se was not a predictor of new-onset constipation when compared 
with the orthopaedic group in our study, although some studies have indicated 
otherwise (Bracci et al., 2007; Otegbayo et al., 2006). Instead, factors such as 
length of stay, prophylactic laxatives, mobility gains and use of bedpan were 
associated with the new-onset constipation. The previous studies by Bracci et 
al. (2007) and Otegbayo et al. (2006) were conducted using cross-sectional 
designs and measured prevalence of constipation. Bracci et al., (2007) 
compared stroke with orthopaedic patients with at least three months of 
physical immobility whereas Otegbayo et al. (2006) compared stroke with 
normal volunteers and inpatients with non-neurology/gastroenterology 
conditions a few hours of their admission. This study compared stroke with 
orthopaedic patients without pre-existing bowel dysfunction and prospectively 
followed them through their hospitalisation measuring incidence of new-onset 
constipation.  
 
4.10.3 Physical Exercises and New-Onset Constipation 
Constipation is often associated with physical inactivity and low functional 
status (Robain et al., 2002). Physical exercises can enhance colonic propulsion 
(S. S. Rao, Beaty, Chamberlain, Lambert, & Gisolfi, 1999) and regular 
exercise regimes  improve defecation symptoms (De Schryver et al., 2005; 
Dukas, Willett, & Giovannucci, 2003). In patients with acute stroke, 
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constipation was found to be associated with low functional status (Yi, Chun, 
Kim, Han, & Park, 2011). In this study, the mean mobility scores of both 
groups on admission was low, reflecting that the patients were either requiring 
‘total assistance’ of score 1 or ‘maximum assistance of score 2.’ The stroke 
rehabilitation was initiated early and most patients attended at least one PT 
session. The number of PT sessions that the patients attended positively 
correlates with their mobility gains. However, the intensity and duration of the 
PT sessions vary according to patients’ conditions. The ultimate goal of PT 
sessions is to achieve optimal mobility gains and our findings indicate that 
higher mobility gains significantly reduce the likelihood of developing 
constipation. In clinical practice, it is difficult to pre-determine the degree of 
mobility or functional gains in each patient as it also depends on other factors 
such as severity of disability, cognitive status, psychological factors and length 
of stay (Cameron, Schaafsma, Wilson, Baker, & Buckley, 2012; Kortte, 
Stevenson, Hosey, Castillo, & Wegener, 2012; Ng et al., 2007). Since early 
ambulation through standardised mobility protocols have shown to improve 
functional status from admission to discharge of hospitalised older adults and 
patients recovering from surgery (Pashikanti & Von Ah, 2012), efforts could 
be directed to initiate early ambulation through PT. As to the optimal amount 
of PT needed to achieve significant mobility gains however this need further 
investigation.  
 
4.10.4 Use of Bedpan and New-Onset Constipation 
The use of a bedpan is a common practice in hospitals. In acute care, it was 
found that 18.2% of patients used bedpans for a certain time during 
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hospitalisation. Departments that were frequently associated with the use of 
bedpans were orthopaedic and surgical wards followed by medical wards 
(Saxer, Gattinger, Dopler, Scheffel, & Werner, 2011). Patients who used 
bedpans were often confronted with pain and inconveniences (coldness and 
hardness of bedpan; uncomfortable positions and hygiene inconveniences) 
(Gattinger, Werner, & Saxer, 2013).  In this study, the number of patients who 
used bedpans is relatively small (10.9%).  Most reported difficulty in 
defecation using the bedpan especially in lying position.  Body positioning can 
have a significant influence in successful defecation. In lying position, there is 
a dyssynergic pattern of defecation (paradoxical increase in anal sphincter and 
a rise in the intrarectal pressure) observed in healthy person which influence 
the expulsion of stool. In sitting position with distended rectum, a normal 
defecation pattern (a rise in intrarectal pressure that synchronized with 
relaxation of anal sphincter) is observed with the ability to expel stool (Rao, 
Kavlock, & Rao, 2006). Moreover, a correct sitting position with legs 
adequately flexed in a commode or at a toilet opens the anorectal angle at its 
maximal width and further promotes defecation (Altomare et al., 2001). The 
gravitational effect of  sitting position also maximizes the use of voluntary 
control of intra-abdominal pressure which trigger increased activity in the 
enteric nervous system and influences the process of defecation (Brading & 
Ramalingam, 2006).  At times, the use of bedpan other than of a habit and 
convenience is also based on the assumption that patients may exert 
themselves more if they are to use alternatives such as a bedside commode. On 
the contrary, energy expenditure in terms of oxygen consumption was 
observed to be consistently higher while on a bedpan than a commode (Benton, 
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1950). Sitting position appears to be more effective than the lying position in 
successful defecation and thus practice protocol should perhaps extensively 
advocate the use of defecating devices that allows proper sitting positioning to 
promote a normal defecating pattern. Future studies could also explore the 
influence of positioning and measure the individual contributions of 
abdominal muscles and pelvic floor muscles in promoting successful 
defecations.   
 
4.10.5 Use of Prophylactic Laxatives and New-Onset Constipation 
Laxatives are often used to relieve existing symptoms of constipation and 
rarely as a prophylactic treatment except in some settings such as palliative 
care (Klaschik, Nauck, & Ostgathe, 2003). In acutely hospitalised elderly 
patients, it was found that almost one third of them needed a laxative at least 
once every three days (Cardin et al., 2010). Laxatives aid defecation by 
increasing stool volume (bulk), decreasing stool consistency (softening) and/or 
stimulate colon motility. In this study, we observed that prescribing 
prophylactic laxatives was not a standard practice in either Stroke or 
Orthopaedic Units, although impaired mobility and use of pain medications 
are factors that could potentially increase the risk of developing constipation 
(Bell et al., 2009; Sendir, Buyukiylmaz, Asti, Gurpinar, & Yazgan, 2012). Our 
findings indicate that patients who were prescribed prophylactic laxatives 
were less likely to develop constipation. The two most commonly used 
laxatives were osmotics (lactulose) and stimulants (sennosides). These 
laxatives were used as a single agent or in combination with two or more 
agents. The difference in frequency of laxatives used could be due to the 
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different prescribing norms between the two units or doctors. There was no 
specific sequence of order on the types of laxatives prescribed. Some 
guidelines on managing chronic constipation recommended treatment starting 
with osmotic laxatives, stool softener and bulk-forming agents followed by 
stimulant laxatives as the last option when non-pharmacological treatment 
fails (Bove et al., 2012; Tack et al., 2011). Laxatives are generally well-
tolerated when used for the treatment of chronic constipation (Fleming & 
Wade, 2010). When used as prophylaxis, they effectively reduce the incidence 
of opioid-induced constipation in cancer patients (Ishihara et al., 2010; 
Ishihara et al., 2012) and critically-ill patients (Masri, Abubaker, & Ahmed, 
2010). Hence, perhaps one of the preventive measures to consider is to use 
laxatives as a short-term prophylaxis on acutely hospitalised patients with 
stroke and orthopaedic conditions. Future studies should further explore the 
use of various short-term prophylactic laxatives and monitor its efficacy, 
tolerability and cost-benefits.  
 
4.10.6 Opioids and New-Onset Constipation 
Medications such as opioids which are known for their effect on constipation 
were not identified as a predictor in this study. Most of the opioids users were 
from the orthopaedic group where these medications were prescribed to 
relieve their acute pain after surgery and for a short period of time.  The 
cumulative doses which were not presented in this study and short-term use 




4.10.7 Length of Stay and New-Onset Constipation 
In-hospital medical complications including constipation are often associated 
with longer length of stay (Ingeman, Andersen, Hundborg, Svendsen, & 
Johnsen, 2011a; Pizzi et al., 2012; Su et al., 2009). This is in line with the 
knowledge that longer hospitalisation increases the risk of developing medical 
complications. In this study, patients who stayed longer were more likely to 
develop constipation. The first occurrence of constipation in our study was at 
Day 2 of admission which calls for an early preventive intervention.  However, 
the incidence of constipation ceased from Day 14. This is probably attributable 
to the fact that most of the patients were undergoing physical therapy as part 
of their rehabilitation treatment and thus would have gained gradual 
improvements in their mobility status as they stayed longer, contrary to the 
general belief that longer hospital stay equates prolonged bedboundness. 
These findings suggest that preventive interventions should be initiated as 
early as Day 1 of admission and continued for 14 days. 
 
4.11 Limitations of Phase 1 Study and Recommendations for Future 
Study 
This study compared stroke with orthopaedic patients. As such, the findings 
could only indicate that stroke was not a predictor of constipation when 
compared to orthopaedic conditions. Both groups of patients might share 
certain similar characteristics which could be further explored. Critically ill 
patients were excluded from the study as the diagnostic criteria of constipation 
were symptom based. This might have resulted in a certain percentage of 
patients with constipation being missed. The involvement of one large tertiary 
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hospital limits the generalisability of the findings. Future studies could 
investigate patients with other medical conditions and involve multiple sites. 
This study could serve as a reference for future larger scale studies in 
developing a hospital wide constipation management protocol.  
 
4.12 Conclusion and Implications for Practice  
In conclusion, this study highlighted that new-onset constipation is a common 
complication after acute stroke as well as in patients admitted to hospital with 
orthopaedic conditions. As such, healthcare providers should be more aware 
and actively screen, prevent and manage constipation in this group of 
hospitalised patients. The early occurrence of constipation calls for prompt 
preventive measures which should be initiated from Day 1 of admission and 
continued until Day 14. Mobility gains and the use of prophylactic laxatives 
were protective against constipation. Bedpan use and longer length of stay 
increased the risk of developing new-onset constipation. These study findings 
should be translated into a practice protocol to guide clinical practice.  
 
One manuscript was accepted for publication by the International Journal of 
Clinical Practice (IF 2.427) on 18 July 2014 based on this Phase 1 Study 
(Appendix 18). 
 
Following this study, a bowel management programme was developed based 
on the modifiable predictors identified in this Phase 1 study and is presented in 
the next chapter.  
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Chapter 5 
Bowel Management Programme Framework 
 
5.1 Introduction 
This chapter presents the development and integration process of the new 
bowel management programme based on the results of the Phase 1 study. 
From the Phase 1 study, it was identified that the incidence of constipation 
was high for both stroke and orthopaedic groups during acute hospitalisation. 
The onset was as early as Day 2 of hospitalisation and several factors were 
identified as predictors of constipation. The modifiable predictors were 
specified and incorporated into a new bowel management programme which 
serves as part of the preventive strategies in managing constipation in patients 
with stroke. 
 
5.2 Development Process 
5.2.1 Aim of the Bowel Management Programme 
The primary aim of establishing a bowel management programme was to 
reduce the incidence of constipation in patients with stroke during acute 
hospitalisation.  The identified predictors of constipation were Indian, 
dysphagia, length of hospital stay, mobility gain, fluid intake, use of bedpan, 
use of prophylactic laxatives and antacids. Out of the eight predictors, three 
were modifiable. The modifiable predictors were fluid intake, bedpan use and 
the use of prophylactic laxatives. These modifiable predictors were 
incorporated into the bowel management programme. 
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5.2.2 Defining Programme Framework and Structure  
The bowel management programme framework consisted of the following 
components:  
1) Practice protocols: clinical and education  
2) Education materials: flashcards and poster/bookmark  
3) Flowchart of bowel management programme 
4) Bowel management programme checklist  
 
5.2.2.1 Practice Protocols 
One of the strategies to implement clinical guidelines or protocols that can 
change clinical practice effectively is to have a properly developed guideline, 
followed by dissemination using an active educational intervention and 
implementing it using patient-specific reminders (Centres for Reviews and 
Dissemination, 1999). As such, there were two sections of practice protocol: 
clinical and education. The education session and patient-specific reminders 
such as poster/bookmarks were introduced to serve as a reinforcement to 
enhance programme compliance.  
 
Clinical Protocol 
There were three key elements in the clinical protocol: oral fluids, use of 
prophylactic laxatives and avoidance of bedpan. 
 
1. Oral Fluids 
Patients are required to consume at least 800 ml of oral fluids per day, if 
there are no contraindications.  
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Rationale: This amount was decided based on the findings of Phase 1 
study where the mean amount of oral fluid consumed in patients who did 
not develop constipation was 663 ml as compared to patients who 
developed constipation (530 ml).  Hence, a minimum amount of 800 ml 
per day was determined. The definition of fluid intake included oral and 
enteral intake of water, other beverages and soup. 
 
2. Use of prophylactic laxatives 
Physicians are to assess patients on their suitability for prophylactic 
laxatives. If patients are deemed fit with no contraindications, a single or 
combination of two or three laxatives are prescribed. 
Rationale: Based on Phase 1 study findings, patients who consumed at 
least one laxative were less likely to develop constipation. 
 
3. Avoidance of bedpan 
Nurses are to assess the patients’ mobility status. Bedpan must be 
avoided if patients are not on ‘Complete Rest In Bed’ (CRIB) and able to 
transfer safely with or without assistance. Nurses are to assist patients to 
the toilet or offer other defecating equipments such as bedside commode.  
Rationale: In Phase 1 study, patients who used bedpan for defecation 







There were three elements in the education protocol: a one-to-one education 
session, flashcards and poster/bookmark. 
  
1. One-to-one education session 
Patients will receive an education session at their bedside instead of 
group teaching in a classroom setting due to their acute condition, which 
requires them to be monitored closely in the Stroke Unit. This education 
session provides them information on the definition of constipation and 
modifying factors affecting constipation.  
There are five sections in this education session: 
 
• What is constipation? 
This section introduces constipation as a common symptom after 
stroke, its early onset and early measures to prevent it. The 
symptoms leading to the diagnosis of constipation are also presented. 
 
• A fluid way to prevent constipation: Drink at least 800 ml of fluids 
daily 
This section specifies the daily amount of fluids to drink during 
hospitalisation, the rationale for drinking adequate fluids and 
recommends types of fluids to drink. Patients are also encouraged to 
consume oral fluids during and between each meal, to drink fluids 
during the day and limit their intake in the evening to decrease the 
need to urinate during the night. 
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• Exercising constipation out of your life: Start exercise early 
This section explains the benefits of exercise and mobility gains in 
reducing the likelihood of developing constipation. 
 
• Defecating device: Limit the use of bedpan 
This section links the likelihood of developing constipation with 
bedpan use and how using bedpans affect the mechanism of normal 
defecation. It suggests alternatives such as a bedside commode or 
going to the toilet if patients are not required to rest in bed 
completely or are able to transfer safely. 
 
• Safe use of laxatives: Take your drugs as prescribed  
This section explains the benefit of short-term prophylactic laxatives 
in reducing the likelihood of developing constipation and how the 
laxatives work. It further emphasises the safe use of laxatives and to 
use it only with a doctor’s prescription. 
 
On Day 2 of recruitment, a second session is held for feedback and 
clarification. 
 
5.2.2.2 Education Materials: Flashcards and Poster/Bookmark 
Flashcards 
The five sections of the education session would be presented through 
the use of flashcards in English. The flashcards were designed with 
characteristics to increase patients’ readability and understanding: 
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large font size and colourful pictures to complement the text 
(Appendix 10). The content was written at the level of 7th to 8th grade 
(equivalent to reading age 13) to match an average stroke patient’s 
reading literacy (Eames, McKenna, Worrall, & Read, 2003; Hoffmann 
& McKenna, 2006). 
 
Poster/Bookmark 
In addition to the education session, a set of constipation 
poster/bookmark in four languages (English, Chinese, Malay and 
Tamil) were developed. Once patients’ preferred languages were 
determined, the selected posters would be pasted on their bedside rails. 
The purpose of the posters was to serve as a reminder for patients to 
comply with the bowel management programme. The posters could be 
converted to four bookmarks for patients to bring home upon their 
discharge (Appendix 11). 
 
5.2.2.3 Flowchart of Bowel Management Programme 
The bowel management programme flowchart diagrammatically displays an 
overview and sequence of the clinical and education protocols (Figure 5.1). 
The purpose of developing the flowchart was to provide the staff a common 









Figure 5.1.  Bowel Management Programme Flowchart
Education 
1st session (Day 1 of Recruitment) 
Information about constipation and preventive 
measures – focusing on modifying factors 
affecting constipation e.g use of 
prophylactic laxatives, oral fluid intake 
and avoidance of bedpan 
2nd session (Day 2 of Recruitment) 
Feedback and clarification session 
Education Protocol 





to laxatives e.g 
drug allergy 
Physician to prescribe 
single or combined 
laxatives (two to 
three) e.g forlax, 




Not on CRIB and 




equipment such as 
bedside commode or 
assist to toilet. Avoid 




to oral fluids e.g 
NBM, restrict fluid 
<800 ml/day 
Ensure oral fluids 
at least 800 ml/day  
Clinical Protocol 
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5.2.2.4 Bowel Management Programme Checklist 
The bowel management programme checklist was developed to provide a 
comprehensive list of steps to be taken in a specific order (Appendix 12). 
There were seven sections in the checklist. 
 
First Section 
The first section records patient’s demographic data.  
 
Second and Third Sections 
The second and third sections list the inclusion and exclusion eligibility 
criteria for the bowel management programme.  
 
Fourth to Six Sections 
The fourth to sixth sections consist of the work process of the clinical protocol 
which focuses on prophylactic laxatives, oral fluids and defecating equipment. 
The sections on prophylactic laxatives and oral fluids are to be completed by a 
doctor. The section on defecating equipment is to be completed by the nurse 
in-charge. To address patients’ safety, this section provides nurses with a 
simple patient assessment component to guide their decision making. The 
safety components include assessing patients’ medical fitness to be moved out 
of bed and patients’ ability to transfer safely with or without assistance. 
 
Seventh Section 
The last section is the workflow process of the educational protocol.  
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5.2.3 Defining Intervention Level  
The intervention would affect three levels: Individual, team and department. 
The bowel management programme would be implemented in a Stroke Unit 
which admits all patients with stroke from the Department of Emergency 
Medicine. 
 
Department: This change would impact the Department of Neurology and 
Nursing. As such, team and individual change were necessary. In order to 
support the department appropriately during the change, numerous 
interventions at different levels will be required. 
 
Team: This change would impact the neurology and nursing team working in 
the Stroke Unit as this bowel management programme involves new processes 
and tasks. Team dynamics might be affected which will likely affect 
communication, interaction and cooperation. Strategies to support the team 
before and during implementation of the bowel management programme are 
important. 
 
Individual: This change would impact individual staff working in the Stroke 
Unit. Firstly, staff that would be affected will be identified. Secondly, the 
ways in which they would be affected will be explored to determine the 




  116 
 
5.2.4 Defining Intervention Agent 
Clinical Protocol 
The intervention agents for the clinical protocol were the ward physicians and 
nurses in the Stroke Unit.  
 
Educational protocol 
The intervention agent for the educational protocol was the PhD candidate. 
 
5.2.5 Defining Target Population 




•  Patients age ≥ 21 years old   
•  Admitted within 24 hours for stroke 
•  Stroke diagnosis confirmed by neurologist and supported by CT scan / 
MRI 
•  No pre-existing bowel dysfunctions 
 
Exclusion criteria: 
• Patients who are  
-  on the dangerously ill list 
-  unable to communicate  
-  on fluid restriction less than 800 ml per day 
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5.2.6 Review of Drafts 
The bowel management programme was reviewed by a panel of experts.  
 
First Draft 
The first draft was written by the PhD candidate, who is an Advanced Practice 
Nurse specialising in medical/surgical care and rehabilitation medicine.  
 
First Review 
The first draft was reviewed by a rehabilitation physician and a rehabilitation 
specialty nurse. Amendments were made after the first review. 
 
Second Review 
The second draft was reviewed by a panel consisting of a rehabilitation 
physician, a biostatistician and an academic professor, all of whom have 
experience relevant to this clinical research. The second draft was revised 
according to the panel’s suggestions. 
 
Final Review 
The final draft was presented to a neurologist who manages the stroke 
population. The programme was revised until comments from all reviewers 
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5.3 Framework for Implementing the New Bowel Management 
Programme 
The Roger’s Diffusion of Innovation Theory was used as the framework to 
integrate the new bowel management programme into practice (Rogers, 
1995b). The theory provides a conceptual paradigm for understanding the 
process of diffusion and social change, and explicitly connects diffusion of 
innovations to communication processes among members of a social system. 
The bowel management programme was an innovation and had to be widely 
adopted in the designated Stroke Unit in order to be self-sustaining. The 
successful integration process of this new programme was dependent on 
human factors. As such, this theory was appropriate as it provides a structured 
framework for integrating new ideas and its process focuses on human capital.  
 
Diffusion is a process by which 1) an innovation 2) is communicated through 
certain channels 3) over time 4) among the members of a social system 
(Rogers, 1983). The four key elements are innovation, communication 
channels, time and social system. The integration of the new bowel 
management programme was based on these four key elements: 
 
1. Innovation 
Innovation is defined as “an idea, practice, or object that is perceived 
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2. Communication channels 
Communication is a “process by which participants create and share 
information with one another in order to reach a mutual understanding”. 
The communication channel was the “means by which messages get 
from one individual to another” (Rogers, 1983). 
 
3. Time 
The time dimension involved in diffusion is in three phases: 1) time 
required in the innovation decision process by an individual, from 
receiving the first knowledge of an innovation through its adoption or 
rejection; 2) time required for an innovation to be adopted in an 
individual compared with other members of a system; 3) an 
innovation’s rate of adoption in a system  (Rogers, 1983). 
 
4. Social system 
A social system is “a set of interrelated units that are engaged in joint 
problem solving to accomplish a common goal” (Rogers, 1983). 
 
With the four elements, there are a number of factors required for the 
successful adoption of innovation.  
 
Intrinsic factors influence the rate of adoption, which is the relative speed in 
which an innovation is adopted by members of a social system. Rogers (1995a) 
outlined the intrinsic factors including: (1) perceived attributes of innovations, 
(2) type of innovation decision, (3) communication channels, (4) nature of the 
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Figure 5.2. Variables Determining the Rate of Adoption of Innovation.  
Note: From Attributes of Innovations and their Rate of Adoption In Diffusion of 
Innovations, p207, by Rogers, 1995a, New York: The Free Press. 
 
5.3.1 Perceived Attributes of Innovations 
About 49% to 87% of the variance in rate of adoption is explained by five 
attributes. Innovations that are perceived as having greater relative advantage, 
compatibility, trial ability, observability, and less complexity are adopted more 
rapidly (Rogers, 1995a). As such, the presentation of the new bowel 
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Table 5.1  
 
Characteristics of Change 
 
Characteristics Description Effect of Change 
Relative Advantage  The degree to which 
the bowel management 
programme is 
perceived as better than 
the idea it supersedes 
e.g standard care. 
The new bowel management 
programme offers relative 
advantage to patients and 
healthcare workers. 
Patients 
- reduce incidence of 
constipation 
- minimise discomfort of 
developing constipation 
- maximise rehab outcomes 
Nurses & Doctors 
- enhance status through 
utilisation of evidence-
based practice in patient 
management 
- minimise risk of managing 
complications of 
constipation 
Compatibility  The degree to which 
the bowel management 
programme is 
perceived as being 
compatible with 
existing values, past 
experiences, and the 
needs of potential 
adopters. 
The new bowel management 
programme integrates well into 
the existing stroke clinical care 
pathway designed to enhance 
quality of care and reduce the 
length of hospital stay. It 
promotes: 
• adequate hydration needs by 
encouraging patients to drink 
at least 800 ml of fluids per 
day 
• elimination needs by 
encouraging the use of 
devices which enhance  
elimination manoeuvres 
• regular bowel habits by 
using prophylactic laxatives 
to prevent constipation. 
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Characteristics Description Effect of Change 
Complexity  The degree to which 
the bowel management 
programme is 
perceived as difficult to 
understand and use. 
The integration process of the 
new bowel management 
programme was planned in stages 
to ensure that it was not 
implemented too rapidly and 
drastically for clinicians to accept.  
The programme was transcribed 
into a clinical and education 
protocol and presented 
diagrammatically in a flowchart 
for easy understanding. A 
working checklist was developed 
to provide a comprehensive list of 
steps to be taken in a specific 
order.   The programme 
complements the existing stroke 
clinical care pathway which is 
easy to understand and is 
adoptable. 
Trial ability The degree to which 
the bowel management 
programme may be 
trialled and modified. 
The new bowel management 
programme would be tested for 
feasibility in actual clinical 
settings targeting at a small group 
of stroke patients admitted to the 
Stroke Unit. This is to explore its 
acceptability to patients, nurses 
and clinicians and its potential 
outcomes in preventing 
constipation. The programme 
would be modified based on the 
feasibility study’s findings before 
it is implemented across the 
whole unit.  
Observability The degree to which 
the results of the bowel 
management 
programme are visible 
to others. 
The adoption and compliance to 
the bowel management 
programme would be presented as 
compliance outcomes in the 
feasibility study. The overall aim 
of the bowel management 
programme was to reduce the 
incidence rate of constipation 
among patients with stroke. The 
incidence of constipation would 
be monitored and presented as a 
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5.3.2 Types of Innovation Decision 
There are three types of innovation decision: 
1. Optional Innovation Decision : Decision is made by an individual who is 
in some way distinguished from others in a social system 
2. Collective Innovation Decision: Decision is made collectively by all 
individuals of a social system 
3. Authority Innovation Decision: Decision is made for the entire social 
system by few individuals in positions of influence or power. 
 
Generally, innovations that require optional innovation decision are adopted 
more rapidly and the rate of adoption is slower when more people are involved 
in making an innovation-decision (Rogers, 1995a). As such, one of the 
strategies to speed the rate of adoption was to alter the unit of decision so that 
fewer people would be involved in the decision making. Two persons were 
involved in the decision to adopt the new bowel management programme; the 
Head of Department and the Senior Nurse Manager of the Neurology 
Department. They were approached separately to explain the proposed new 
idea and its expected outcomes.  
 
5.3.3 Communication Channels 
5.3.3.1 Identifying Opinion Leaders 
Identifying members of the social system in which they exert influence 
could enhance the rate of adoption. The bowel management 
programme would be implemented on a group of stroke patients 
admitted to the stroke unit. The Stroke Unit was under the helm of the 
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Head of Neurology Department (HOD) and Senior Nurse Manager 
(SNM) of the Neurology Ward. Both were identified as opinion leaders. 
 
5.3.3.2 Identifying Communication Process 
The first step of the communication process was to convince and 
obtain buy-in support from influential and respected clinicians or 
opinion leaders, for example, HOD and SNM. This would prompt the 
other neurologists and ward nurses to adopt the programme. The HOD 
and SNM were engaged through one-to-one briefings based on the 
evidence findings and recommendations from Phase 1 study. This was 
followed by a detailed powerpoint presentation communicated by e-
mail. The programme was further disseminated to the teams of 
neurologists via electronic communication networks (for example 
emails sent by the HOD). Subsequently, small group briefing sessions 
were conducted for the ward staff over a period of one month. 
Multifaceted interventions of two or more interventions were more 
likely to produce effective clinical behaviour change than single 
interventions (Centres for Reviews and Dissemination, 1999). As such, 
a follow-up was done by using other means of communication 
strategies to promote the bowel management programme  
i) a reference file was put up in the Stroke Unit; 
ii) a bowel management checklist was implemented to facilitate work 
processes and  (Appendix 12); 
iii) a poster/bookmark was pasted at the patients’ bedside rails by the 
PhD Candidate to serve as a reminder to both patients and staff 
(Appendix 11). 
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5.3.3.3 Time (Decision-Making Process) 
Individuals and organisations move through the decision–making 
process at different rates, depending upon whether they are innovators, 
early or late adopters. The adoption of the bowel management 
programme was first targeted at convincing the opinion leaders and 
early adopters e.g. HOD, SNM and Nurse Managers (NMs) of the 
neurology ward. 
 
5.3.3.4 Adopter Categories 
An individual’s adopter category determines the rates of adoption for 
an innovation. Early adopters require a shorter adoption period than 
late adopters. There are several strategies to enhance and ensure that 
the innovation reaches the stage of critical mass where the continued 
adoption is self-sustaining. Based on the innovation adoption curve of 
Rogers, some individuals are more open to adaptation of changes 
(Figure 5.3). 
The adopter categories are identified as:  
• innovators (venturesome) 
• early adopters (respectable) 
• early majority (deliberate) 
• late majority (sceptical) 
• laggards (traditional) 
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Figure 5.3. Diffusion of Innovation Adopter Categories. 
Note: From  “Diffusion of Innovation Theory” by Kaminski, 2011, Canadian Journal 
of Nursing Informatics, 6(2), Figure 1. 
 
The change process was first targeted at convincing the opinion leaders and 
early adopters, for example HOD, SNM, NMs and so on. 
 
5.3.4 Nature of the Social System 
There was a strong leadership that was committed to effecting change in the 
Department of Neurology. As such, strategies were aimed targeting through 
the bureaucratic system (from HOD and SNM), emphasising on the impact of 
the bowel management programme towards patient outcomes. Reassurance 
was given that there would be outcome measures on compliance rate and 
adverse effects. 
 
5.3.5 Extent of Change Agent’s Promotion Efforts 
The extent of effort a change agent provides can influence an innovation’s rate 
of adoption. One of the factors that can enhance the rate is communication 
activities with adopters. The most significant gain from the change agent’s 
effort is when opinion leaders agree to adopt the innovation. Thereafter, the 
innovation will continue to diffuse with little promotion effort needed by the 
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change agents till critical mass is reached. Two change agents were actively 
promoting the bowel management programme. One was a rehabilitation 
physician who reviews the rehabilitation needs of patients admitted for stroke 
in the Stroke Unit. In his consultation review, the integration of the new bowel 
management programme was strongly recommended. Another agent was the 
PhD Candidate who was in charge of disseminating the evidence-based 
findings (Phase 1 study) and recommending this evidence-based practice 
(bowel management programme) at various platforms: local and overseas 
scientific meetings, meetings with HOD, SNM and small group briefings. She 
was also physically present at the Stroke Unit to promote the programme and 
answer queries during the implementation phase. 
 
5.4 Evaluation 
After the implementation of the bowel management programme, it is 
important to evaluate the results of the programme related to the objectives. 
This is to determine the feasibility of the process of implementing the new 
programme. Two types of evaluation would be used to measure the 
programme:  process evaluation for evaluating programme implementation 
and outcome evaluation for evaluating programme effectiveness. Evaluating 
both the process and outcome would enable future processes of the 





  128 
 
5.4.1 Process Evaluation  
Process evaluation examines the steps and activities taken in implementing the 
bowel management programme.  It determines the feasibility of the process of 
implementing the programme and assesses elements such as adherence rates, 
adverse effects and implementation barriers. 
 
The process evaluation was planned to address the following questions: 
1. To what extent is the new bowel management programme being 
implemented as planned? Were the process objectives met? 
Process measure: Screening rates, recruitment rates, retention rates 
 
2. Is the new bowel management programme appropriate for patients with 
stroke? Did the programme cause any unexpected problems? 
Implementation and safety measures: adherence rates for fluid intake, 
avoidance of bedpan and prophylactic laxatives, adverse effects of 
prophylactic laxatives  
 
3. Did the implementation process deviate from the plans? What barriers did 
the physicians and nurses encounter during the implementation phase?  
Process measure: Identify barriers in implementing the bowel 
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5.4.2 Outcome Evaluation  
Outcome evaluation examines the programme’s effectiveness. It measures 
reduction in the incidence of constipation.  
 
The outcome evaluation was planned to address the following question: 
1. What impact of change does it have on patients? Were the outcome 
objectives met? 
Outcome measures: Incidence of new-onset constipation   
 
After the successful buy-in from stakeholders and establishing the workflow 
of the Bowel Management Programme, a second phase of the study was 
conducted to evaluate the process of implementing the new Bowel 
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Chapter 6 
Phase 2 Study 
Feasibility of a Bowel Management Programme in Managing 
Constipation in Patients after Stroke 
 
6.1 Introduction  
This chapter presents the Phase 2 feasibility study of the new bowel 
management programme. The previous chapter detailed the development of 
the new bowel management programme. It also puts in place a proposed 
evaluation component which involves process and outcome evaluation. As the 
bowel management programme was new, the Roger’s Diffusion of Innovation 
Theory was used as a framework to systematically integrate the programme 
for professional practice. Many factors could affect the successful 
implementation of the new bowel management programme, hence a feasibility 
study was first undertaken to assess the potential for successful 
implementation. This feasibility study provides information and evidence to 
support the development and validity of future intervention studies. 
 
6.2 Background of Study 
Bowel management programmes are usually developed using a pragmatic 
approach to manage bowel dysfunction. There is a wide range of bowel 
programmes established for different purposes and conditions. It usually 
consists of various combinations of interventions which are delivered by 
healthcare professionals, carers or patients themselves. The programmes vary 
in terms of aims, frequencies and interventions, depending on the changing 
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needs of individuals or populations. Some bowel programmes are designed for 
patients with chronic constipation and some are targeted at different 
populations such as the elderly, children, adults with spinal cord injury, etc. 
Most bowel management programmes are used to address existing bowel 
symptoms rather than prevent the development of the condition, hence there 
are limited bowel management programmes designed to prevent acute 
constipation. For a bowel management programme to effectively serve the 
purpose it proposes, its practice recommendations have to reflect the best 
available scientific knowledge. Chapter 3 presented a systematic review on 
effective bowel management strategies to manage constipation in adults with 
stroke which found limited evidence. With limited evidence available, it 
remains a challenge to develop an acceptable, safe and effective preventive 
bowel management programme for patients with stroke. 
 
 6.3 Aim of Study 
The aim of the study was to examine the feasibility of the new bowel 
management programme in reducing the incidence of constipation in patients 
with stroke during their acute hospitalisation.  
 
The research questions comprised of two outcomes.  The research questions 
based on the primary outcomes (process, implementation and safety) were:   
1. What are the screening, recruitment and retention rates of the 
feasibility study? 
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2. What are the adherence rates to the education and clinical protocols of 
the Bowel Management programme? 
3. What are the rates of patients developing adverse effects to the 
prophylactic laxatives? 
 
The research question based on the secondary outcome was: 
1. What is the incidence of constipation in patients with stroke after the 




6.4.1 Study Design  
A feasibility study was conducted using a single quasi-experimental post-test 
study design. Patients were recruited within a period of four months (June to 
September 2013). The intervention consisted of a bowel management 
programme. Patients were followed-up during the period of their 
hospitalisation or within the first four weeks, whichever was earlier. 
 
6.4.1.1 Feasibility Study 
Feasibility studies are often conducted before major clinical trials in clinical 
areas. The purpose is to assess the feasibility of conducting a larger scale study 
or simply, to build the foundation of a larger study. There are various specific 
reasons for conducting feasibility or pilot studies. These reasons can be 
grouped under several broad classifications of process, resources, management 
and scientific goals  (Thabane et al., 2010).  
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Process 
This assesses the feasibility of the processes such as recruitment rates, 
retention rates, refusal rates, non-compliance or adherence rates. 
 
Resources 
This assesses the time and resources needed which include capacity of 
investigators or participating centres in performing the tasks. 
 
Management 
This assesses human and data management issues. Some examples include 
challenges faced by study centre or personnel in managing the study, matching 
data from different sources and entering data into the computer. 
 
Scientific 
This assesses the treatment safety, dose, response, effect and variance of the 
effect. Some examples include the safety of the interventions or drugs and 
whether patients respond to the drugs. 
 
In addition to the suggested four reasons, there are also other key areas of 
focus recommended for feasibility studies. One key area is to focus on how the 
programme deliverers and recipients accept and react to the new programme 
(acceptability). Another key area is the extent, likelihood and manner of 
successful implementation of the programme as planned and proposed, usually 
in an uncontrolled design. It measures degree of execution or success / failure 
of the execution (Bowen et al., 2009).  
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An effective bowel management programme is fundamental to the successful 
prevention of constipation. Various factors can affect and determine the 
successful implementation of the programme. A feasibility study using single 
quasi-experimental post test design was used in Phase 2 as firstly, there were 
few existing studies using structured bowel management strategies; secondly, 
the multi-components of the clinical and education sections added to the 
complexity of the intervention; thirdly, there were no studies using this 
specific bowel management programme; and lastly, there was a lack of in-
depth research or scientific knowledge guiding bowel management 
programmes particularly for patients with stroke and during the period of 
acute hospitalisation. Quasi-experimental designs utilise similar structures as 
experimental designs but lack random assignment and comparison groups 
(Portney & Walkins, 2009). This design was chosen as it was not feasible to 
conduct a randomised controlled trial before testing the process and safety of 
specific interventions in the new bowel management programme.  
 
This study assessed the aspects of process, resources, management and 
scientific feasibility of the programme in actual clinical settings. The findings 
would be used to determine whether the bowel management programme could 
be recommended for further efficacy testing against constipation.  
 
6.4.2 Study Intervention 
The bowel management programme framework was developed based on the 
modifiable predictors identified in Phase 1 study. The framework consisted of 
four components: 1) one education protocol and three clinical practice 
  135 
 
protocols; 2) education materials (flashcards and poster/bookmark); 3) a 
flowchart of bowel management programme and 4) a bowel management 
programme checklist. The bowel management programme went through three 
phases of expert panel reviews and focuses on two practice protocols: 1) an 
education protocol and 2) three clinical protocols (avoidance of bedpan, 
prophylactic laxatives and oral fluid intake) (refer Figure 5.1 in Chapter 5).  
 
6.4.2 1 Education Protocol 
Patients were provided with an education session at their bedside. This 
education session provided them information on the definition of constipation 
and modifying factors affecting constipation (fluid intake, exercising, limit use 
of bedpan and safe use of prophylactic laxatives). The education session was 
conducted with the use of flashcards (Appendix 10). In addition to the 
education session, a set of constipation poster/bookmark in patient’s preferred 
language were pasted on their bedside rails to serve as a reminder (Appendix 
11). The poster could be converted to a set of four bookmarks and given to 
patients upon their discharge. On Day 2 of patients’ recruitment, a second 
feedback session was conducted for feedback and clarification. 
 
6.4.2.2 Clinical Protocol 
Interventions which were based on the three clinical protocols (oral fluid 
intake, use of prophylactic laxatives and the avoidance of bedpan) were 
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1. Oral Fluids 
Patients were prescribed to consume at least 800ml of oral fluids per day 
after being clerked and assessed by their attending physicians to ensure 
there were no contraindications.  
 
2. Use of Prophylactic Laxatives 
Patients were prescribed suitable prophylactic laxatives by their 
attending physicians after being clerked and assessed to ensure there 
were no contraindications. The physicians could prescribe a single or a 
combination of two or three laxatives.  
 
3. Avoidance of Bedpan 
Patients’ mobility status was assessed by their attending nurses before 
each defecation episodes to decide on the types of defecation devices to 
be used. Bedpans must be avoided if patients fulfilled the criteria of 
- not on ‘Complete Rest In Bed’ (CRIB)  
- able to transfer safely with or without assistance.  
Patients would be assisted to the toilet or offered other defecating 
equipments such as bedside commode 
 
Preparation of Staff: Staff Briefing 
Staff in the Stroke Unit was briefed in small groups over a period of one 
month. In addition to the briefings, other means of communication strategies 
were included to promote the bowel management programme.  
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These strategies included the followings: 
• a reference file containing all the teaching materials used for staff 
briefing including the PowerPoint slides was put up in the stroke unit  
• a bowel management checklist was implemented to facilitate work 
process (Appendix 12) 
• a poster/bookmark was pasted at the patients’ bedside rails to serve as 
a reminder to both patients and staff (Appendix 11). 
 
6.4.3 Study Settings 
This study was conducted in a Stroke Unit at a 1600-bedded large tertiary 
hospital in Singapore. This setting was chosen as it was the largest tertiary 
hospital in Singapore with a dedicated stroke unit.  
 
6.4.4 Study Participants 
All patients who were admitted to the Stroke Unit were invited to participate 
and screened for eligibility.  
 
Inclusion criteria  
The new-onset stroke must be diagnosed by patients’ primary 
neurologists and further confirmed by CT scan or MRI. Patients must 
be aged 21 years old or older, communicative and recruited within 24 
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Exclusion criteria  
Excluded from the study were: 1) patients with pre-existing 
gastrointestinal dysfunction including constipation, faecal incontinence, 
pathological diseases or cancer of the colon or rectum; 2) patients who 
are on the dangerously ill list, 3) patients who are unable to 
communicate and 4) patients who are on fluid restriction of <800 ml. 
 
6.4.5 Criteria for Recruitment and Recruitment Process 
The list of potential participants was obtained from the Stroke Unit Admission 
List in the EMR system. All patients admitted to the Stroke Unit presenting 
with acute stroke symptoms were screened consecutively for eligibility using a 
Patient Eligibility Check form (Appendix 13). The form consisted of all the 
predetermined inclusion and exclusion criteria of the study.  After determining 
the participants’ eligibility, a detailed explanation of the study was given to 
the participants or their legal representatives. Informed consent was obtained 
from participants or their legal representatives using the Patient Information 
Sheet and Informed Consent Form (Appendix 14). Demographic and baseline 
assessment were conducted immediately after patients’ enrolment. The bowel 
management programme was initiated on Day 1 of admission. Participants 
were followed-up daily till the day of their discharge or at Week 4, whichever 
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Obtain list of potential participants from the Stroke Unit admission list in the Electronic Medical System
Screen potential participants for eligibility based on the inclusion and exclusion criteria using Eligibility 
Check Form 
Approach eligible potential participants or their legal representatives and provide verbal explanation 
regarding the study as indicated in the Participant Information Sheet and Informed Consent Form 
Provide Participant Information Sheet and Informed Consent Form to potential participants or their legal 
representative and obtain informed consent if they agree to participate in study
Enter study participants’ particulars in the study entry register
Obtain study participants’ demographic data and conduct baseline assessment on Day 1 of Admission
Initiate Bowel Management Programme on Day 1 of Admission
Follow-up on study participants till their discharge or at Week 4, whichever was earlier 
 
Figure 6.1.  Phase 2 Flowchart of Study Procedure.  
 
6.4.6 Outcome Measures and Instruments 
6.4.6.1 Primary Outcomes  
The primary outcomes were feasibility of the bowel management programme, 
specifically assessing: 
1. Process outcomes: screening rates, recruitment rates and retention rates 
2. Implementation outcomes: completion rates of receiving education on Day 
1 of admission (education protocol) and adherence rates to the clinical 
protocols of the Bowel Management programme. Fifty percent (50%) 
adherence rates was the threshold set a priori to deem the intervention as 
feasible. 
3. Safety outcome: adverse effects of prophylactic laxatives. 
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Process Outcomes 
1. Screening rates: The number of potential participants screened per 
month.  
All participants admitted to the Stroke Unit were screened by the PhD 
candidate using the eligibility check form for eligibility to enter the 
study within 24 hours of admission. The list of participants screened 
was recorded by the PhD candidate. 
 
2. Recruitment rates: The number of participants enrolled per month 
based on the inclusion and exclusion criteria. 
Participants were enrolled if they meet the inclusion and exclusion 
criteria. The list of participants enrolled was recorded by the PhD 
candidate.  
 
3. Retention rates: The number of participants completed the study. 
Participants were followed-up daily till their discharge or at Week 4, 




1. The number of participants successfully received education on Day 1 
of admission (education protocol) 
Each participant received an education session at his/her bedside 
conducted by the PhD candidate on Day 1 of admission. Participants 
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who successfully received the education on Day 1 of admission were 
recorded by the PhD candidate. 
 
2. The adherence rates to the three clinical protocols (clinical protocols) 
 
Adherence rate to consuming oral fluid ≥ 800 ml/day 
Patients’ oral fluid intakes were monitored throughout the study period. 
Oral fluid intake was measured in millilitres (ml). Each patient who 
was able to drink from a cup independently was given a standard cup 
and to self-document their fluid intake. For patients who were on tube 
feeding and not able to self-document, their caregivers (family and/or 
nurses) documented their fluid intake. The amount of fluids consumed 
was based on the mean average of fluid intake per day within the study 
period. The adherence rate was calculated by dividing the number of 
participants who drank an average of ≥ 800 ml per day over the total 
number of participants in the study.  
 
          Adherence to avoidance of bedpan  
The use of defecating devices such as diapers, bedpan, bedside 
commode or toilet at each defecation was recorded throughout the 
study period. The adherence rate was calculated by dividing the 
number of participants who successfully avoided the bedpan under 
appropriate circumstances (not on CRIB, able to transfer safely) over 
the total number of participants in the study.  
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Adherence to use of prophylactic laxatives 
The use of prophylactic laxatives was recorded throughout the study 
period. The adherence rate was calculated by dividing the number of 
participants who consumed prophylactic laxatives at least once per day 
over the total number of participants in the study. 
 
Safety Outcome 
1. Adverse effects of prophylactic laxatives 
The adverse effects of prophylactic laxatives were monitored throughout 
the study period. The PhD candidate followed-up with patients daily. 
Patients’ medical and medication records were reviewed daily. Any 
discontinuation of laxatives was investigated by following through with 
the patients’ attending physicians. 
 
6.4.6.2 Secondary Outcomes 
Incidence of Constipation 
Constipation was defined based on the symptoms adapted from Rome III 
criteria (Rome Foundation, 2010) as: (1) having two or more of the following 
symptoms: straining, lumpy or hard stools, sensation of incomplete evacuation, 
sensation of anorectal obstruction/blockage, less than three defecations per 
week and requires manual maneuvers to facilitate defecations; (2) Loose stools 
were rarely present without the use of laxatives and (3) Insufficient criteria for 
irritable bowel syndrome. Daily records of patients’ symptoms were collected 
by the PhD candidate using a standardised criteria form to determine the 
incidence of constipation (Appendix 15). 
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6.4.6.3 Demographics and Baseline Characteristics 
Demographics 
Information about demographic factors (age, gender, ethnicity) and social 
status (educational level) were obtained through an interview process using a 
structured questionnaire (Appendix 16). Co-morbidities (diabetes, heart 
disease, previous stroke) were identified through patients’ electronic medical 
records. All interviews were conducted by the PhD candidate.  
 
Baseline Characteristics  
Stroke severity measured by NIHSS (Brott et at, 1989) 
Stroke severity was assessed by the admitting staff nurses in the Stroke 
Unit using the NIHSS (refer Chapter 4, p79 for further details of the 
scale). 
 
Cognitive status measured by MMSE (Folstein et al., 1975) 
Cognitive status was assessed using the local version of MMSE by the 
PhD candidate (refer Chapter 4, p80-81 for further details of the scale). 
 
Dysphagic and Dysphasic Status  
The initial dysphagia and dysphasia screenings were conducted by the 
PhD candidate based on an established ST screening criterion. Positive 
results if any, were further confirmed with the speech therapists’ 
reports. The results were coded as present or absent. 
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Admission Mobility Score measured by FIM (The Uniform Data System for 
Medical Rehabilitation [UDSMR], 1987).  
Mobility scores were assessed on admission by the PhD candidate 
(refer Chapter 4, p82-83 for further details of the scale). 
 
6.4.7 Rigor of Study 
Strategies were implemented to enhance the rigor of this study. The first step 
was to minimise validity threats in order to minimise bias in the study. 
 
6.4.7.1 Statistical Conclusion Validity 
Large sample size, although it could increase statistical power, was not 
indicated in this feasibility study. Efforts were made to ensure reliable 
measuring tools were used. A local version of MMSE was used in the 
cognitive assessment for the local population (Appendix 9) (T.-P. Ng, et al., 
2007). The assessments and study data were collected by one investigator 
(PhD candidate) to ensure reliability of the study results. Patients were 
recruited within 24 hours of their admission to ensure that the bowel 
management programme could be initiated on Day 1 of admission. Fluid 
measurements were standardised by providing patients who were able to drink 
independently a standardised cup to self-record their fluid intake in millilitres. 
Same standardised cups were provided to patients who were dependent on 
caregivers for their fluid intake. To standardise the deliverance of the bowel 
management programme, an education/clinical protocol flowchart and 
checklist were developed as references. Additional measures include staff 
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briefing and daily monitoring of the deliverance of interventions and outcome 
measures.  
 
6.4.7.2 Internal Validity 
Randomisation is one of the methods to control extraneous variables and 
address confounding variables (Gravetter & Forzano, 2011). However, 
randomisation was not indicated in this study as the aim was to test the 
feasibility of the new bowel management programme. All patients admitted to 
the Stroke Unit during the study period were screened for eligibility. Stroke 
patients with their stroke diagnosis unconfirmed by either CT scan or MRI 
were excluded from the study. All potential patients were screened for history 
of any pre-existing bowel dysfunctions for the past three months prior to this 
hospitalisation. This is to ensure that the secondary outcome, which is 
incidence of constipation, if any, relates to new-onset after stroke. 
 
6.4.7.3 Construct Validity 
The instruments used to assess the baseline assessment such as NIHSS, 
MMSE and FIM were reliable and well validated. 
 
6.4.8 Sample Size Calculation 
The main focus of this study was to assess the feasibility of various 
interventions in the practice protocols of the bowel management programme 
and not testing its effectiveness. Sample size calculation may not be required 
for some pilot studies. However, it should be based on the same inclusion and 
exclusion criteria as the intended main study and large enough to provide 
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useful information on the aspects that are being assessed for feasibility 
(Thabane et al., 2010). Hence, this feasibility study aimed to recruit 30 
participants, which was deemed appropriate to provide adequate information 
on the stated feasibility outcomes and with a set of predefined inclusion and 
exclusion criteria.  
 
6.4.9 Statistical Analysis 
Descriptive statistics for quantitative variables were presented as mean ± sd, 
median and range and n (%) for categorical variables. The quantitative 
variables included demographics (age), length of stay and baseline 
characteristics (NIHSS, MMSE, Admission mobility scores), The categorical 
variables included demographics (gender, ethnicity, educational level), 
primary outcomes (screening rates, recruitment rates, retention rates, 
adherence rates to education and clinical protocols, number of participants 
developed side effects of prophylactic laxatives) and secondary outcomes 
(incidence of constipation). Binomial test was used to compare the adherence 
rates of the clinical protocols with an adherence rate of 50% to deem the 
intervention as successful. Data were analysed using SPSS Version 19.0. 
Statistical significance was set as p<0.05. 
 
6.5 Ethical Considerations  
This study was approved by the SingHealth Centralised Institutional Review 
Board  (CIRB) and conducted in accordance with the ethical principles that 
have their origin in the Declaration of Helsinki and that were consistent with 
the Singapore Good Clinical Practice (SGCP) and the applicable regulatory 
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requirements. The final study protocol and Patient Information and Informed 
Consent Form were approved in writing by SingHealth CIRB prior to 
enrolment of any patient into the study. 
 
The aim and study procedures were explained to all potential participants. The 
following information were provided to them 
 
1. If they agree to take part in this study, their treatment plan will include 
a bowel management programme. The bowel management programme 
includes an education session and three clinical protocols. At the entry 
of the study, a nurse will provide them an education session on 
constipation and its preventive measures.  This will take approximately 
5 to 10 minutes of their time. Next, their care will include the 
followings: 
• they will be scheduled to drink at least 800 ml of fluids per day if 
there are no contraindications. Participants were informed that they 
need to drink an approximate of at least six cups of fluids per day 
to simplify the amount of oral fluid required. These intakes 
coincide with their meals and medication timings (breakfast, lunch, 
tea, dinner, 2pm and 8pm medication) 
• they will be assessed and assisted to use the toilet or commode 
instead of the bedpan for defecation if they are able to transfer 
safely with or without assistance 
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• they will be assessed by a doctor for suitability of short-term 
prophylactic laxative/s. They will be prescribed short term 
prophylactic laxatives if they are deemed suitable. 
 
2. No additional imaging or blood tests will be added on top of the 
standard treatment usually provided by the hospital. 
 
3. Their participation in this study will last till the day of their discharge 
or at Week 4, whichever is earlier. 
 
4. They should follow the instructions given to them by the study team. 
 
5. They should also inform the Principal Investigator as soon as possible 
about any side effects that they may encounter. 
 
6. They are free to withdraw their consent and discontinue their 
participation at any time without prejudice to them or effect on their 
medical care. If they decide to stop taking part in this study, they 
should tell the Principal Investigator. 
 
7. Their participation may be stopped by their doctor, the Principal 
Investigator and/or the Sponsor of this study at any time for the 
following reasons:  
• failure to follow the instructions of the Principal Investigator 
and/or study staff  
  149 
 
• unanticipated circumstances. 
 
They were given opportunities to ask questions and were informed that their 
participation in this study was entirely voluntary. Written consent was 
obtained for all participants or their representatives after they expressed 
willingness to participate. The informed consent was obtained by the PhD 
candidate in compliance with the Singapore Good Clinical Practice guidelines 
and to the ethical principles that have their origin in the Declaration of 
Helsinki. A copy of the information sheet and consent form was given to them 
along with the contact details of the Principal Investigator and SingHealth 
CIRB. 
 
6.6 Confidentiality of Study and Medical Records 
Participants were informed that the information collected for this study would 
be kept confidential. The study participants' records, to the extent of the 
applicable laws and regulations, would not be made publicly available. Only 
the study investigators had access to the confidential information being 
collected. However, the Regulatory Agencies, Institution Review Board and 
Ministry of Health would be granted direct access to the original medical 
records to check study procedures and data, without making any of the 
participant’s information public. All research data were stored in a hard disk 
which was kept locked in the main office of the Principal Investigator. Study 
participants’ confidentiality was protected through coding of research data and 
the links between subjects’ identifiers and the codes were stored separately 
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from the research data. In the event of any publication regarding this study, the 
participant’s identity would remain confidential. 
 
6.7 Potential Risks, Discomforts or Inconvenience of Study 
This study involved minimal risks. Minimal risk was defined as any risk 
where the probability and magnitude of harm or discomfort anticipated in the 
research were not greater, in and of themselves than those ordinarily 
encountered in daily life or during the performance of routine physical or 
psychological examinations or tests (National University of Singapore-
Insitutional Review Board, 2014). It might cause inconvenience to some 
subjects as the initial baseline assessments, education session and subsequent 
follow-up sessions required some of the subjects’ time. In some rare instances, 
some subjects might experience abdominal discomfort, nausea, vomiting or 
loose stool after taking the prophylactic laxative/s. The prophylactic laxative/s 
would be discontinued if that occurs. This information was provided and 
explained to the study participants.  
 
6.8 Potential Benefits of Study 
Participants were informed that they might reasonably expect to benefit from 
the study in the following ways: 
• they would receive an education session on constipation and its 
preventive measures at no extra cost 
• their likelihood of developing constipation might be reduced. 
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6.9 Funding 




A total of 45 patients admitted to the Stroke Unit were screened for eligibility. 
Out of the 45 patients, 15 were excluded from the study. Four patients had pre-
existing bowel dysfunction, six patients declined to participate, two patients 
were critically ill, two patients were unable to communicate and one patient 
was on renal dialysis and fluid restrictions. Thirty patients met the inclusion 
criteria and were recruited in the study. During the study period, there were no 
lost to follow-up. At the end of the study, a total of 30 patients were studied. 






Assessed for eligibility (n=45)
Excluded (n=15)
- pre-existing bowel dysfunctions (n=4)
- declined to participate (n=6)
- critically ill (n=2)
- dysphasic (n=2)
- on dialysis and fluid restrictions (n=1 )
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6.10.1 Demographics and Baseline Characteristics 










no (%) / median 
(range) 
n=30 
Age  58.5 (37-75) 
Gender  
Male 19 (63.3) 
             Female 11 (36.7) 
Ethnicity  
Chinese 21 (70) 
Malay 3 (10) 
Indian 4 (13.3) 
Others 2 (6.7) 
Educational Level   
Degree 2 (6.7) 
Diploma 3 (10) 
Secondary 13 (43.3) 
Primary 10 (33.3) 
None 2 (6.7) 
Co-morbidity  
Previous stroke 1 (3.3) 
Diabetes 8 (26.7) 
Heart Disease 3 (10) 
Dysphasia 1 (3.3) 
Dysphagia 12 (40) 
Length of Stay 8 (1-45) 
GCS 15 (15) 
MMSE 27 (19-30) 
FIM Admission Mobility Score 4 (1-7) 
NIHSS 4 (0-17) 
 
The participants’ median age was 58.5 (37-75). Nineteen participants (63%) 
were male. Chinese formed the largest ethnicity group with 21 participants 
(70%). Three participants (10%) were Malay followed by four Indians (13.3%) 
and two Eurasians (6.7%). The majority of patients completed secondary 
school (43.3%) and primary school (33.3%). One patient (3.3%) had a history 
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of previous stroke. Eight patients (26.7%) had diabetes and three (10%) had 
heart disease. The median length of stay was 8 days (1-45).The median 
MMSE score was 27 (19-30). One patient declined to complete the MMSE 
assessment as she was tired. The median mobility score on admission was 4 
(1-7) which indicates minimum assistance. The median NIHSS of 4 (0-17) 
indicates mild severity of stroke. All patients were admitted for ischemic 
stroke. 
 
6.10.2  Primary Outcomes 
6.10.2.1 Screening Rates 
All patients who were admitted to the Stroke Unit for acute stroke were 
screened for eligibility. A total of 45 patients were screened within the four 
months of recruitment period (Figure 6.3). Nine patients were screened in June,  
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6.10.2.2 Recruitment Rates 
A total of 30 out of 45 patients (66.7%) screened were recruited within four 
months. An average of seven to eight patients was recruited per month (Figure 
6.3). 
 
6.10.2.3 Retention Rates 
All patients (n=30) (100%) who were recruited were followed-up till their 
discharge or within the first four weeks. No patients withdrew from the study 
or were lost to follow-up. 
 
6.10.2.4 Completion Rates of Patients Receiving Education on Day 1 of 
Admission  
All patients (n=30) (100%) successfully received the education session at their 
bedside on Day 1 of their admission. 
 
6.10.2.5 Adherence Rate to Oral Fluids ≥ 800 ml Per Day 
Twenty-four patients (80%) successfully consumed an average of at least 800 
ml of oral fluids per day (Table 6.2). The mean average of oral fluids 
consumed was 993.5 ml (308.9 ml) ranging from 545 ml to 1875 ml. 
 
6.10.2.6 Adherence Rate to Avoidance of Bedpan 
All patients (100%) successfully avoided the use of bedpan during their 
hospitalisation or within the first four weeks of their hospitalisation whenever 
their condition permits (not on CRIB and able to transfer safely) (Table 6.2). 
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6.10.2.7 Adherence Rate to Use of Prophylactic Laxatives 
Twenty-one patients (70%) consumed prophylactic laxatives during the study 
period (Table 6.2).  
 
Table 6.2  
 
Adherence Rates to Clinical Protocols 
 










Oral fluids at least 800 ml/day  24 6 80% 
Avoidance of bedpan 30 0 100% 
Use of prophylactic laxatives 21 9 70% 
 
 
6.10.2.8 Adherence to Clinical Protocols Compared to Threshold of 50% 
Adherence Rate 
The adherence rates to the clinical protocols were statistically significant 
compared to the adherence rate of 50%: oral fluids ≥ 800 ml at 80% (p = 
0.001), avoidance of bedpan at 100% (p<0.001) and use of prophylactic 
laxatives at 70% (p = 0.043) (Table 6.3). 
 
Table 6.3  
Proportion of Adherence to Clinical Protocols Compared to Threshold of 50% 
Adherence Rate 
 






Oral fluids at least 800 ml/day 24 (80%) 50% 0.001 
Avoidance of bedpan 30 (100%) 50% < 0.001 
Use of prophylactic laxatives 21 (70%) 50% 0.043 
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6.10.2.9 Adverse Effects to Prophylactic Laxatives  
No patients experienced adverse effects of the prophylactic laxatives which 
resulted in any discontinuation of medications. 
 
6.10.3 Other Outcomes 
6.10.3.1 Types of Prophylactic Laxatives 
Patients were prescribed one or more prophylactic laxatives during the study 
period. The most frequently prescribed laxatives was lactulose (n=21) 
followed by sennosides tablet (n=3) (Figure 6.4). Seventeen patients were 
prescribed one laxative, three patients were prescribed two laxatives and one 






























Figure 6.4. Types of Prophylactic Laxatives. 
 
6.10.3.2 Day of Prescribing Prophylactic Laxatives 
Thirty-eight percent (n=8) of patients were prescribed prophylactic laxatives 
on Day 1, followed by forty-three percent (n=9) on Day 2 and nineteen percent 
(n=4) on Day 3 of their admissions (Table 6.4).  
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Table 6.4  
 
Day of Prescribing Prophylactic Laxatives 
 
Day of Prescribing 
Prophylactic Laxatives  
(in days of admission) 
Number of Patients 
n=21 Percentage 
 
1 8 38% 
2 9 43% 
3 4 19% 
 
6.10.3.3 Number of Physiotherapy Sessions 
Twenty five patients (83%) attended at least one physiotherapy session during 
the study period. Five patients (16.7%) did not receive any physiotherapy.  
 
6.10.4 Secondary Outcomes 
6.10.4.1 Incidence of Constipation 
Five patients (16.7%) developed new-onset of constipation during the study 
period. There were not the same five patients who did not receive 
physiotherapy. Two patients developed the first onset of constipation on Day 4 
of their admission. Three other patients developed new-onset constipation on 
Day 5, Day 9 and Day 14 respectively. After Day 14, no patients developed 
constipation. The incidence of constipation in Phase 1 study was 33%. With 
the intervention of the new bowel management programme in Phase 2 study, 
the incidence of constipation was 16.7%. Patients who did not adhere to one or 
more of the three clinical protocols had a 33.3% chance of developing new-
onset constipation. Patients who adhered to all three clinical protocols had a 
94.4% chance of not developing new-onset constipation (Table 6.5). 
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Table 6.5  
 
Incidence of Constipation  
 
  Constipation  
  Yes No Total 











 No                           

















6.11.1 Screening, Recruitment and Retention Rates 
The total of 45 patients admitted for stroke over the four months period was 
unexpectedly low as compared to the 102 patients in Phase 1 study. However, 
the recruitment rate of 66.7% (n=30) in this study was higher compared to 
58.8% (n=60) in Phase 1 study.  One of the concerns that the investigators had 
with this study was participants’ refusal to participate due to the oral fluids 
requirement. Although setting the target of 800 ml minimally was considered a 
reasonable amount which could be easily achievable, there might still be 
patients with the psychological fear of the need to go to the toilet frequently. 
These patients might associate drinking fluids with toilet needs. As such, the 
investigators used the association of meals and medication timings with fluids 
intake. This was to allow potential participants to better gauge the amount they 
were required to consume if they decide to participate. Another concern was 
the use of prophylactic laxatives which some of the potential participants 
might not agree for fear of the side effects. Potential participants were 
informed clearly of the potential minimal risk with the use of prophylactic 
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laxatives and that the laxatives would be prescribed by the attending 
physicians only when there were no contraindications. They were also 
informed that the laxatives would be discontinued immediately if there were 
any side effects encountered. There were six out of the fifteen potential 
participants who declined to participate in the study. None of them cited fluid 
intake or the use of prophylactic laxatives as the reasons for declining to 
participate. There was one patient with pre-existing renal disease which 
required fluid restriction. There were no drop-outs or lost to follow-up during 
the study period. Based on the recruitment and retention rates, it is suggestive 
that the study recruitment process is feasible and the study is acceptable by 
potential participants.  
 
6.11.2 Completion Rates of Patients Receiving Education on Day 1 of 
Admission  
One of the challenges in conducting education session to patients after an 
acute stroke is their cognitive ability to effectively receive and retain the 
teachings. Cognitive impairment after an acute stroke is common and there are 
reported generalised profiles of cognitive deficits such as decreased attention, 
memory and visuospatial skills (Hochstenbach, Mulder, van Limbeek, 
Donders, & Schoonderwaldt, 1998; Tatemichi et al., 1994). This study 
required preventive interventions to be carried out on Day 1 of admission as 
Phase 1 study has shown that new-onset constipation after stroke can develop 
as early as Day 2 of patients’ admission. There are various neuropsychological 
tests available to assess cognitive function in different domains.  This study 
used GCS and MMSE to assess participants’ conscious level and cognitive 
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status respectively. All recruited participants had a full GCS score of 15 and 
median MMSE score of 27 ranging from a minimum of 19 to a maximum of 
30.  The education session was successfully delivered to all the participants on 
Day 1 of admission. One participant had moderate expressive dysphasia so the 
education session was delivered to both the participant and his caregiver. A 
second session was conducted on Day 2 of recruitment for feedback and 
clarification purposes. This second session was provided as studies have 
suggested  that when information was provided in a way that actively involved 
patients by offering repeated opportunities such as planned follow-up for 
clarifications and reinforcement instead of a one-off session, patients’ mood 
were more positively affected (Forster et al., 2012). This finding suggests that 
the implementation of the education protocol is feasible to be delivered to 
patients who are admitted with acute stroke on Day 1 of admission. The 
effectiveness of the education session in terms of knowledge retention was not 
evaluated in this study. The effects of providing educational session at acute 
stage such as Day 1 of admission and use of follow-up session to reinforce 
teachings require further investigations. Future work should focus on 
strategies to impart and reinforce teachings to patients with various degrees of 
cognitive impairments and the number of follow-up sessions required to 
effectively achieve the desired outcomes of knowledge retention and/or 
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6.11.3 Adherence Rates to Clinical Protocols 
Overall, the adherence rates to the clinical protocols were significant when 
compared to the adherence rate of 50%, which indicates that the bowel 
management programme was successful. 
 
6.11.3.1 Adherence to Avoidance of Bedpan 
The highest adherence rate was the avoidance of bedpan which was 100%, 
although there were high tendencies for patients and staff to use bedpan for 
patients’ defecation due to patients’ impaired mobility. All patients’ mobility 
status was assessed using the FIM tool on admission. The median admission 
mobility score was ‘4’ which indicates ‘minimum assistance’ within the range 
of 1 to 7. Risk of falls is high after stroke, with a reported incidence of about 
7% occurring in the first week after stroke (Indredavik et al., 2008). There 
could be an element of fall risk involved with transferring and moving patients 
with impaired mobility out of bed for defecations. There was no incidence of 
falls associated with patients’ toileting either during patients’ transfer, enroute 
or at the toilet during the study period. All the staffs in the Stroke Unit were 
trained in transferring techniques as well as handling transfers and ambulation 
in patients with stroke. This probably explains their willingness to cooperate 
and adhere to this clinical protocol. Another possible factor is early 
rehabilitation. Stroke rehabilitation in the Stroke Unit started as early as 24 
hours within patients’ admissions if their condition permitted. This further 
promotes patients’ increased mobility thus facilitated their willingness to 
move out of bed for defecation. The adherence rate of 100% with no incidence 
of falls indicates that this clinical protocol is deeming practical within the 
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existing means, resources and circumstances. It can be successfully 
implemented to patients admitted for acute stroke by staff in the Stroke Unit. 
Future study needs to explore safe patient handling and focus on staff’s 
competency in patient assessment, transfer and ambulation techniques and use 
of transfer equipments and walking aids if this intervention is to be 
implemented across other medical or surgical units. 
 
6.11.3.2 Adherence to Fluid Intake of at least 800 ml Per Day 
The adherence to oral fluid intake of at least 800 ml per day was 80%. There 
was an overall increased fluid intake of 993.5 ml (308.9 ml) as compared to 
Phase 1 study where the observed average fluid intake was 530 ml (348 ml). 
Fluid intake was assessed from a combination of beverages. The strategies of 
associating meals and medication timings with fluid intake and 
poster/bookmark reminders appeared to work effectively in 24 out of the 30 
patients. Two of the six patients who did not comply with the fluid intake 
protocol had mild to moderate dysphagia. Achieving calculated fluid 
requirements in patients with dysphagia can be challenging as insufficient 
fluid intake has been associated with dysphagia. Patients diagnosed with 
dysphagia and requiring thickened fluids during hospitalisation were unable to 
meet their calculated fluid requirements unless they received enteral and 
parenteral fluids (Finestone, Foley, Woodbury, & Greene-Finestone, 2001; 
Vivanti, Campbell, Suter, Hannan-Jones, & Hulcombe, 2009). As such, it was 
suggested that supplemental enteral or parenteral fluid may be necessary to 
achieve the minimum calculated fluid requirements for this group of patients.  
The remaining ten other patients with dysphagia managed to adhere to the 
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required amount of fluid intake. Their dysphagia severity was similarly at mild 
to moderate level. The fluid intake protocol in this study did not require a 
written time schedule. As such, patients were given the flexibility to decide 
when and how much fluid to consume throughout their day. This might have 
led to insufficient fluid intake for some patients. Further improvements to the 
protocol should include a written time schedule with specified amount of fluid 
intake. Based on this written schedule, a feedback mechanism can be 
established where staff evaluate patients’ fluid intake at the end of each shift 
instead of end of the day. These interim evaluation and feedback allow 
patients the opportunity to meet their calculated fluid requirements. 
 
6.11.3.3 Adherence Rate to Use of Prophylactic Laxatives 
The adherence rate to using prophylactic laxatives was 70%, the lowest among 
the three clinical protocols. Patients were prescribed one or a combination of 
two or more laxatives by their attending physicians. The most common 
prescribed laxatives were lactulose and sennosides tablets, similar to the 
observed findings in Phase 1 study. There were some variations in the onset of 
prescription by respective attending physicians. The prophylactic laxatives 
were prescribed between Day 1 to Day 3 of patients’ admission. Nine patients 
(30%) were not prescribed prophylactic laxatives by their attending physicians 
during the study period. The study patients were under the care of different 
neurologists and these findings indicate that there are practice differences in 
prescribing among the neurologists. Discrepancies in prescribing laxatives as 
prophylaxis for patients are also common in other medical settings and 
populations (Bouvy, Buurma, & Egberts, 2002; Essa, Santo, Fleming, Mitchell, 
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& Abish, 2013). Future work should focus on exploring the attitudes of 
neurologists towards the use of prophylactic laxatives in preventing 
constipation in patients with acute stroke. Based on the low toxicity profile of 
prophylactic laxatives and no reported incidence of adverse effects in this 
study, the use of prophylactic laxatives in patients after stroke during acute 
hospitalisation is feasible and safe. This less than ideal adherence rate suggests 
that more efforts are needed to educate patients, family and physicians on the 
awareness of constipation risk in patients after an acute stroke and the options 
of using prophylactic laxatives prior to the development of constipation 
symptoms. 
 
6.11.4 Incidence of Constipation 
The incidence of constipation was 16.7%, significantly lower as compared to 
33% in Phase 1 study. Other observational studies conducted on patients with 
stroke at acute stage similarly reported higher incidence rate: 42% (Cai et al., 
2013) and  55% (Su et al., 2009). The onset of constipation was also delayed 
to Day 4 of admission as compared to Day 2 in Phase 1 study. Similar to 
Phase 1 study, there was no incidence of constipation after Day 14. These 
findings suggest that the new bowel management programme has the potential 
to delay and even reduce the development of new-onset constipation in 
patients after stroke during acute hospitalisation. Patients who did not adhere 
to one or more of the clinical protocols had 33.3% chance of developing new-
onset constipation. Patients who adhered to all three of the clinical protocols 
had 94.4% chance of not developing new-onset constipation. This finding is 
promising and the next stage of study can be developed to test the 
  165 
 
effectiveness of this new bowel management programme in a larger 
population of patients with acute stroke, utilising a randomised controlled 
study design. 
  
6.12 Limitations and Recommendations for Future Study 
The bowel management programme has multiple interventional components. 
As such, the effect of each component towards the adherence and incidence 
rate has to be specifically measured if investigators wish to determine the 
effect respectively. The effect of education and feedback sessions on patients’ 
understanding of constipation and its preventive measures, and the use of 
reinforcement (bedside poster/bookmark) could be further explored. These 
measurements can determine the usefulness of the teaching sessions and 
materials in enhancing adherence rates and the subsequent reduction in 
incidence rate. As the clinical protocols were developed and tested for use in 
patients with acute stroke in the Stroke Unit, the successful 100% adherence 
rate to the avoidance of bedpan use is limited to settings where staff was 
trained to assess and mobilise patients using transfer equipment and walking 
aids. The adherence rate of 80% to oral fluid intake was based on the patient 
population where several of them (40%) were having mild to moderate 
dysphagia. The staff was also trained to manage and assist patients who 
require various fluid consistencies. Strategies to improve the adherence rates 
should include a written schedule with timings and the amount of fluids 
required at each time for interim evaluation and feedback. This study did not 
include a survey on attitudes of neurologists in prescribing prophylactic 
laxatives as part of the stroke treatment protocol. The adherence rate of 70% 
  166 
 
indicates a need to explore these attitudes and willingness of attending 
physicians towards the use of prophylactic laxatives in patients with acute 
stroke. There is also a role for including guidelines on prevention of 
constipation into the existing stroke protocol.  
 
In addition, other similar studies could be evaluated to enhance the rigor of 
future study. Although there are limited studies on structured bowel 
management programme to benchmark, out of those available, positive 
outcomes were reported. The randomised controlled trial by Harari et al. (2004) 
focused on assessment and education. It utilised a one-off assessment by a 
nurse leading to targeted patient/ carer education with provision of a booklet 
and a diagnostic summary and treatment recommendations sent to the patient’s 
general practitioner or ward physician. Although the interventional group 
achieved better outcomes, the study patients’ adherence to treatment 
recommendations was not assessed therefore it was difficult to determine 
whether the positive effects were due to the treatment recommendations. 
Hence, future study built on this Phase 2 bowel management programme study 
should continue to measure adherence rate to clinical protocols and evaluate 
the effectiveness of education protocol, besides looking at other confounding 
factors that could affect the outcome of constipation. The study by 
Munchiando and Kendall (1993) utilised daily versus every other day digital 
stimulation to establish a regulated bowel evacuation. The study stated the loss 
of participants as one of its limitation. Another limitation was the failure to 
determine any pre-existing bowel dysfunctions in its study participants prior to 
intervention. The screening (inclusion and exclusion criteria) and recruitment 
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rates of this study indicate the feasibility of the bowel management 
programme.  Its full retention rate also indicates that the intervention is 
acceptable by patients. The same inclusion and exclusion criteria to screen 
potential patients could be utilised in future study. Reasons for non-retention if 
any should be obtained for further evaluation of the programme. Venn et al. 
(1992) compared four bowel programmes based on the timing of bowel 
evacuations and suppository use and found that patients assigned to the 
morning bowel schedule were more efficient than those assigned to the 
evening schedule. The study had unreported patients’ baseline characteristics 
(severity of stroke, concomitant treatment etc) which could have affected the 
outcomes. In addition, there were no description of the amount and types of 
suppository used. The measurements were based on several staff observations 
which might influence the reliability of the outcomes. Future study should 
continue to include detailed assessment and description of patients’ baseline 
characteristics and medications that could influence outcomes. This Phase 2 
study utilised mostly one investigator (PhD candidate) in data assessments and 
measurements. If more than one staff is involved in data measurement, 
strategies to ensure inter-rater reliability should be implemented.  
 
6.13 Conclusion 
The screening and recruitment rates indicate that the recruitment process of 
the bowel management programme is feasible to patients admitted to hospital 
with acute stroke. Based on the 100% retention rates, the interventions are 
deemed acceptable to patients. The successful completion of the education 
session on Day 1 of admission and the high adherence rates of clinical 
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protocols suggest that the bowel management programme can be successfully 
implemented. The reduction in the incidence rate of constipation also suggests 
that the new bowel management programme has potential benefits and could 
be further developed to test for effectiveness in a larger population of patients 
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Chapter 7 
Overall Conclusion and Future Work 
 
7.1 Introduction  
This final chapter highlights the overall study findings. It summarises the 
contribution of this study and outlines the direction for practice and future 
work. As presented in Chapters 2 and 3, constipation is a neglected subject of 
study as it is often viewed as a non-life threatening medical complications. 
There are many studies on complications post-stroke but these studies often 
investigate a pre-set of complications which did not include constipation. 
There is also limited evidence on effective management of constipation in 
patients with stroke to guide clinical practice. This two-phase study addressed 
both the research and practice gaps in managing constipation in patients with 
stroke.  
 
7.2  Significance of Study 
The current study is the first study in local context that investigated incidence 
and predictors of constipation in hospitalised patients with stroke and 
orthopaedic conditions. It addressed a significant yet neglected fundamental of 
basic care.  
 
The overall aim of the study, which was to develop a feasible and evidence-
based bowel management programme was met. Firstly, the study highlighted 
that the incidence of constipation is high and with onset as early as Day 2 of 
admission. This calls for prompt preventive measures for constipation. The 
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few previous studies conducted locally or in overseas were predominantly 
focused on prevalence of constipation or at chronic stage of constipation. 
Secondly, this study identified predictors of constipation. The identified 
modifiable predictors were fundamental in the development of the bowel 
management programme as a preventive strategy against new-onset 
constipation. Pre-existing studies on management strategies often targeted at 
managing constipation rather than preventing the development of new-onset 
constipation. Lastly, this study indicates that the bowel management 
programme is feasible and safe. As such, the bowel management programme 
can serve as a useful guide to clinicians and enhance the quality of care for 
patients with stroke, optimising their stroke rehabilitation outcomes. This 
study also highlights the significant collaborations between physicians, allied 
health professionals and nurses in delivering interventions (prescribing 
prophylactic laxatives, enhancing mobility gains, ensuring fluid intake and 
avoidance of bedpans) which could effectively manage a health condition such 
as constipation.  
 
7.3 Implications for Practice and Recommendations for Future Work 
The following recommendations are provided based on the findings of the 
study: 
1. Definition of constipation should be standardised and based on 
established criteria as studies with different definitions make 
comparison of outcomes challenging. 
2. The first occurrence of constipation after a stroke was at Day 2 of 
admission which calls for an early preventive intervention and ceased 
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after Day 14. This is probably attributable to the gradual improvements 
in patients’ mobility status after the initial stay. These findings suggest 
that constipation preventive interventions should be initiated as early 
as Day 1 of admission and continue for a minimum of 14 days. 
 
3. The incidence of constipation in patients with stroke was similarly high 
compared to patients with orthopaedic condition. As such, the 
constipation preventive measures should also target patients with 
orthopaedic conditions.  Subsequent studies could investigate subjects 
of other medical conditions and involve multiple sites where findings 
could be further generalised.  
 
4. Mobility gains were protective against new-onset constipation and 
correlated to number of PT sessions attended. As such, efforts could be 
directed to initiate early ambulation through PT. Further study should 
investigate the optimal PT needed to achieve significant mobility gains.  
 
5. Bedpan use increased the likelihood of developing new-onset 
constipation. As such, the use of bedpan should be discouraged unless 
necessary. Practice protocol should advocate the use of defecating 
devices that allows proper sitting positioning to promote normal 
defecation pattern instead of the lying position. Future studies could 
explore the influence of positioning and measure the individual 
contributions of abdominal muscles and pelvic floor muscles in 
promoting successful defecations.  There is also a need to assess safe 
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patient handling and staff competency in patient assessment, transfer 
and ambulation techniques, use of transfer equipment and walking aids 
if this practice is to be implemented across other medical or surgical 
units. 
 
6. Prophylactic laxatives were protective against new-onset constipation 
and safe to be used. As such, it could be use as a short-term 
prophylaxis. Other than exploring the use of various short-term 
prophylactic laxatives and monitor their efficacy, tolerability and cost-
benefits, future work should explore the attitudes and willingness of 
neurologists on using laxatives as a prophylaxis in patients with acute 
stroke during hospitalisation. More work is needed to educate patients, 
families and physicians on constipation risk after an acute stroke and 
the options of using laxatives prior to the development of constipation. 
There is also a role for including constipation prevention guidelines 
into the existing stroke protocol. 
 
7. Oral fluid intake was associated with new-onset constipation. 
Strategies to improve adherence rates of fluid intake to at least 800 ml 
per day should include a written time schedule with specified amount 
of fluid intake. Interim evaluation and feedback allow patients the 
opportunity to meet their calculated fluid requirements before the end 
of the day. 
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8. The effectiveness of education session, follow-up session and use of 
bedside poster/bookmark as reinforcement could be further explored to 
determine their usefulness in enhancing knowledge retention and 
subsequent adherence rates to the clinical protocols. Future work 
should focus on investigating the number of follow-up sessions 
required to effectively achieve the desired outcomes of knowledge 
retention and/or adherence rates.  
 
7.4 Main Conclusion 
New-onset constipation is a common complication of stroke and orthopaedic 
conditions during acute hospitalisation. Healthcare providers should actively 
assess, prevent and manage constipation in this group of hospitalised patients. 
The early occurrence of constipation calls for prompt preventive intervention 
which should be initiated as early as Day 1 of admission. The bowel 
management programme is feasible and safe. It has the potential to be further 
tested for effectiveness in a larger population of patients with acute stroke, 
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Appendix 3  










1 Meta-analysis (with homogeneity) of 
experimental studies (e.g. 
Randomised Controlled Trials (RCT) 
with concealed randomization) 
OR 
One or more large experimental 
studies with narrow confidence 
intervals 
0  
2 One or more smaller RCTs with 
wider confidence intervals 
OR 
Quasi-experimental studies (without 
randomisation) 
3 Venn et al. (1992) 
Munchiando & Kendall 
(1993) 




Cohort studies (with control group) 
Case-controlled 





4 Expert opinion, or physiology bench 
















List of Excluded Studies Reason for 
Exclusion 
Huang XB, Li ZX. Clinical observation on effect of qirong 
runchang oral liquid in treating constipation after 
stroke. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2002 
Aug;22(8):622-3. 
Article in Chinese 
Wang DS, Wang S, Kong LL, Wang WY, Cui XM. Clinical 
observation on abdominal electroacupuncture for 
treatment of poststroke constipation. Zhongguo Zhen 
Jiu. 2008 Jan;28(1):7-9. 
Article in Chinese 
Jeon SY, Jung HM. The effects of abdominal meridian 
massage on constipation among CVA patients. Taehan 
Kanho Hakhoe Chi. 2005 Feb;35(1):135-42. 
Article in Korean 
 
Lee GN, Shon KH. The Effects of Meridian Acupressure on 
Decreasing Constipation for Stroke Patients. Journal of 
Korean Academy  Adult Nursing 2006 Dec; 18(5):760-
770. 
Article in Korean 
 
Ikari H, Miura S, Ando F, Ito I, Kono K, Goto T, et al. The 
effect of soluble fiber dietary supplement on 
constipation in 3 patients with dysphagia who suffered 
from cerebral infarction with special reference to 
serum diamine oxidase activity. Nippon Ronen Igakkai 













  202 
 
Appendix 5 




(a) Indicate the study’s design with a commonly used term in the title or the 
abstract 
 Title and 
abstract 
1 
(b) Provide in the abstract an informative and balanced summary of what was 




2 Explain the scientific background and rationale for the investigation being 
reported 
Objectives 3 State specific objectives, including any prespecified hypotheses 
Methods 
Study design 4 Present key elements of study design early in the paper 
Setting 5 Describe the setting, locations, and relevant dates, including periods of 
recruitment, exposure, follow-up, and data collection 
(a) Give the eligibility criteria, and the sources and methods of selection of 
participants. Describe methods of follow-up 
Participants 6 
(b) For matched studies, give matching criteria and number of exposed and 
unexposed 
Variables 7 Clearly define all outcomes, exposures, predictors, potential confounders, and 
effect modifiers.  
Give diagnostic criteria, if applicable 
Data sources/ 
measurement 
8*  For each variable of interest, give sources of data and details of methods of 
assessment (measurement). Describe comparability of assessment methods if 
there is more than one group 
Bias 9 Describe any efforts to address potential sources of bias 
Study size 10 Explain how the study size was arrived at 
Quantitative 
variables 
11 Explain how quantitative variables were handled in the analyses. If applicable, 
describe which groupings were chosen and why 
(a) Describe all statistical methods, including those used to control for 
confounding 
(b) Describe any methods used to examine subgroups and interactions 
(c) Explain how missing data were addressed 




(e) Describe any sensitivity analyses 
Results 
(a) Report numbers of individuals at each stage of study—eg numbers potentially 
eligible, examined for eligibility, confirmed eligible, included in the study, 
completing follow-up, and analysed 
(b) Give reasons for non-participation at each stage 
Participants 13* 
(c) Consider use of a flow diagram 
(a) Give characteristics of study participants (eg demographic, clinical, social) and 
information on exposures and potential confounders 
(b) Indicate number of participants with missing data for each variable of interest 
Descriptive data 14* 
(c) Summarise follow-up time (eg, average and total amount) 
Outcome data 15* Report numbers of outcome events or summary measures over time 
(a) Give unadjusted estimates and, if applicable, confounder-adjusted estimates 
and their precision (eg, 95% confidence interval). Make clear which confounders 
were adjusted for and why they were included 
(b) Report category boundaries when continuous variables were categorized 
Main results 16 
(c) If relevant, consider translating estimates of relative risk into absolute risk for 
a meaningful time period 
Other analyses 17 Report other analyses done—eg analyses of subgroups and interactions, and 
sensitivity analyses 
Discussion 
Key results 18 Summarise key results with reference to study objectives 
Limitations 19 Discuss limitations of the study, taking into account sources of potential bias or 
imprecision. Discuss both direction and magnitude of any potential bias 
Interpretation 20 Give a cautious overall interpretation of results considering objectives, 
limitations, multiplicity of analyses, results from similar studies, and other 
relevant evidence 
Generalisability 21 Discuss the generalisability (external validity) of the study results 
Other information 
Funding 22 Give the source of funding and the role of the funders for the present study and, if 
applicable, for the original study on which the present article is based 
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Appendix 6 
Phase 1 Eligibility Check Form 
 
Phase 1 Study: Eligibility Check Form  Tick (√) as 
appropriate 
Inclusion Criteria 
At least 21 years old 
 
Admitted within 48 hours  
 









Recruit within 5 days of matched stroke group 
 
Exclusion Criteria 
No prior history of gastrointestinal dysfunctions including 
constipation, faecal incontinence, pathological diseases or cancer 
of the rectum or colon 
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Appendix 7 
Phase 1 Patient Information Sheet and Informed Consent 
 
 
                                  PARTICIPANT INFORMATION SHEET 
 
You are being invited to participate in a research study. 
Before you take part in this research study, the study must be explained to you and 
you must be given the chance to ask questions. Please read carefully the information 
provided here. If you agree to participate, please sign the informed consent form. You 
will be given a copy of this document to take home with you. 
STUDY INFORMATION 
Protocol Title: Constipation in Patients with Stroke: Incidence, Associated Risk 
Factors and Management at a Tertiary Hospital in Singapore (Phase one study). 
Principal Investigator(s): Lim Su Fee 
                                           Nursing Specialty Care 
                                           Department of Rehabilitation Medicine  
                                           Singapore General Hospital, Outram Road 
                                           Singapore 169608 
                                           Mobile (65) 81275584 
PURPOSE OF THE RESEARCH STUDY 
You are being invited to participate in a research study of constipation in patients 
with stroke. We hope to learn about the incidence, associated risk factors and 
management of constipation in patients with stroke.  
You are selected as a possible subject in this study because you are currently 
undergoing treatment at Singapore General Hospital. 
Constipation is one of the most common complications in patients after stroke. 
Identifying risk factors for prevention is essential in ensuring a successful stroke 
rehabilitation outcome. This study is part of a two-phase study which aims to 
investigate constipation in stroke patients with a focus on the followings: 
1. incidence of constipation in stroke versus non stroke at 4 weeks (Phase 
1a) 
2. risk factors associated with the incidence of constipation in stroke (Phase 
1b) 
3. feasibility of a new bowel management protocol in reducing the incidence of 
constipation (Phase 2) 
You will only be involved in Phase 1a & Phase 1b study. 
The Phase 1a & 1b study will recruit 120 subjects from Singapore General Hospital 
over a period of 6 months. 
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STUDY PROCEDURES AND VISIT SCHEDULE 
If you agree to take part in this study, you will be followed up during the study 
period. You will be evaluated at the beginning of the study and weekly until at 4 
weeks. The evaluation is performed through questionnaires and observation. No 
additional imaging or blood tests will be added on top of the standard treatment 
usually provided by this hospital. Your participation in the study will last at 4 weeks 
or till the day of your discharge from hospital (whichever is earlier). 
Schedule of visits and procedures:  
If you agree to take part, the following will happen to you 
Visit 1 (at entry of study) 
Once your eligibility in the study is confirmed, a nurse will assess your condition by 
asking you some questions. This will take approximately 20 minutes of your time 
Visit 2 (week 2), 3 (week 3) & Final visit (week 4 or at discharge, whichever is 
earlier) 
A nurse will assess you by asking you some questions. This will take approximately 5 
minutes of your time. 
YOUR RESPONSIBILITIES IN THIS STUDY 
If you agree to participate in this study, you should follow the instructions given to 
you by the study team. You should also be prepared to be assessed and answer some 
questions when visited by a nurse. 
WITHDRAWAL FROM STUDY 
You are free to withdraw your consent and discontinue your participation at any time 
without prejudice to you or effect on your medical care. If you decide to stop taking 
part in this study, you should tell the Principal Investigator. 
WHAT IS NOT STANDARD CARE OR EXPERIMENTAL IN THIS STUDY 
The study is being conducted because the incidence and associated risk factors on 
constipation in stroke is not known.  We hope that your participation will help us to 
determine the incidence rate and its associated risk factors. The findings of this 
research study will also help us develop a new bowel management protocol in 
managing constipation in patients with stroke. 
In this study, the assessment visits by the nurse is only performed for the purpose of 
this study, and not part of your routine care. 
POSSIBLE RISKS, DISCOMFORTS AND INCONVENIENCES 
This study will not involve any risks or discomforts. It may cause some 
inconveniences to some subjects as the visit sessions will require some of the 
subjects’ time. 
POTENTIAL BENEFITS 
There is no assurance that you will benefit from this study. However, your 
participation may contribute to the medical knowledge about the incidence and risk 
factors of constipation in stroke. 
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ALTERNATIVES 
If you choose not to take part in this study, the alternative is to have what is 
considered standard care for your condition.  
SUBJECT’S RIGHTS  
Your participation in this study is entirely voluntary. Your questions will be 
answered clearly and to your satisfaction.  
CONFIDENTIALITY OF STUDY AND MEDICAL RECORDS 
Information collected for this study will be kept confidential. Your records, to the 
extent of the applicable laws and regulations, will not be made publicly available. 
Only your Investigator(s) will have access to the confidential information being 
collected. 
However, the Regulatory Agencies, Institution Review Board and Ministry of 
Health will be granted direct access to your original medical records to check study 
procedures and data, without making any of your information public. By signing the 
Informed Consent Form attached, you or your legal representative is authorizing 
such access to your study and medical records. 
Data collected and entered into the Data Collection Form(s) are the property of the 
designated institution. In the event of any publication regarding this study, your 
identity will remain confidential. 
COSTS OF PARTICIPATION 
Not applicable  
RESEARCH RELATED INJURY AND COMPENSATION 
We do not foresee that there will be any research related injury for this study.  
The Hospital does not make any provisions to compensate study subjects for 
research related injury. However, compensation may be considered on a case-by-
case basis for unexpected injuries due to non-negligent causes 
By signing this consent form, you will not waive any of your legal rights or release 
the parties involved in this study from liability for negligence.  
WHO TO CONTACT IF YOU HAVE QUESTIONS 
If you have questions about this research study and your rights or in the case of any 
injuries during the course of this study, you may contact the Principal Investigator, 
Ms Lim Su Fee. She can be reached by mobile at (65) 81275584). 
If you have questions about the study or your rights as a participant, you can call the 
SingHealth Centralised Institutional Review Board, which is the committee that 
reviewed and approved this study, the telephone number is 6323 7515 during office 
hours (8:30 am to 5:30pm). 
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CONSENT BY RESEARCH SUBJECT 
Details of Research Study 
Protocol Title: Constipation in Patients with Stroke: Incidence, Associated Risk 
Factors and Management at a Tertiary Hospital in Singapore (Phase one study) 
Principal Investigator:     Lim Su Fee 
                                           Nursing Specialty Care 
                                           Department of Rehabilitation Medicine  
                                           Singapore General Hospital, Outram Road 
                                           Singapore 169608 
                                           Mobile (65) 81275584 
Subject’s Particulars 
Name:       NRIC No.: 
Address: 
Sex:  Female/Male     Date of birth _______________ 
                           dd/mm/yyyy                    
Race:  Chinese/ Malay/ Indian /Others (please specify)   
________________________       
Part I – to be filled by participant 
I,__________________________________(NRIC/PassportNo.________________) 
                   (Name of patient) 
agree / do not agree to participate in the research study as described and on the 
terms set out in the Patient Information Sheet. The nature of my participation in the 
proposed research study has been explained to me in   
_______________________ by Dr/Mr/Ms ______________________________  
       (Language / Dialect)                                        (Name of healthcare worker) 
I have fully discussed and understood the purpose and procedures of this study. I 
have been given the Participant Information Sheet and the opportunity to ask 
questions about this study and have received satisfactory answers and information.  
I understand that my participation is voluntary and that I am free to withdraw at any 
time, without giving any reasons and without my medical care being affected.  
I also give permission for information in my medical records to be used for 
research. In any event of publication, I understand that this information will not 
bear my name or other identifiers and that due care will be taken to preserve the 
confidentiality of this information. 
 
____________________________________     __ ______________________ 
[Signature/Thumbprint (Right / Left) of participant]           (Date of signing) 
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Part II – to be filled by parent / legal guardian, where applicable 
 
I, ___________________________ hereby give consent for the above participant to     
(parent / legal guardian)  
participate in the proposed research study.  The nature, risks and benefits of the 
study have been explained clearly to me and I fully understand them. 
 
   
________________________________                               ___________________ 
[Signature/Thumbprint (Right / Left) of parent /legal guardian]       (Date of signing) 
 
Part III – to be filled by witness, where applicable 
 
An impartial witness should be present during the entire informed consent 
discussion if a subject or the subject’s legally acceptable representative is unable to 
read. After the written informed consent form and any written information to be 
provided to subjects, is read and explained to the subject or the subject’s legally 
acceptable representative, and after the subject or the subject’s legally representative 
has orally consented to the subject’s participation in the study and, if capable of 
doing so, has signed and personally dated the consent form, the witness should sign 
and personally date the consent form.  
 
Witnessed by:______________________       ______________________ 
                               (Name of witness)             (Designation of witness) 
 
 
_________________________        ________________________ 
(Signature of witness)  (Date of signing) 
   
Part IV– Investigator’s Statement 
 I, the undersigned, certify to the best of my knowledge that the patient/patient’s 
legally acceptable representative signing this informed consent form had the study 
fully explained and clearly understands the nature, risks and benefits of his/her / his 
ward’s / her ward’s participation in the study. 
 
________________________ ______________________ 















Phase 1 Data Collection Form: Symptoms of Constipation 






























Defecate                              
Straining during defecations                             
Lumpy or hard stools in defecations                             
Sensation of incomplete evacuations                               
Sensation of anorectal 
obstructions/blockage   
                            
Requires manual maneuvers to facilitate 
defecations 
                            
Loose stools are present                              
Use of laxatives               
Pain or discomfort during defecation                             
Devices used for defecation                             
Difficulty in defecating with the device 
stated above                             
Use of self-treatment for defecations                             
Tick (√ ) as appropriate               
Legends               
D-Diaper               
BP-Bedpan               
BC - Bedside Commode               




















Education Poster/Bookmark  











Bowel Management Programme Checklist 
 
Bowel Management Programme Checklist
Date of Assessment:
Affix patient data sticker here    Ward: 
    Bed: 
    Sex :    Male   Female
    Race:   Chinese   Malay   Indian  Others
Inclusion criteria    
(to be completed by investigator) Tick 
Exclusion criteria  
(to be completed by investigator)                                                                          Tick 
▪ Admitted for stroke  ▪ Patients who are on DIL 
▪ Age 18 years old and above  ▪ Patients who are unable to communicate 
▪ No previous history of bowel dysfunction 
▪ Patients who are on fluid restriction < 800 
mls 
▪ Recruit within 24 hours of Admission 
Recruit patient if ALL  of the above criteria 
are met
Exlcude patient if ANY  of the above criteria 
are met
Prophylactic Laxatives 
(to be completed by doctor) Tick 
Oral Fluids  
(to be completed by doctor) Tick 
▪ Not allergic to laxatives  ▪ Not on NBM 
▪ No contraindications to laxatives  ▪ Not on Fluid restrictions of ≤800mls 
Doctor to prescribe prophylactive laxatives if 
ALL of the above criteria are met
Schedule oral fluids ≥ 800 mls per day if ALL 
of the above criteria are met
One or combination of the following two or 
three laxatives can be prescribed
▪ Forlax  ▪ Oral Fluids  ≥ 800 mls per day 
▪ Lactulose  




(to be completed by nurse in-charge) Tick 
Education Protocol 
(to be completed by investigator) Tick 
▪ Not on CRIB  ▪ 1st session: Information Providing 
▪ Able to transfer safely with / without 
assistance  ▪ 2nd session: Q&A 
Provide commode  / bring to toilet if ALL  of 
the above criteria are met
Choose either one or both 
▪ Commode 
▪ Toilet 
Please note: To reassess patient and insert updated sheet if there is a change in patient's health  status
Study Title: Constipation in Patients with Stroke: Incidence, Associated Risk Factors and 






Phase 2 Eligibility Check Form 
 
Phase 2 Study: Eligibility Check Form  Tick (√) as 
appropriate 
Inclusion Criteria 
 ≥ 21 years old 
 
Admitted within 24 hours  
 
Able to communicate 
 
New onset of stroke confirmed by CT scan or MRI  
 
Exclusion Criteria 
No prior history of gastrointestinal dysfunctions including 
constipation, faecal incontinence, pathological diseases or cancer 
of the rectum or colon 
 
Not on dangerously ill list 
 
Not on fluid restriction < 800 ml 
 
 















Phase 2 Patient Information Sheet and Informed Consent 
 
                               
                           PARTICIPANT INFORMATION SHEET 
 
You are being invited to participate in a research study. 
Before you take part in this research study, the study must be explained to you and 
you must be given the chance to ask questions. Please read carefully the 
information provided here. If you agree to participate, please sign the informed 
consent form. You will be given a copy of this document to take home with you. 
STUDY INFORMATION 
Protocol Title: Constipation in Patients with Stroke: Incidence, Associated Risk 
Factors and Management at a Tertiary Hospital in Singapore (Phase Two) 
Principal Investigator(s): Lim Su Fee 
                                           Nursing Specialty Care 
                                           Department of Rehabilitation Medicine  
                                           Singapore General Hospital, Outram Road 
                                           Singapore 169608 
                                           Mobile (65) 81275584 
Sponsor: Ministry of Health Nursing Research Committee 
PURPOSE OF THE RESEARCH STUDY 
You are being invited to participate in a research study of constipation in patients 
with stroke. We hope to learn about the feasibility of a new bowel management 
programme. 
You are selected as a possible subject in this study because you are currently 
undergoing treatment at Singapore General Hospital. 
Constipation is one of the most common complications in patients after stroke. It 
not only causes discomfort but can also affect a person’s physical and 
psychological well-being. Its prevention is essential in ensuring a successful stroke 
rehabilitation outcome.  
This study is part of a two-phase study which aims to investigate constipation in 
stroke patients with a focus on the followings: 
1. incidence of constipation in stroke versus non stroke at 4 weeks (Phase 1a) 
2. risk factors associated with the incidence of constipation in stroke (Phase 
1b) 
3. feasibility of a new bowel management  programme in reducing the 
incidence of constipation (Phase 2) 





The Phase 2 study will recruit 60 subjects from Singapore General Hospital over a 
period of 4 months. 
STUDY PROCEDURES AND VISIT SCHEDULE 
If you agree to take part in this study, your treatment plan will include a bowel 
management programme. This bowel management programme includes an 
education session and a clinical protocol.  
No additional imaging or blood tests will be added on top of the standard treatment 
usually provided by this hospital. Your participation in the study will last till the 
day of your discharge or at 4 weeks (whichever is earlier). 
Schedule of visits and procedures:  
If you agree to take part, the following will happen to you 
Visit 1 (at entry of study) 
Firstly, once your eligibility in the study is confirmed, a nurse will provide you an 
education session on constipation and its preventive measures.  This will take 
approximately 5 to 10 minutes of your time.  
Secondly, You will be started on the following clinical protocol: 
• You will be scheduled to drink at least 800 mls of fluids per day if 
there is no contraindication 
• You will be assessed and assisted to use the toilet or commode instead 
of bedpan for defecation if you are able to transfer safely with or 
without assistance 
• You will be assessed by a doctor for suitability of short-term 
prophylactic laxative/s. You will be prescribed short term prophylactic 
laxatives if you are deem suitable. 
Final Visit (week 2)  
A nurse will visit you and follow-up on the education provided earlier. This visit 
allows you to ask questions and provide feedback on the bowel management 
programme. This will take approximately 5 to 10 minutes of your time. 
YOUR RESPONSIBILITIES IN THIS STUDY 
If you agree to participate in this study, you should follow the instructions given to 
you by the study team. You should also inform the Principal Investigator as soon 
as possible about any side effects that you may have encountered.  
WITHDRAWAL FROM STUDY 
You are free to withdraw your consent and discontinue your participation at any 
time without prejudice to you or effect on your medical care. If you decide to stop 
taking part in this study, you should tell the Principal Investigator. 
Your doctor, the Principal Investigator and/or the Sponsor of this study may stop 
your participation in the study at any time for one or more of the following 
reasons: 





 Unanticipated circumstances. 
WHAT IS NOT STANDARD CARE OR EXPERIMENTAL IN THIS 
STUDY 
The study is being conducted because the incidence of constipation after stroke is 
high and we have developed a new bowel management programme for the purpose 
of preventing constipation.  We hope that your participation will help us determine 
the feasibility of this new bowel management programme. The findings of this 
research study will help us decide on the start of this new bowel management 
protocol in managing constipation in patients with stroke. 
In this study, the education session on constipation by the nurse and the clinical 
protocol are implemented for the purposes of this research, and not part of your 
routine care. 
POSSIBLE RISKS, DISCOMFORTS AND INCONVENIENCES 
The possible risks in this study are minimal. It may cause some inconveniences to 
some subjects as the educational session and feedback session will require some of 
the subjects’ time. In some rare instances, some subjects may experience 
abdominal discomfort, nausea, vomiting or loose stool after taking the prophylactic 
laxative/s. The prophylactic laxative/s will be discontinued if that occurs. 
POTENTIAL BENEFITS 
If you participate in this study you may reasonably expect to benefit from the study 
in the following way:  
• You will receive an education session on what is constipation and its 
preventive measures at no extra cost 
• Your likelihood of developing constipation may be reduced  
ALTERNATIVES 
 If you choose not to take part in this study, the alternative is to have what is 
considered standard care for your condition.  
SUBJECT’S RIGHTS  
Your participation in this study is entirely voluntary. Your questions will be 
answered clearly and to your satisfaction.  
In the event of any new information becoming available that may be relevant to 
your willingness to continue in this study, you or your legal representative will be 
informed in a timely manner by the Principal Investigator or his/her representative. 
By signing and participating in the study, you do not waive any of your legal rights 
to revoke your consent and withdraw from the study at any time. 
CONFIDENTIALITY OF STUDY AND MEDICAL RECORDS 
Information collected for this study will be kept confidential. Your records, to the 




Only your Investigator(s) will have access to the confidential information being 
collected. 
However, the Sponsoring company (Ministry of Health Nursing Research 
Committee), Regulatory Agencies, Institution Review Board and Ministry of 
Health will be granted direct access to your original medical records to check study 
procedures and data, without making any of your information public. By signing 
the Informed Consent Form attached, you or your legal representative is 
authorizing such access to your study and medical records. 
Data collected and entered into the (Case Report Form(s) or Data Collection 
Form(s)) are the property of the Institution. In the event of any publication 
regarding this study, your identity will remain confidential. 
COSTS OF PARTICIPATION 
Not Applicable 
RESEARCH RELATED INJURY AND COMPENSATION 
The Hospital does not make any provisions to compensate study subjects for 
research related injury. However, compensation may be considered on a case-by-
case basis for unexpected injuries due to non-negligent causes. 
By signing this consent form, you will not waive any of your legal rights or release 
the parties involved in this study from liability for negligence.  
WHO TO CONTACT IF YOU HAVE QUESTIONS 
If you have questions about this research study and your rights or in the case of any 
injuries during the course of this study, you may contact the Principal Investigator 
(Ms Lim Su Fee. She can be reached by mobile at (65) 81275584). 
If you have questions about the study or your rights as a participant, you can call 
the SingHealth Centralised Institutional Review Board, which is the committee 
that reviewed and approved this study, the telephone number is 6323 7515 during 














CONSENT BY RESEARCH SUBJECT 
Details of Research Study 
Protocol Title: Constipation in Patients with Stroke: Incidence, Associated Risk 
Factors and Management at a Tertiary Hospital in Singapore (Phase Two) 
Principal Investigator: 
                                           Lim Su Fee 
                                           Nurse Clinician Specialty Care 
                                           Department of Rehabilitation Medicine  
                                           Singapore General Hospital, Outram Road 
                                           Singapore 169608 
                                           Mobile (65) 81275584 
Subject’s Particulars 
Name:     NRIC No.: 
Address: 
Sex:  Female/Male    Date of birth   _______________ 
                  dd/mm/yyyy                     
Race:  Chinese/ Malay/ Indian /Others (please specify)   
________________________       
Part I  
 
I,_____________________________________(NRIC/PassportNo._____________) 
                   (Name of patient) 
agree to participate in the research study as described and on the terms set out in the 
Patient Information Sheet. The nature of my participation in the proposed research 
study has been explained to me in   
 
_______________________ by Dr/Mr/Ms ______________________________  
       (Language / Dialect)                                        (Name of healthcare worker) 
 
I have fully discussed and understood the purpose and procedures of this study. I 
have been given the Participant Information Sheet and the opportunity to ask 
questions about this study and have received satisfactory answers and information.  
 
I understand that my participation is voluntary and that I am free to withdraw at any 
time, without giving any reasons and without my medical care being affected.  
 
I also give permission for information in my medical records to be used for research. 
In any event of publication, I understand that this information will not bear my name 
or other identifiers and that due care will be taken to preserve the confidentiality of 
this information. 
 
___________________________                           ________________________ 





Part II – to be filled by parent / legal guardian / legal representative, where 
applicable 
 
I, _______________ hereby give consent for the above participant to participate in  
        (parent / legal guardian) 
the proposed research study.  The nature, risks and benefits of the study have been 
explained clearly to me and I fully understand them. 
   
 
___________________________                           ___________________ 
  [Signature/Thumbprint (Right / Left) of parent /legal guardian]     (Date of signing) 
 
Part III – to be filled witness, where applicable 
 
An impartial witness should be present during the entire informed consent 
discussion if a subject or the subject’s legally acceptable representative is unable to 
read. After the written informed consent form and any written information to be 
provided to subjects, is read and explained to the subject or the subject’s legally 
acceptable representative, and after the subject or the subject’s legally representative 
has orally consented to the subject’s participation in the study and, if capable of 
doing so, has signed and personally dated the consent form, the witness should sign 
and personally date the consent form.  
 
Witnessed by: _____________________        ________________________ 
 (Name of witness)                      (Designation of witness) 
 
 
 ____________________        ________________________ 
                          (Signature of witness)                 (Date of signing) 
   
Part IV– Investigator’s Statement 
 I, the undersigned, certify to the best of my knowledge that the patient/patient’s 
legally acceptable representative signing this informed consent form had the study 
fully explained and clearly understands the nature, risks and benefits of his/her / his 
ward’s / her ward’s participation in the study. 
 
____________________________        _________________  












Phase 2 Data Collection Form: Symptoms of Constipation 



























Use of self 
treatment for 
defecations
































(√) Tick as appropriate 




Phase 2 Data Collection Form: Demographics and Baseline 
Characteristics 
 
Time from Stroke Onset 
1. Date of admission: ___________________(DD/MM/YY) 
2. Date of recruitment to research: ________________(DD/MM/YY) 
3. Date of discharge: _______________________(DD/MM/YY) 
 
Stroke Diagnosis 
1. Ischaemic Stroke,  please specify diagnosis________________________ 




Please circle or write the answer/answers for each question. 
1. Age     ________ 
 
2. Gender 
1. Male    
2. Female  
 
3. Race      : 
1. Chinese   
2. Malay 
3.   Indian    
4.  Others, please specify:________________  
 
4. Educational level 
 1. Degree  
2. Diploma 
 3. Secondary   
4. Primary 
5. None    
6. Others, please specify:___________________ 
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5. Medical History 
1. Diabetes  
2. Heart Disease 
3. Stroke 
4. Others, please specify____________________ 
 
Fluid Intake 
6. How much fluid do you usually drink per day for the past 3 months? 
________________(e.g 8 glasses) 
 
Bowel History 
7.  Is your bowel habit regular for the past 3 months? 
            1. Yes 
a. Daily 
b. Every Other Day 
c. Twice per week 
d. Others please specify _______________________ 
2. No 
 
Clinical Assessment Data 
8. National Institute of Health Stroke Scale (NIHSS) score  _________ 
9. Glasgow Coma Scale score ________________ 
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Appendix 17  
Publications 
 
1. Lim, S. F., & Childs, C. (2011). Effectiveness of Non-Surgical 
Management Strategies for Constipation in Adults with Stroke: A 
Systematic Review. JBI Library of Systematic Reviews, 9(64), 2875 - 
2914.  
 
2. Lim, S. F., & Childs, C. (2013). A systematic review of the 
effectiveness of bowel management strategies for constipation in adults 
with stroke. International Journal of Nursing Studies, 50(7), 1004-











































List of Local Conference Presentations 
 
Local Conference Presentations  
Title Venue Date 
Oral Presentation 
Constipation in Adults with Stroke. 





Constipation in Patients with Stroke: Incidence, 
Associated Risk Factors and Management at a 







Constipation in Patients with Stroke: Incidence, 
Associated Risk Factors and Management at a 
Tertiary Hospital in Singapore. 





Constipation in Patients with Stroke: Incidence, 
Associated Risk Factors and Management at a 
Tertiary Hospital in Singapore. 
East Asian Forum for 




Constipation in Patients with Stroke: Incidence, 
Associated Risk Factors and Management at a 
Tertiary Hospital in Singapore. 






A Prospective Study of Constipation in Patients 
with Stroke versus non-stroke at a Tertiary 






Effectiveness of Non-Surgical Management 
Strategies for Constipation in Adults with 







Effectiveness of Non-Surgical Management 
Strategies for Constipation in Adults with 
Stroke: A Systematic Review 






Incidence and predictors of new-onset 
constipation during hospitalisation in patients 
with stroke versus orthopedic conditions: A 
propsective cohort study. 






Incidence and predictors of new-onset 
constipation during hospitalisation in patients 
with stroke versus orthopedic conditions: A 
prospective cohort study. 
 
 
20th SGH Annual 
Scientific Meeting, 
Singapore. 
Won Best Poster for 
Clinical Research 
(Nursing). 










List of Overseas Conference Presentations 
 
Overseas Conference Presentations 
Oral Presentations 
Title Venue Date 
Effectiveness of Non-Surgical 
Management Strategies for 
Constipation in Adults with Stroke: A 
Systematic Review. 
 
The 3rd International 
Nursing Student Forum at 
Khon Kaen, Thailand. 
 






Constipation in Patients with Stroke: 
Incidence, Associated Risk Factors 
and Management at a Tertiary 
Hospital in Singapore. 
U21 Nursing Doctoral 





Incidence and predictors of new-onset 
constipation in patients with stroke 
versus non-stroke at a large tertiary 
hospital in Singapore. 




21 to 22 
February 
2013 
Incidence and Predictors of 
Constipation in Patients with Stroke 





Research: A Step Towards 
World Class University at 
Chulalongkorn University, 
Bangkok, Thailand. 






















Invited Speaker at Local and Overseas Conferences 
 
Lecture Title Conference Title and Venue Year  
Neurorehabilitation – Nursing Perspective. 
 
Plenary Speaker 
8th Asian Congress of Neurological 
Surgeons 
Kuala Lumper, Malaysia. 
22 to 24 
November 
2010 
Neurorehabilitation for Traumatic Brain Injured 





Kuala Lumper, Malaysia. 
 
7 to 9 
December 
2011 
Rehabilitation Nursing : More Than Just Nursing 














26th Annual Scientific Meeting 






A Nurse-led Evidence-based Practice: Caregiver 
Training At A Large Tertiary Hospital in 
Singapore. 
Plenary Speaker 
9th Asian Congress of Neurological 
Surgeons 
Istanbul, Turkey. 
2 to 5 
September 
2012 









A Nurse-led Initiative in Managing Constipation 
in Patients with Stroke in a Large Tertiary 
Hospital. 
Plenary Speaker 
2nd Singapore Rehabilitation 
Conference, Singapore. 
27 to 28 
February 
2013 
Overview Of Neurorehabilitation in Singapore 
The First Step To Evidence-Based Practice In 
Neurosciences. 
The Effect Of Bedside Clinical Teaching For 
Nurses By Nurses. 
Life After A Head Trauma - Assessment Of 
Cognitive Function In Neuro Rehabilitation. 
Plenary Speaker 
13th Annual Scientific Meeting of 
Neurosurgical Association of 
Malaysia 
Kuala Lumpur, Malaysia. 
6 to 7 July 
2013 
The Expert Panel: Rehabilitation Research in 
Singapore – Past, Present and Future. 
Expert Discussion Panelist 
3rd Singapore Rehabilitation 
Conference, Singapore. 
27 to 29 
March 
2014 
Oral Presentation Session. 
 
Oral Paper Judge 
3rd Singapore Rehabilitation 
Conference, Singapore. 
27 to 29 
March 
2014 
Education in Rehabilitation: 
Rehabilitation Nursing – The Age of The APN. 
Symposium Speaker 
3rd Singapore Rehabilitation 
Conference, Singapore. 








List of Overseas Attachment 
 
Visiting Venues 
1. Durham Veterans Affairs Medical Centre, North Carolina, USA. 
2. Duke University School of Nursing. 
 
Date of Visiting 












List of Awards Received 
 
1. Name of Award 
Best Oral Presentation  
 
Event and Awarding Body 
The 3rd International Nursing Student Forum, Khon Kaen University, 
Khon Kaen, Thailand 
 
Title of Presentation 
Effectiveness of Non-Surgical Management Strategies for Constipation in 
Adults with Stroke: A Systematic Review 
 
Date of Event 
20 May 2011 
 
 
2. Name of Award 
Best Poster for Clinical Research (Nursing) 
 
Event and Awarding Body 
      20th Singapore General Hospital Annual Scientific Meeting, Singapore 
 
Title of Presentation 
Incidence and Predictors of New-Onset Constipation During 
Hospitalisation in Patients with Stroke Versus Orthopedic Conditions: A 
Prospective Cohort Study 
 
Date of Event 
5 April, 2013 
 
